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Abstract
This thesis combines comprehensive microarray-based studies contributing to 
a better understanding of the role of bifidobacteria in relation to the human host. 
It reviews recently described modes of interaction between bifidobacteria and 
human gastrointestinal cells and highlights the unique characteristics of the genus 
Bifidobacterium that are indicative for its role in our gut. A microarray platform has 
been developed that enables genomic comparison of Bifidobacterium species 
originating from our gastrointestinal tract (GIT). Based on the obtained high-
resolution data, species-unique genomic sequences could be identified. A large 
fraction of these predicted genes encode proteins belonging to the bifidobacterial 
glycobiome.  An unique ability of the microarray platform is to zoom in on the strain 
level. Direct mapping of genomic hybridization patterns was applied on different 
B. breve isolates. This revealed a relatively high genomic variation, testifying for 
the existence of various subspecies within the species B. breve. Clustering of the 
same hybridization patterns resulted in clear grouping of isolates originating from 
the same infant, indicating specific niche adaption. Additionally, DNA extracts from 
Bifidobacterium populations from different infant fecal samples were analyzed. 
This enabled the analysis of the bifidobacterial population dynamics in breast- and 
formula-fed infants. The applied microarray platform showed the potential to monitor 
temporal development and effects of dietary regimens. The observed differences 
in the composition of bifidobacterial populations could be linked to dietary effects. 
Additionally, mapping of hybridization patterns enabled monitoring shifts in genomic 
content within one bifidobacterial species in time. Sequence analysis of DNA 
fragments showing discriminating hybridization characteristics, resulted in the 
selection of genes that are either conserved or strain-specific within the species B. 
breve. Next to studying genomic variation, transcript profiling experiments in both 
bifidobacterial cells and human intestinal epithelial cell lines were performed. Analysis 
of bifidobacterial transcriptional responses provided clear proof of transcriptional 
activity in bifidobacterial cells isolated from infant feces. To the best of our knowledge, 
this is the first demonstration of in situ activity of bifidobacteria in the human GIT. 
Furthermore, our results indicate a link between transcription patterns and the infants’ 
diet, as bifidobacteria in fecal samples from breast-fed infants showed differential 
transcriptional responses in comparison to those in fecal samples from formula-fed 
infants. Additionally, transcript sequence analysis revealed expression of genes that 
are homologous to genes known to be involved in folate production, testifying for 
the production of this important vitamin in early life. Finally, transcriptome analysis 
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on human intestinal epithelial cells (HIECs) showed species-specific suppression by 
B. breve M-16V of genes upregulated by TNF-α. Other B. breve strains showed an 
extreme mild or no effect on TNF-α stimulation. Although we did not observe complete 
suppression of the TNF effect, we could show that apoptotic and immune regulatory 
pathways were affected by incubation with cells of B. breve M-16V. In conclusion, the 
work presented in the thesis, which formed part of a larger IOP Genomics project, 
contributed to an advanced insight in the interaction between bifidobacteria and the 
human host. Furthermore, it resulted in the development of genome-based molecular 
platforms suited for analyzing genomic diversity between and within species, as well 
as population dynamics in complex microbial communities. We anticipate that the 
molecular approaches pioneered in this thesis will be instrumental in the further 
elucidation of the host-microbe interactions in the GIT of human an other animals.
Keywords: Bifidobacterium, microarray, comparative genome hybridization, 
Bifidobacterium – cell line interaction, transcriptomics
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Aim and outline of the thesis
Since the day of birth, our body is subjected to a world full of microbes. Some will 
colonize our intestinal tract and are collectively known as microbiota. A growing 
body of scientific evidence supports a link between our intestinal microbiota and 
health status. This has caused significant interest in the host interactions of our 
commensal microbiota. Various studies have predicted an important role of the 
human commensal bacteria from the genus Bifidobacterium in the development of 
the human intestinal microbiota. Furthermore, bifidobacteria are abundant intestinal 
inhabitants throughout our entire healthy life. The present genomics era has led to 
a rapidly growing set of global and high resolution molecular tools that have been 
instrumental in advancing our understanding of complex biological processes. This 
thesis describes research that started as an IOP Genomics project on applying these 
genomics approaches to study the interplay between bifidobacteria and the human 
host. It describes microarray-based molecular techniques that revealed significant 
insight in the development, divergence and activity of Bifidobacterium populations in 
the intestinal tract and their interactions with human intestinal epithelial cells.
Chapter 1 provides an overview of the specific characteristics of bifidobacteria 
and lactobacilli, focusing on the interplay with the human host cells. Based on recent 
omics-based developments, it reviews the scientific findings on host─microbe 
interactions. Moreover, is presents a basis for defining the complete set of interacting 
components, collectively known as the interactome.
The construction and application of the Bifidobacterium mixed-species 
(BMS) microarray was described in Chapter 2. DNA fragments originating from 
Bifidobacterium species mostly found in the human intestinal tract, were arrayed 
on a glass slide. The goal of this work was to design a tool that enables detailed 
genome analysis of Bifidobacterium species without the need of unraveling their 
whole genome sequence first. The BMS-array served as a high-resolution diagnostic 
tool that facilitated the detection of strain- and species-specific characteristics of 
bifidobacteria. Moreover, its application to cognate Bifidobacterium spp. revealed 
this genus to contain species-specific diagnostic nucleotide sequences that are 
mainly predicted to code for its complex glycobiome next to functions involved in 
DNA metabolism.
A comprehensive analysis of 20 infant fecal isolates of Bifidobacterium breve by 
comparative genome hybridization using the BMS-array is presented in Chapter 
3. The study should provide information about the applicability of the microarray 
platform as a tool for extensive genome comparison of isolates within one species 
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of bifidobacteria. A high degree of genomic variation between the isolates derived 
from different infants was revealed, testifying for the existence of various subspecies 
within the species.
A further application of the BMS-microarray platform is discussed in Chapter 4. 
The objective of the presented experiment was to test the usability of this approach 
for the screening of complex microbial samples. A proof-of-principle study was 
performed to address the composition and development of bifidobacterial populations 
in fecal samples, based on extracted DNA. The samples were collected periodically 
over a period of two years since birth and derived from infants that were breast-fed, 
standard formula-fed or received a prebiotic formula during their weaning period. 
Bifidobacterium population analyses were performed by direct mapping of genomic 
hybridization patterns. This study shows that the described platform can be used 
for comparative genome hybridizations and serves as a culture-independent tool to 
analyze the dynamics of Bifidobacterium populations. It was not necessary to enrich 
the DNA samples for bifidobacterial DNA, obviating the need for PCR amplification 
that may introduce errors. The obtained high-resolution data enabled us to zoom 
in at the species and strain level, revealing an obvious link between diet and 
Bifidobacterium populations.
Next to genomic comparisons, the BMS-microarray was also applied in 
determining the transcriptional responses of bifidobacteria in breast- and formula-
fed human infants (Chapter 5). The goal of this work was to increase insight in the 
bifidobacterial molecular processes in relation to our diet. Total RNA was extracted 
from rapidly processed infant fecal samples. The obtained RNA samples were 
labeled and hybridized on the BMS microarray in order to analyze differences in 
bifidobacterial gene expression. A selection of approximately 270 clones that showed 
the most prominent hybridization with the extracted mRNA were further analyzed. 
The largest fraction (14%) was predicted to be involved in carbohydrate metabolism. 
This study showed a significant impact of diet on the transcriptional responses of 
bifidobacteria in breast- and formula-fed infants.
To accommodate gain of insight in the molecular basis for intestinal host─microbe 
interactions was the aim of the study described in Chapter 6. The genome-wide 
transcriptional response of human epithelial intestinal cells exposed to cells of B. 
breve was determined. To select an appropriate test system reflecting inflammatory 
conditions, the responsiveness to TNF-α was compared of T84, Caco-2 and HT-29 
human intestinal epithelial cell lines. The highest TNF-α response was observed in 
HT-29 cells and this cell line was selected for exposure to the B. breve strains M-16V, 
NR246 and UCC2003. Transcriptome analysis of the exposed HT-29 cells indicated 
that B. breve strains modulate gene expression under inflammatory conditions in a 
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strain-specific manner.
Finally, Chapter 7 provides a summary and general discussion of the work 
presented in this thesis. The correlation between bifidobacteria and human health 
is discussed. Furthermore, it focuses on the applicability of the BMS-microarray 
platform and its potential future role in research on the intriguing interaction of 
microbe and host.
Thesis-Rolf-v3.indd   11 2-1-2011   23:33:04
Thesis-Rolf-v3.indd   12 2-1-2011   23:33:04
Chapter 1
Interactomics in the Human Intestine – Lactobacilli and 
Bifidobacteria Make a Difference
Rolf J. Boesten and Willem M. de Vos
Scientific evidence that supports a correlation between our intestinal microbiota and 
health status has caused significant interest in microbe─host interaction studies. 
It has generated a paradigm shift from analyzing pathogens to that involving com-
mensal and probiotic bacteria. This review summarizes the interaction mechanisms 
described for lactobacilli and bifidobacteria based on recent omics-based develop-
ments. This information is expected to provide new avenues for further unravelling 
the set of interactions that includes the interactome of microbial and host cells.
Journal for Clinical Gastroenterology, 2008, 42, Supp.3, Part2; S163-167
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INTROduCTION
The microbial world within us includes an astonishing array of intestinal microbes, 
collectively known as microbiota, consisting of more than 1000 species and 
dominated by gram-positive bacteria (Eckburg et al., 2005; Rajilic-Stojanovic et al., 
2007; Zoetendal et al., 2006). The dynamics of this microbial diversity in time and 
space has attracted considerable attention and confirmed earlier notions that the 
density and architecture of the microbial communities differ at the various locations 
in the intestinal tract. The effect of the microbiota on the intestinal tract is underlined 
by its important and specific metabolic, trophic, and protective functions (Guarner 
and Malagelada, 2003). Most notable differences in the microbiota are found when 
the ileum and colon are considered, where there are large differences in intestinal 
anatomy, nutrient processing and food transit time (see Fig.1). Recent molecular 
sequence-based observations indicate that the human host is colonized by a 
core group of microbes that show significant stability in time and are likely to have 
specific interactions with the human host and other microbes (Rajilic-Stojanovic et 
al., 2007). Some of these interactions have been studied at the molecular level in 
mammalian model systems, notably in germ-free mice colonized by Bacteroides 
thetaiomatmicron (Hooper et al., 2002; Sonnenburg et al., 2005; Sonnenburg et 
al., 2006). Bacteroides spp. are abundant gram-negative intestinal commensals 
that in some cases are also pathogens in animal species, including human. These 
developments extended the paradigm of pathogen-host interactions and focus the 
interest on commensal bacteria that have developed symbiosis in the intestinal 
tract (Dethlefsen et al., 2007). Specific attention has been given to Lactobacillus 
and Bifidobacterium spp., notably the species that are among the first colonizers 
of the human intestinal tract (Favier et al., 2002; Heilig et al., 2002). Their location, 
abundance and genomic potential of these gram-positive bacteria differs markedly, 
with lactobacilli predominantly present in the ileum and bifidobacteria in the colon 
(see Fig. 1). Hence it is of significant interest to compare and contrast the rapidly 
accumulating information on the molecular details of their interaction with the human 
host and other microbes. This is done here from an -omics perspective as it provides 
the basis for unravelling the complete set of host─microbe interactions that includes 
all interacting components, collectively known as the interactome.
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The LactobaciLLus INTeRaCTOMe
The impact of Lactobacillus spp. on the human host has received considerabe 
attention, notably as many of their genomes have been determined and some strains 
are marketed as probiotics (De Vos et al., 2004; Saxelin et al., 2005). It is known that 
lactobacilli are notably prevalent in the human ileum but their abundance has been 
overestimated (Vaughan et al., 2005). This has been recently confirmed in molecular 
diversity studies that also showed recovery from the colonic mucosa (Heilig et 
al., 2002; Zoetendal et al., 2002). Hence, the present picture of the Lactobacillus 
interactome that is visualized here in the ileum, is necessarily an oversimplification, 
which – as all schematic representations – needs to be interpreted with care (Fig. 
1). 
 Predictions based on the complete genome sequence of L. plantarum, the first 
Lactobacillus spp. analyzed at the genomic level, confirm the significant interaction 
with the environment as evidenced by the panoply of secreted proteins and two-
component sensory transduction systems (Kleerebezem et al., 2003). Subsequent 
genomic analysis of other intestinal and probiotic lactobacilli confirmed this specifc 
Figure 1. Schematic overview of the interactions between Lactobacillus spp. and the human ileum (left) 
and Bifidobacterium spp. and the human colon (right). For a further explanation see text.
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environmental interactions (Klaenhammer et al., 2005; Makarova et al., 2006; van 
Pijkeren et al., 2006). These and other genetic studies also reinforced the metabolic 
interactions that include the production of folic acid and pseudovitamin B12, a B12 
derivative, that are encoded by specific gene clusters in L. plantarum and L. reuteri, 
respectively (Santos et al., 2008; Wegkamp et al., 2004). 
The annotation of more than a dozen Lactobacillus genomes resulted in the 
identification of various sets of secreted proteins that are predicted to interact with 
human compounds, including extracellular matrix (ECM) proteins and mucus. The 
majority of these includes secreted proteins with a likely structural function that are 
retained at the cell envelope via covalent interactions effected by the sortase enzyme 
or mainly electrostatic interactions, such as the S-layer proteins (Avall-Jääskeläinen 
and Palva, 2005; Marraffini et al., 2006). However, none of the predicted interactions 
of these Lactobacillus proteins has been experimentally determined, apart from that 
of a widely distributed mucus binding proteins (Boekhorst et al., 2006). Recently, 
however, several sortase substrates have been found to specifically interact with the 
human host. A mannose-specific adhesion was identified in L. plantarum that binds 
to the mannose residues that decorate human glycoproteins (Pretzer et al., 2005). 
As these are also receptors for various pathogens, such as enterotoxic Escherichia 
coli (ETEC), this may form the molecular basis for competitive exclusion, one of the 
probiotic mechanisms. Moreover, recent evidence also indicates specific signalling 
of a L. plantarum sortase substrate and L. acidophilus S-layer with the DC-SIGN 
receptor of dendritic cells (DC) that are abundant in the ileum (Konstantinov et 
al., 2008; Marco et al., 2006). The observation that sortase substrates play an 
important role in the Lactobacillus-host interactome stems from observations in their 
expression in human and mouse models that also pointed to the involvement in 
the intestinal persistence of a L. plantarum gene for a sortase substrate (Bron et 
al., 2007). A last specific interaction that has been described recently, includes the 
signalling of specifically decorated lipotechoic acids (LTA) of L. plantarum to TLR2, 
one of the Toll-like receptors (TLRs) that enable the immunosensory cells of the 
host to discriminate between pathogen and commensal (O’Hara et al., 2006). It has 
been observed that reducing the incorporation of D-alanine in the L. plantarum LTA 
changes the response of colonized conventional mice from pro-inflammatory to anti-
inflammatory (Grangette et al., 2005). 
The transcriptome analysis of Lactobacillus spp. also allowed for further detailing 
the metabolic interactions with substrates and other microbes. Some lactobacilli can 
utilize oligosaccharides including those not metabolized by human, such as. fructo-
oligosaccharides (FOS). Lactobacillus acidophilus was found utiliuze FOS by inducing 
the transcription of a specific transport and degradation system (Barrangou et al., 
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2007). These data are compatible with the possibility that at least some lactobacilli 
have metabolic functions in the colon where most non-digestable oligosaccharides 
are thought to be accumulating.
Post-genomic studies also provided insight in the quorum sensing systems that 
in gram-positive bacteria involve specific communication peptides. These sensing 
systems provide a coordinated response at high cell densities that result in specific 
survival strategies. Reports of multiple quorum sensing systems found in intestinal 
lactobacilli underline the importance of intercellular communication and its ecological 
impact as many are involved in the production of bacteriocins or other anti-microbial 
peptides (AMP) (Sturme et al., 2002). Experimental evidence for the impact of a L. 
salivarius bacteriocin on Listeria monocytogenes was recently established in a mouse 
model and if applicable to human, may constitute another probiotic mechanism (Corr 
et al., 2007). In L. plantarum, a quorum sensing system was recently discovered 
that is involved in the production of a novel cyclic peptide that appears to control 
exopolysaccharide (EPS) production and hence the cell surface properties that 
affected biofilm formation and adhesion to surfaces (Sturme et al., 2005). 
The bifidobacterium INTeRaCTOMe
Members of the genus Bifidobacterium are numerically abundant commensals that 
populate the human intestinal tract since birth. Next to their ability to produce a variety 
of vitamins, degrade a multitude of milk, mucus and other dietary oligosaccharides, 
the described immune modulating and adhesion capacities testify for a specialization 
of bifidobacteria to a symbiotic relationship with the human host as is discussed 
below (Fig. 1).
With the exception of species isolated from human dental caries, sewage or 
insects, the majority of Bifidobacterium spp. are found in the mammalian intestinal 
tract. Bifidobacteria are known to be host-specific and studies in the human intestinal 
tract have shown a temporal development of the major species that include B. 
adolescentis, B. bifidum, B. breve, B. catenulatum,  B. longum (Ventura et al., 2004). 
While dominant in early life, culture-dependent methods showed bifidobacteria to 
comprise up to 10% of the human adult intestinal microbiota but latest molecular 
estimations show lower numbers but this partly is due to the discovery of new and 
not-yet cultured bifidobacteria (Ben-Amor et al., 2005; Klijn et al., 2005).
A major source of energy is the fermentation of non-digestible dietary residues 
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and endogenous mucus by the intestinal microbiota. Moreover, some bifidobacteria 
are specialized in degrading human milk oligosaccharides (HMO) such as B. longum 
subsp. infantis, previously known as B. infantis (Ward et al., 2006). A specific and 
dedicated degradation system for human oligosaccharides was recently discovered 
and includes a gene cluster encoding a transporter and novel hydrolase (Kitaoka et 
al., 2005). Remarkably, expression analysis in baby fecal communities established 
this gene cluster to be specifically upregulated in the intestinal tract of young 
infants that are abundantly colonized by bifidobacteria (Klaassens et al., 2009). 
Bifidobacteria can also utilize sialic acid-containing complex carbohydrates in 
mucin, glycosphingolipids, and human milk (Schell et al., 2002; Ventura et al., 2004; 
Ventura et al., 2007). Thus, the mammalian host supplies substrates for its intestinal 
commensals including bifidobacteria, in a specific symbiotic relationship, that 
includes for instance the production of a large array of essential vitamins (see Fig.1). 
Although only the genome of B. longum NCC2705 has presently been published, 
its annotation predicts complete pathways for the synthesis of folic acid, thiamine 
and nicotinate (Schell et al., 2002). However, it is likely that the analysis of other 
bifidobacterial genomes will reveal the genetic information for the synthesis of other 
relevant vitamins (Ventura et al., 2007).
 It is has been suggested that bifidobacteria owe their specific ecological success 
to their capacity to metabolize complex carbohydrates. Hence, gene clusters coding 
for complex plant-derived sugar degradation pathways are abundant in the genomes 
of B. breve and B. longum biotype longum (Ventura et al., 2007). Similarly, the first 
intestinal metatranscriptomics studies also showed that a large set of bifidobacterial 
genes that were predicted to code for sugar degradation pathways were expressed 
in the human infant gut (Klaassens et al., 2009). 
The genome sequence of B. longum and that of other bifidobacteria predicts 
the production of glycoprotein-binding fimbriae and mucus- and fibronectin-binding 
proteins that could be involved in the bacterial adhesion to the intestinal tract 
(Klaassens et al., 2009; Schell et al., 2002). Bifidobacterium adolescentis strains 
adhere to immobilized type I and type V collagens, but not to other ECM proteins, 
and its interaction involves two cell surface proteins that bind galactose chains 
by their lectin-like activity (Mukai et al., 1997). It seems that multiple adherence 
factors from the bacterial surface, including EPS, are responsible for the adhesion of 
bifidobacteria to the intestinal mucosa but no molecular data have been presented 
(Ruas-Madiedo et al., 2006).
It has been suggested that bifidobacteria provide yet another level of symbiosis 
with the host by competing with pathogens but only limited information about the 
interacting molecules is known. Some bifidobacteria have been reported to produce 
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L. monocytogenes (Moroni et al., 2006). However, molecular details are lacking 
and it appears that only a limited number of bacteriocins have been found to be 
produced by Bifidobacterium spp. (Ventura et al., 2007). Competitive binding has 
been reported between several species of Bifidobacterium spp. BL2928 and ETEC-
expressing colonization factor antigen (CFA) II, to gangliotetraosylceramice (asialo 
GMT1 or GA1), a common bacterium-binding structure (Fujiwara et al., 1997). The 
factor produced by BL2928 bacteria in the culture supernatant fluid that inhibits 
the binding of E. coli to GA1 is a >100 kD proteinaceous substance(s) that awaits 
further characterization. Furthermore, bifidobacteria have developed a mechanism 
that enables them to efficiently harvest iron, which is an essential nutrient for many 
intestinal pathogens but not for lactobacilli. This is realized by a membrane-bound 
ferrireductase, which ensures the conversion of iron from ferric to ferrous state at the 
cell surface. This biologically available form of iron is subsequently transported by a 
divalent metal permease, which requires a functioning ATPase and a proton gradient 
(Kot and Bezkorovainy, 1993).
A recent genome-based finding is the discovery of the production by B. longum 
of a human-like serine proteinase inhibitor (SERPIN) (see Fig. 1). This protein was 
shown to efficiently inhibit eukaryotic elastase-like proteases with a stoichiometry 
of inhibition close to 1 (Ivanov et al., 2006). Bifidobacteria may encounter both 
pancreatic elastase and neutrophil elastase in their natural habitat and protection 
against exogenous proteolysis may play an important role in the interaction between 
these commensal bacteria and their host. If so it is likely that the SERPIN action also 
takes place in the ileum where the human serine proteases are abundant, implying 
that bifidobacteria also colonize the ileum.
Several bifidobacteria have been found to interact with intestinal cells and 
modulate the host immune system. However, the signalling pathways have not yet 
been discovered although it is likely that similar pattern recognition receptor (PRR) 
systems operate as in the interaction with lactobacilli, including DC-SIGN and TLRs 
(Furrie et al., 2005; Hart et al., 2004). Notable TLR candidates are TLR2 and TLR9 
that react to LTA and CpG DNA, respectively. As bifidobacteria have a high G+C 
content – in contrast to the low G+C lactobacilli – the latter signalling via TLR9 is 
expected to occur. Bifidobacterium adolescentis and B. longum induced in a murine 
macrophage-like cell line, a more pro-inflammatory cytokine secretion, IL-12 and 
TNF-α,  than did B. bifidum, B. breve, and B. infantis. In contrast, B. adolescentis did 
not stimulate the production of anti-inflammatory IL-10 as the other tested bacteria 
did (He et al., 2002).
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hOST- MICROBe INTeRaCTOMICS: COMpaRe aNd CONTRaST
It is evident that there are several differences between the interaction components of 
Lactobacillus and Bifidobacterium spp. with the human host (Fig. 1). Notably, these 
relate to the differences between the proteins encoded by these important bacterial 
groups. So far no major differences are due to the colonization of different sites of 
the intestine, which is reassuring as the strict separation between ileum and colon 
is an oversimplification as explained above. There are many metabolic differences 
between lactobacilli and bifidobacteria and some of these are indicated (Fig. 1). 
However, they have in common that oligo- or polysaccharides are converted into 
lactic and acetic acid – these acids are subsequently impacting the microbiota and 
can be used, directly or indirectly by butyrate-producing bacteria.
The comparison between Lactobacillus and Bifidobacterium interaction systems 
is complex as only few comparative studies have been done, and none in human. 
Moreover, the knowledge base between the two bacterial groups is different 
as is illustrated by the fact that presently there are more than a dozen published 
Lactobacillus genomes but only a single Bifidobacterium genome. Moreover, various 
advanced studies have been carried out with Lactobacillus spp., including the 
identification of L. rhamnosus GG secreted proteins that upregulate gene expression 
via MAPK in intestinal cells (Tao et al., 2006), the global ileal transcriptome response 
to consumption of L. rhamnosus GG (Di Caro et al., 2005) or perfusion with L. 
plantarum (Troost et al., 2008). Similar molecular studies with bifidobacteria are 
lacking and only the interaction of B. longum and germ-free mice has been reported 
(Sonnenburg et al., 2006). However, the interest in bifidobacteria is expanding 
rapidly, notably in view of their role in early life and new genomes will appear soon, 
paving the way for molecular studies on the interacting components. This level of 
sophistication is essential for concluding whether lactobacilli and bifidobacteria really 
make a difference.
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A Bifidobacterium mixed-species microarray for high-
resolution discrimination between intestinal 
bifidobacteria
Rolf J. Boesten, Frank h.J. Schuren, and Willem M. de Vos
A genomic DNA-based microarray was constructed containing over 6,000 randomly 
cloned genomic fragments of approximately 1-2 kb from six mammalian intestinal 
Bifidobacterium spp., including B. adolescentis, B. animalis, B. bifidum, B. catenula-
tum, B. longum and B. pseudolongum. This Bifidobacterium Mixed-Species (BMS) 
microarray was used to differentiate between type-strains and isolates belonging to 
a set of nine Bifidobacterium spp. Hierarchical clustering of genomic hybridization 
data confirmed the grouping of the Bifidobacterium spp. according to the 16S rRNA-
based phylogenetic clusters. In addition, these genomic hybridization experiments 
revealed high homology between the type-strain B. animalis subsp. lactis LMG 
18314 and B. animalis subsp. animalis LMG10508 (79%) as well as between the 
type strains B. longum biotype longum LMG13197 and B. longum biotype infantis 
LMG8811 (72%). Nevertheless, discrimination between these species was possible 
due to the high-resolution output of the BMS-array. In addition, it was shown that 
the BMS-array could be used for assigning unknown Bifidobacterium isolates to a 
species group. Finally, a set of 54 diagnostic clones for Bifidobacterium identification 
was selected and sequenced to advance the understanding of the species-related 
differences. Remarkably, a large fraction (31%) of these was predicted to encode 
proteins that belong to the bifidobacterial glycobiome and another 11% had func-
tional homology with genes involved in the protection against foreign DNA. Overall, 
the BMS-microarray is a high-resolution diagnostic tool that is able to facilitate the 
detection of strain- and species-specific characteristics of bifidobacteria.
Journal of Microbiological Methods, 2009, 76:269-277
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Bifidobacterium species are known to be among the first and most dominant gut 
inhabitants in our early life (Favier et al., 2002; Xu and Gordon, 2003; Vaughan et 
al., 2005). Their main habitat is the intestinal tract of humans and other animals. 
Bifidobacteria are reported to derive their specific ecological success from their 
capacity to metabolize complex carbohydrates (Ventura et al., 2007b). This 
characteristic forms the basis for various claims on the prebiotic effect of dietary 
oligosaccharides that selectively stimulate growth of bifidobacteria in the human 
colon (for a review see Gibson et al., 2005) (Gibson et al., 2007). However, there is 
only limited information on the effect of bifidobacteria on human health (Guarner and 
Malagelada, 2003; Klijn et al., 2005) in spite  of the fact that  some Bifidobacterium 
strains are also marketed as probiotics (Juntunen et al., 2001; Parvez et al., 2006; 
Mohan et al., 2006). 
The Bifidobacterium genus presently includes 34 species that are characterized 
by specific host-relations and can be grouped into six phylogenetic clusters (Ventura 
et al., 2006). Two of these contain Bifidobacterium spp. found in the human intestinal 
tract, including the B. adolescentis and B. longum clusters. Another relevant intestinal 
species is B. bifidum, which only includes human isolates but does not belong to any 
of the clusters but has a separate branch (Ventura et al., 2006). A fourth one, the 
B. pseudolongum cluster, is of interest in relation to the human gut because among 
others it contains B. animalis subsp. lactis that is isolated from fermented milk and 
is widely marketed as a human probiotic (Wall et al., 2007). As a consequence, this 
species is increasingly found in human fecal samples that are also known to contain 
B. adolescentis, B. catenulatum, B. longum, and B. bifidum (Matsuki et al., 1999). 
Although, fecal samples of healthy infants are significantly different (Matsuki et al., 
1999) and apparently affected by the health status (Salminen et al., 2005; Marchesi 
and Shanahan, 2007), the Bifidobacterium spp. composition in the intestinal tract 
of healthy adults is stable over time (Zoetendal et al., 1998; Matsuki et al., 2004). 
Sequence analysis of 16S rRNA and 16S-23S spacers (Leblond-Bourget et al., 1996; 
Kwon et al., 2005), but also of highly conserved genes such as tuf, recA (Ventura 
and Zink, 2003) and groEL (HSP60 family) gene sequences (Jian et al., 2001), have 
been used for elucidation of the Bifidobacterium taxonomy. However, controversy 
exists with respect to the phylogenetic position of some industrial strains such as B. 
animalis that is also described as B. lactis (Ventura and Zink, 2002). Furthermore, the 
taxonomic classification of B. longum-related strains is still not completely resolved 
(Mattarelli et al., 2008). 
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While the number of sequenced genomes is rapidly accumulating, so far only the 
B. longum NCC2705 genome has been sequenced and annotated completely (Schell 
et al., 2002). Complete genomes of a variety of other Bifidobacterium species have 
reported to be completed (Liu et al., 2005; Ventura et al., 2007a), including those of 
B. animalis, B. breve and B. adolescentis, but only that of the latter one has been 
deposited in a public database. This may be due to their application potential, as is 
illustrated by the discovery of a serpin-encoding gene in the B. longum genome that 
has the capacity to inhibit eukaryotic elastase-like serine proteases and may play an 
important role in the interaction between these commensal bacteria and their host 
(Ivanov et al., 2006).
One of the outstanding characteristics of the bifidobacterial genome is the 
presence of numerous genes that allow acquisition, transport and metabolism of 
a broad range of complex dietary polysaccharides that can not be processed by 
the human host. This arsenal of genes encoding proteins involved in carbohydrate 
depolymerization, uptake and metabolism is known as glycobiome. Over 8% of the 
annotated genes of B. breve UCC2003 and B. longum biotype longum NCC2705 
encode enzymes involved in the carbohydrate metabolism (Ventura et al., 2007b). 
Some sugar-degrading abilities are restricted to certain species or strains of 
a particular species (Ward et al., 2007; LoCascio et al., 2007). Comparative 
genome hybridization suggested that these sugar-degrading genes and those that 
encode restriction modification systems belong to the variable clusters within the 
Bifidobacterium genome that have been acquired via horizontal gene transfer (Schell 
et al., 2002; Ventura et al., 2007b). In addition, mobile elements such as prophage-
like elements and plasmids, although not ubiquitous in bifidobacteria, can also cause 
variation between strains and species (Ventura et al., 2007a).
In addition, a B. longum and an unpublished B. breve microarray have been 
used as genotyping tools in comparative genome hybridizations (Parche et al., 2007; 
Ventura et al., 2007a). To provide an alternative in absence of published genome 
sequences, we developed an approach based on random clone-based microarrays 
(Vlaminckx et al., 2007; Leavis et al., 2007). This approach is ideally suited for 
determination of genomic differences of not or not yet completely sequenced 
genomes. A genomic DNA-based microarray was constructed, containing random-
clones of six Bifidobacterium species relevant for the intestinal tract of humans. In 
this study we show the applicability of this microarray as a diagnostic tool in the 
analysis of diversity and function of bifidobacteria.
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Bacterial strains, culturing, dNa isolation and 16S rRNa sequencing
The origin and other information of the used bacterial strains is summarized in 
Table 1. All Bifidobacterium strains were grown anaerobically in MRS broth (Difco, 
Detroit, USA) supplemented with 0.05% L-cysteine hydrochloride monohydrate 
(Sigma-Aldrich, Steinheim, D) and incubated at 37°C. Genomic DNA (gDNA) was 
extracted using a protocol based on enzymatic lysis (Baess, 1974). Additionally, after 
precipitation the supernatant was discarded and the pellet was washed using 250 μl 
of 70% ethanol solution and dissolved in 100 μl 1 x TE/RNase (10 mg/ml) (Sigma-
Aldrich, Steinheim, D) solution. The mixture was incubated at room temperature for 
30 min and subsequently purified by ethanol precipitation and resuspended in 100 
μl 1 x TE buffer. The DNA was quantified using the Agilent 2100 Bioanalyser (DNA 
12000 kit, Agilent Technologies, Palo Alto, CA).
All strains were characterized by sequence analysis of their 16S rRNA genes 
which were obtained via PCR amplification using two DNA primers complementary 
to universally conserved regions of 16S rRNA. These primers were synthesized 
by Isogen Bioscience, Maarssen, The Netherlands - the two primers complement 
positions 8 to 30 (primer 8FE; 5’-CAGAGTTTGATCHTGGYTCAG), and 537-
556 (primer 556R; 5’-CTTTACGCCCARTRAWTCCG) (Baker et al., 2003). Per 
amplification reaction 5 μl GoldStar buffer (10 x, Eurogentec, Seraing, BE), 5 μl 
dNTP solution (2 mM), 3 μl MgCl2 sollution (25 mM), 1 μl 8FE primer (50 pmol/μl), 1 
μl 556R primer (50 pmol/μl), 0.4 μl Gold Star DNA polymerase (4U/μl, Eurogentec, 
Seraing, BE), 2.5 μl dimethyl sulfoxide (99.9%, Sigma-Aldrich, Steinheim, D), 27 
μl milliQ H2O, and 5 μl DNA (2 ng/μl) was combined. Amplification was carried out 
using a DNA thermal Cycler 480 (Perkin Elmer Cetus, Wellesley, USA) according to 
the following program, 94°C for 5 min, followed by 35 cycles of 94°C for 1 min, 60°C 
for 1 min and 72°C for 2 min ending with one cycle of 72°C for 4 min. The amplified 
16S rRNA genes were loaded on a 1% agarose/1 x TAE gel for electrophoresis. 16S 
rRNA bands were isolated from gel and purified using a QIAquick Gel Extraction 
Kit according to the manufacturer’s protocol (Qiagen Benelux B.V., Venlo, NL). For 
sequencing we used the ABI Prism® BigDyeTM Terminator V3.0 Ready Reaction Cycle 
Sequencing Kit (Applied Biosystems, Maarssen, NL) and the standard procedures 
recommended by the manufacturer. Sequencing reactions were performed using 
an ABI Prism 3100 Genetic Analyzer (Applied Biosystems, Maarssen, NL). The 16S 
rRNA gene sequences were aligned and their relationships were assessed using 
the 3.1 version of MEGA (Molecular Evolutionary Genetics Analysis) software (www.
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Table 1. Bacterial names, sources and references
–a not used for the construction of microarrays; * based on 16S rRNA sequence; TNO Quality of Life, 
Zeist1; Laboratory of Microbiology, Wageningen University2
Strain Code Subarray Collection Origin Reference 
B. adolescentis LMG 10502T ADO SA3 TNO1 Infant and adult feces Reuter, 1963  
B. animalis subsp. animalis LMG 10508T ANI SA3 TNO1 Rat, chicken, rabbit 
and calf feces 
Scardovi and 
Crociani, 1974  
B. bifidum LMG 11041T BIF SA3 TNO1 Infant and adult feces Orla-Jensen,  
1924  
B. breve LMG 13208T BRE – a TNO1/ WUR2 Infant feces Reuter, 1963  
B. breve NCIMB 8807/ UCC2003 BRE 
NCIMB8807 
– a WUR2 Infant feces Reuter, 1963; 
Leahy et al., 2005   
B. catenulatum LMG 11043T CAT SA3 TNO1 Infant and adult feces Scardovi and 
Crociani, 1974  
B. longum biotype infantis LMG 8811T INF – a TNO1/ WUR2 Infant feces and 
vagina 
Reuter,  1963; 
Sakata S et al., 
2002  
B. animalis subsp. lactis Bb-12 LAC Bb12 – a WUR2 Fermented milk Masco et al., 
2004, Chr. 
Hansen, Hørsholm, 
Denmark 
B. animalis subsp. lactis LMG 18314T LAC – a WUR2 Fermented milk Meile et al., 1997; 
Masco et al., 2004  
B. longum LMG 13197T LON SA2/ SA3 TNO1 Infant and adult feces Reuter, 1963  
B. longum NCC 2705 LON 
NCC2705 
– a WUR2 Infant and adult feces Reuter, 1963; 
Schell et al., 2002  
B. pseudolongum subsp. pseudolongum 
LMG 11571T 
PSE SA1/ SA3 TNO1 Piglet, rat, chicken, 
calf feces and rumen 
Yaeshima et al., 
1992  
B1 - B. breve * B1 – a WUR2 Human infant feces This chapter 
B2 – B. adolescentis* B2 – a WUR2 Human infant feces This chapter 
B3 – B. bifidum* B3 – a WUR2 Human infant feces This chapter 
B4 – B. animalis subsp. lactis* B4 – a WUR2 WUR collection This chapter 
B5 – B. animalis subsp. lactis* B5 – a WUR2 WUR collection This chapter 
B6 – B. pseudolongum subsp. 
pseudolongum* 
B6 – a TNO1 TNO strain collection This chapter 
megasoftware.net). For alignment default settings were applied. A Neighbor-Joining 
bootstrap Test of Phylogeny was performed to visualize the evolutionary analysis. 
array design and construction
A genomic library was constructed from six strains representing six different 
Bifidobacterium species. These strains were obtained from the Belgian Co-ordinated 
Collections of Microorganisms, Ghent, Belgium, and include: B. adolescentis 
LMG 10502T, B. animalis subsp. animalis LMG 10508T, B. bifidum LMG 11041T, 
B. catenulatum LMG 11043T, B. longum biotype longum LMG 13197T, and B. 
pseudolongum subsp. pseudolongum LMG 11571T. The constructed gDNA-based 
microarray (Vlaminckx et al., 2007; Leavis et al., 2007) contains three random 
clone-based Bifidobacterium subarrays. The first subarray (SA1) contains a B. 
pseudolongum subsp. pseudolongum gDNA library, the second (SA2) a B. longum 
biotype longum gDNA library and the third subarray (SA3) was constructed from 
genomic material that originated from equivalent amounts of the six different 
Bifidobacterium species mentioned above. For the SA1 and SA2 subarrays, 10 
μg of single strain gDNA was used. For subarray SA3 equimolar amounts of B. 
adolescentis, B. animalis subsp. animalis, B. bifidum, B. catenulatum, B. longum 
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biotype longum, and B. pseudolongum subsp. pseudolongum gDNA were mixed (10 
μg in total) and used. The B. pseudolongum subsp. pseudolongum (SA1) and the 
B. longum biotype longum libraries (SA2) each contain 2000 clones which represent 
about 85% of the genomic material of each strain (calculated according to Akopyants 
et al., 2001 (Akopyants et al., 2001)). SA3 containing 2000 clones represents about 
30% of the genomic material of each of the six species used for this library. DNA 
was precooled and sonicated (Branson 250/450 Sonifier, 6-mm microtip, Branson 
Ultrasonics, Danbury, USA) until an average fragment size of around 1.5 kb was 
obtained. Correct sizing was checked by agarose gel electrophoresis. Fragments of 
approximately 1500 bp were gel isolated, extracted, end-repaired and ligated into a 
pSMART-HCKan vector (CloneSMART Blunt Cloning Kit, Lucigen, Middleton, USA) 
according to the protocol of the manufacturer. Ligation products were transformed 
into E. coli, ElectroMAXTM DH10BTM Cells (Invitrogen, Breda, NL). Per library two 
thousand recombinant positive clones were arrayed into 96-well plates. Each well 
contained 100 μl TY medium plus kanamycin (30 μg/ml) (Sigma-Aldrich, Steinheim, 
D). After an overnight incubation at 37°C, 40 μl glycerol (40%) was added to each 
well and plates were stored at -80°C. Clone inserts were amplified by polymerase 
chain reaction using SMART-L1-NH2: 5’-CAGTCCAGTTACGCTGGAGTC and 
SMART-R1-NH2: 5’-CTTTCTGCTATGGAGGTCAGGTATG primers (described by 
the CloneSMART Blunt Cloning Kit manual, Lucigen, Middleton, USA) with 5’-C6 
amino linkers (20 pmol each, Isogen, Maarssen, NL) to facilitate cross-linking to 
the aldehyde-coated glass slides (European Biotech Network, Dolembreux, BE). 
Alongside primers the PCR reactions contained 1μl bacterial culture (template DNA), 
0.2 units SuperTaq polymerase with 1 x reaction buffer (HT Biotechnology, SpaeroQ, 
Gorinchem, NL), 0.2 mM each dNTP (Roche, Almere, NL), and 5% dimethyl sulfoxide 
(Sigma-Aldrich, Steinheim, D) in 50 μl reaction volume. PCR cycle conditions were 
95°C for 5 min followed by 35 cycles of 95°C for 30 s, 52°C for 30 s, and 72°C 
for 1 min, followed by 72°C for 10 min after cycling was completed. Insert sizes 
were determined by gel electrophoresis using 1% Ready-to-Run gels (Amersham, 
Piscataway, USA). PCR products of the correct size (1000-2000 bp) were purified 
by an isopropanol precipitation and the efficacy of this precipitation/purification was 
checked again by agarose gel electrophoresis on Ready-to-Run gels (Amersham, 
Piscataway, USA). Purified PCR products were arrayed into 384 wells spotting 
plates, concentrated, and dissolved in 3 x SSC (1 x SSC is 150mM sodium chloride 
plus 17 mM sodium citrate, pH 7.2, Sigma-Aldrich, Steinheim, D) solution. All PCR 
products were printed by using ESI three-axis DB-3 robot (versarray ChipWriter Pro, 
Biorad, Hercules, CA) at controlled humidity of 55% on CSS-100 silylated aldehyde 
glass slides (European Biotech Network, Dolembreux, BE). After drying, slides were 
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blocked following the manufacturer’s instructions using sodium-borohydride (Sigma-
Aldrich, Steinheim, D).
Fluorescent labeling and hybridization
Total gDNA samples were labeled by random primed labeling according to the 
protocol supplied with the BIOprime labeling kit (Invitrogen, Breda, NL) using Cy5-
labeled dUTP (Amersham Biosciences, Piscataway, USA). Unincorporated dyes 
were removed using AutoSeq G50 columns (Amersham, Piscataway, USA) as 
described in the protocol of the manufacturer. DNA microarrays were prehybridized 
for 45 min at 42°C in prehybridization solution (1% bovine serum albumin, 5 x SSC, 
and 0.1% SDS). Hybridizations of labeled gDNA samples were performed overnight 
at 42°C in 40 μl Easyhyb buffer (Roche, Almere, NL) according to the manufacturer’s 
protocol. Slides were washed twice in 1 x SSC, 0.2% SDS at 37°C, once in 0.5 x 
SSC, and twice in 0.2 x SSC at RT and dried with N2-flow.
Microarray scan-image and quality analysis 
After washing and drying, slides were scanned with a ScanArray Express 4000 scanner 
(Perkin-Elmer, Wellesley, USA). The obtained images were analyzed using ImaGene 
5.6 software (www.biodiscovery.com). A gene identification file was constructed 
using CloneTracker software (www.biodiscovery.com). Spots were quantified using 
ImaGene 5.6 software (www.biodiscovery.com). During quantification, the ImaGene 
5.6 software (www.biodiscovery.com) determined the average spot quality. Spot 
parameters such as shape regularity of the spots (threshold: 0.4), spot size and 
background signals (signal intensity >2 x background signal) were used for flagging 
poor and empty spots.
Clustering analysis, visualization, correlation mapping and normalization 
of hybridization signals
Genomic DNA samples were hybridized on a microarray. As standard normalization 
methods could not be applied due to the sample-related variation in hybridization 
patterns (Oshlack et al., 2007), we designed an alternative normalization approach. 
This alternative normalization was only used for those analyses which were based 
on absolute values. For Pearson correlation based clustering, untreated Cy5 signal 
intensity data were used as input, which was performed and visualized with TIGR 
MeV 3.1 Software (http://www.tm4.org/mev.html). For this analysis unnormalized 
data was used, to prevent the introduction of noise in the data set.
Correlation mapping was performed and visualized using PLS-toolbox version 
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4.02 (www.eigenvector.com) in MatLab version 7.3 (www.mathworks.com). A 
correlation value of ‘1’ means that the hybridization patterns are similar. A correlation 
value of ‘0’ means there is no similarity between hybridization patterns. Based 
on the gDNA fragments present on the BMS-array, the correlation values give an 
indication of the genomic overlap between the strains tested. The correlation values 
were extrapolated to a percentage of genomic overlap. A correlation range of ‘0 up 
to 1’ was translated to a percentage of genomic overlap of 0% up to 100%. Due 
to the relatively long taxonomic distance between B. longum biotype longum and 
B. pseudolongum subsp. pseudolongum and their high abundance on the BMS-
microarray, a negative correlation value was predicted for these species. Genomic 
overlap between B. longum biotype longum LMG13197 and B. pseudolongum 
subsp. pseudolongum LMG11571 was therefore calculated by correlation mapping 
of the SA1 and SA2 libraries separately (data not shown).
For the selection of diagnostic clones we normalized the obtained hybridization 
data using an alternative approach since this analysis was based on absolute values. 
Per library the median Cy5 signal intensities as generated by image analysis were 
sorted in ascending order. These ranked hybridization patterns were visualised in a 
line chart with the ranked values on the X-axis and the corresponding signal intensities 
on the Y-axis. The cut-off value for discriminating between non-homologous (low) and 
homologous (high) hybridization signals was based on the slopes of the curves. The 
transition point between the high and low values in the curves reflects the transition 
in the data set from low homology to high homology sequences. The exact position 
of the transition point was calculated as the first point where a significant change in 
the tangent line following the non-homology level occurred. To calculate this, results 
of negative control spots (empty spots on the array) were used for defining significant 
changes in signal intensity values between clones next to each other in rank. Based 
on two times the standard deviation of the control spot results, the transition point 
for each dataset was determined. All the spots with a rank higher than the transition 
point clone were classified as ‘high homology sequence’, whereas spots with signal 
intensities above the control spots but below the transition point were labelled as 
the ‘low homology sequence’ group. Spots that did not met these above mentioned 
criteria were labelled as ‘non-significant’ signals.
Significance Analysis for Microarrays (SAM) analysis and Analysis of Variance 
(ANOVA), TIGR MeV 3.1 Software (http://www.tm4.org/mev.html), was used for 
selection of a set of clones that are specific for one species or a group of species.
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Sequencing of gdNa fragments
Plasmid isolation, purification of PCR products and high throughput sequencing 
was performed by GATC Biotech AG, Konstanz, Germany (www.gatc-biotech.com). 
Sequences were compared with public databases by using blastx and blastn. Blast 
analyses were performed against all sequenced genomes in the database and 
against the genome of B. longum NCC2705 and B. adolescentis ATCC 15703, using 
the NCBI website (http://www.ncbi.nlm.nih.gov/).
ReSulTS aNd dISCuSSION
design, construction and application of the BMS-microarray
A Bifidobacterium mixed-species microarray was constructed, carrying genomic 
DNA (gDNA) of six Bifidobacterium species, derived from the adult colon, except for 
B. pseudolongum that was included to address its comparison with the intestinal B. 
longum (Table 1). This so called BMS-array was used to study genomic differences 
both within a single Bifidobacterium species and between bifidobacterial phylogenetic 
clusters (Fig. 1). First, gDNA of the six used Bifidobacterium spp. was hybridized 
to a microarray carrying two sub-arrays consisting of single-species libraries of B. 
pseudolongum (SA1) and B. longum (SA2) with a genomic coverage of 85%. The 
combination of these two sub-arrays allowed for distinct hierarchical clustering of the 
hybridization signals (Fig. 1A). B. longum and B. pseudolongum are known to cover 
a broad taxonomic range (Ventura et al., 2006). They show clearly distinguishable 
hybridization patterns on the combined SA1 and SA2 sub-arrays (Fig. 1A), confirming 
their relatively low genomic overlap. However, the combination of the SA1 and SA2 
sub-arrays has too little discriminating power for the distinction between B. bifidum 
and species belonging to the phylogenetic B. adolescentis cluster, including the 
human commensals B. adolescentis, B. animalis and B. catenulatum. Therefore, 
we constructed a third sub-array (SA3) containing a mixed-species gDNA library, 
covering about 30% of the genomes of each of these four Bifidobacterium species, and 
combined it with the other sub-arrays, resulting in the BMS-microarray. Hybridization 
of gDNA of the six Bifidobacterium spp. to the BMS-microarray resulted in signals 
that showed a distinct hierarchical clustering and allowed separation of all human 
intestinal species (Fig. 1B). The clear clustering of all the different species, and the 
high similarity of these clusters with the defined Bifidobacterium clusters (Ventura 
et al., 2006), indicates that the arrayed DNA contains sufficient unique sequence 
information. Since untreated hybridization signals were used for the clustering, this 
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Figure 1. Hierarchical clustering (Pearson correlation, complete linkage) of Cy5 signal intensity gDNA 
hybridization patterns of gDNA (Y-axis) of the strains (X- axis; codes according to Table 1) used for the 
construction of the BMS-microarray. (A) based on the SA1 and SA2 subarrays, and (B) based on the 
BMS-array combining the SA1, SA2 and SA3 subarrays. Cy5 signal intensity values are indicated in red 
according to the color scale shown in the bar above the image. Species specific groups of clones are 
encircled and assigned.
approach should be used for comparison at the array level but is not suitable for 
comparing signal intensities at the single spot level that requires normalization as 
described below. 
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analysis of genomic diversity by hybridization pattern correlations
To test the applicability of the BMS-microarray as a taxonomic tool, we analyzed an 
independent set of 12 culture collection strains, three unclassified bifidobacterial 
Thesis-Rolf-v3.indd   30 2-1-2011   23:33:08
Bifidobacterium mixed-species microarray for high resolution discrimination
31
Ch
ap
te
r  2
Figure 2. (A) Phylogenetic tree based on partial 16S rRNA sequences, Neighbour-Joining bootstrap Test 
of Phylogeny (B) Hierarchical clustering (Pearson correlation, complete linkage) of Cy5 signal intensity 
hybridization patterns, of Bifidobacterium strains (X-axis; codes according to Table 1), based on 6000 
clones (Y-axis). The dark-grey bars indicate whether the sample is used for the construction of the BMS-
microarray. In the light-gray bars the according phylogenetic clusters are indicated. Cy5 signal intensity 
values are indicated in red according to the scale shown in the bar above the image. On the right, a 
magnified detail of cluster that shows diversity in hybridization patterns between strains ADO and B2.
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strains and three fecal isolates that altogether include nine different Bifidobacterium 
species (Table 1). All strains were typed by sequence analysis of their 16S rRNA 
genes (Fig. 2A). Genomic DNA of each of these 18 Bifidobacterium strains was 
hybridized to the BMS-microarray (Fig. 2B). The hybridization data sets were 
hierarchically clustered and showed a high degree of similarity with the 16S rRNA 
based phylogenetic clusters described by Ventura et al. (2006) (Ventura et al., 2006) 
and the generated partial 16S rRNA sequence based phylogenetic tree (Fig. 2A). 
The tree obtained by hierarchical clustering of the hybridization data contains three 
main branches (Fig. 2). These main branches have similarity to the Bifidobacterium 
clusters defined by Ventura et al. (2006) (Ventura et al., 2006). One branch is similar 
to the B. pseudolongum group, one branch is similar to the B. longum group, and 
one branch contains the B. adolescentis group and the separate B. bifidum branch 
(Fig. 2).
The set of Bifidobacterium strains tested contains fecal and other isolates with 
an unknown identity at the species level. Correlating the hybridization patterns of 
these isolates with Bifidobacterium type-strains enabled their rapid classification that 
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Figure 3. Correlation mapping of hybridization patterns of gDNA samples (codes according to Table 1) of 
tested Bifidobacterium strains based on the BMS-array. Colouring applied according to the scale legend 
on the right. Groups of strains that belong to the same species are highlighted by black lines and closely 
related strains by dashed lines.
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was confirmed by 16S rRNA sequencing (data not shown). However, hybridization 
to the BMS-array also allowed determination at the strain level as is illustrated by 
the fecal isolate B2 that belongs to B. adolescentis but detailed analysis shows its 
hybridization response to differ from that of the B. adolescentis type-strain, indicative 
of genomic differences (Fig. 2 close-up). 
To clarify the genomic overlap between every combination of strains tested, we 
used a correlation mapping approach. Correlation mapping describes the similarity 
between the hybridization patterns (Fig. 3). This approach formed the basis of the 
BMS-microarray as a molecular genomic tool, which we applied to analyze the 
genomic diversity of a set of Bifidobacterium strains. Confirming the results of the 
hierarchical clustering, we were able to define several groups of strains with highly 
similar hybridization patterns (Fig. 3, highlighted squares).
Taking in account that strains with genomic homology above 70% should be 
interpreted as similar species (Lauer and Kandler, 1983), we identified strain B1 
as a B. breve and strain B2 as a B. adolescentis, as their genomic overlaps with 
these species were 93 % and 81 %, respectively. The genomic overlap of the used 
B. animalis subsp. animalis LMG10508 and B. animalis subsp. lactis LMG18314 
strains was found to be 79%, confirming that they belong to the same species. 
Strains B4 and B5 show all high homology to B. animalis subsp. lactis LMG18314 
(98%), indicating that they are highly similar B. animalis subsp. lactis strains. Due 
to its high homology to B. bifidum LMG11041 (86%), we concluded that strain B3 
belongs to B. bifidum. B. longum NCC2705 and B. longum biotype infantis LMG8811 
overlapped B. longum LMG13197 for 80%, and 72%, respectively. This makes it 
debatable whether B. longum and B. infantis belong to the same species and it 
strengthens their grouping as different biotypes as proposed recently  (Ventura et al., 
2006; Mattarelli et al., 2008). Finally, in contrast with the suggestion made by their 
nomenclature, B. longum LMG13197 and B. pseudolongum LMG11571 showed only 
low genetic homology of 9% (data not shown), confirming their present taxonomic 
position (Ventura et al., 2006).
Characterization of species-specific sequences
The possibility was studied to use the BMS-arrays for detecting bifidobacterial 
sequences that are specific at the level of strain, species or phylogenetic cluster. 
Such sequences could be developed as molecular markers that could be useful for 
diagnostic discrimination and provide underlying functional information relating to 
their unique presence. In order to select specific clones we needed to classify spot 
signals as ‘absent’ (no or weak hybridization signal) or ‘present’ (strong hybridization 
Thesis-Rolf-v3.indd   33 2-1-2011   23:33:09
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signal). Hence, we developed a signal amplitude-independent normalization method, 
which enabled us to discriminate between clones that contain sequences with varying 
degree of homology in relation to the hybridized gDNA (see Materials and Methods). 
This classification allowed for determining the characteristics of a single spot after 
hybridization with different Bifidobacterium gDNA samples. From a set of 800 strain- 
or species-specific clones that were obtained by applying the SAM tool, we selected 
54 discriminating clones that showed relatively high hybridization intensities. The 
insert sequences of these clones were determined and compared with database 
entries (Fig. 4). Clones that were selected as specific for B. longum, B. adolescentis or 
originating from closely related strains gave BLAST-hit results with high probabilities 
(Fig. 4). As expected, clones specific for Bifidobacterium spp. with genomes that are 
not in the public database gave BLAST hits with lower probabilities (Fig. 4). Only 
two percent of the clones spotted on the BMS-array showed hybridization to other 
genera than Bifidobacterium used as control and these were found to represent 16S 
and 23S rRNA genes. In summary, these findings strengthen the appropriateness of 
our method for selection of strain- and species-specific DNA sequences. 
Subsequently, we analysed the distribution of the ontology groupings of the 
predicted genes encoded by the 54 diagnostic clones (Fig. 5). A high percentage 
of predicted hypothetical proteins (39%) and predicted genes with low homology 
BLAST hits was found, as we used Bifidobacterium strains that have not or not 
fully been sequenced yet, while the main fraction of the diagnostic sequences was 
related to the bifidobacterial glycobiome (31%). As a reference, less than 9% of the 
Figure 5. Distribution of KEGG ontologies of predicted proteins encoded by the 54 diagnostic sequences 
listed in Figure 4. The group described as ‘House Keeping Function (11%)’ encompasses the following 
ontology groups: Bacterioferrin Comigration Protein (3%), Lipid Metabolism (2%), Metabolism of Cofactors 
and Vitamins (2%), Signalling Molecules and Interaction (2%), and Amino Acid Metabolism (2%).
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BLAST
gi|28377951|ref|NP_784843.1| polysaccharide biosynthesis protein [Lactobacillus plantarum WCFS1]
gi|50954295|ref|YP_061583.1| glycosyl transferase [Leifsonia xyli subsp. xylistr. CTCB07]
gi|50954297|ref|YP_061585.1| rhamnosyltransferase [Leifsonia xyli subsp. xylistr. CTCB07]
ref|ZP_02028516.1|  hypothetical protein BIFADO_00949 [Bifidobacterium adolescentis L2-32]
ref|NP_695369.1|  possible arabinosidase [Bifidobacterium longum NCC2705]
gi|15614430|ref|NP_242733.1| hypothetical protein BH1867 [Bacillus haloduransC-125]
gi|29827685|ref|NP_822319.1| secreted protein [Streptomyces avermitilis MA-4680]
gi|68250155|ref|YP_249267.1| putative type I restriction enzyme HindVIIPspecificity protein [Haemophilus influenzae 86-028NP]
gi|119025199|ref|YP_909044.1| hypothetical protein BAD_0181 [Bifidobacterium adolescentis ATCC 15703]
gi|23464766|ref|NP_695369.1| possible arabinosidase [Bifidobacterium longum NCC2705]
gi|23465412|ref|NP_696015.1| hypothetical protein BL0837 [Bifidobacterium longum NCC2705]
gi|23466239|ref|NP_696842.1| ATP binding protein of ABC transporter forpentoses [Bifidobacterium longum NCC2705]
gi|23464662|ref|NP_695265.1| ATP binding protein of ABC transporter [Bifidobacterium longum NCC2705]
gi|23464774|ref|NP_695377.1| very narrowly conserved hypothetical protein [Bifidobacterium longum NCC2705]
gi|23465808|ref|NP_696411.1| hypothetical membrane protein with unknownfunction [Bifidobacterium longum NCC2705]
gi|19703892|ref|NP_603454.1| hypothetical protein FN0557 [Fusobacteriumnucleatum subsp. nucleatum ATCC 25586]
ref|NP_695859.1|  possible cell surface protein with gram positive anchor domain [Bifidobacterium longum NCC2705]
gi|81428209|ref|YP_395209.1| Hypothetical prophage lsa1protein [Lactobacillussakei subsp. sakei 23K]
gi|38234327|ref|NP_940094.1| Putative DNA methyltransferase [Corynebacterium diphtheriae NCTC 13129]
gi|86741650|ref|YP_482050.1| putative transposase, IS891/IS1136/IS1341 [Frankiasp. CcI3]
ref|ZP_02029086.1|  hypothetical protein BIFADO_01537 [Bifidobacterium adolescentis L2-32]
gi|23465347|ref|NP_695950.1| hypothetical protein BL0771 [Bifidobacterium longum NCC2705]
gi|23465346|ref|NP_695949.1| hypothetical protein BL0770 [Bifidobacterium longum NCC2705]
gi|23465203|ref|NP_695806.1| hypothetical protein BL0619 [Bifidobacterium longum NCC2705]
gi|23465396|ref|NP_695999.1| possible thioredoxin-dependent thiol peroxidase [Bifidobacterium longum NCC2705]
gi|85375778|ref|YP_459840.1| hypothetical protein ELI_14755 [Erythrobacterlitoralis HTCC2594]
gi|54026395|ref|YP_120637.1| hypothetical protein nfa44220 [Nocardia farcinicaI FM 10152]
gi|23465507|ref|NP_696110.1| possible pyridoxine kinase [Bifidobacterium longum NCC2705]
gi|119026125|ref|YP_909970.1| peptidoglycan synthetase; penicillin-bindingprotein 3 [Bifidobacterium adolescentis ATCC 15703]
gi|119025720|ref|YP_909565.1| hypothetical protein BAD_0702 [Bifidobacterium adolescentis ATCC 15703]
gi|23465898|ref|NP_696501.1| narrowly conserved hypothetical protein withpossible isomerase function [Bifidobacterium longum NCC2705]
gi|23464646|ref|NP_695249.1| aspartyl-tRNA synthetase [Bifidobacterium longum NCC2705]
gi|55822649|ref|YP_141090.1| MutT/nudix family protein [Streptococcusthermophilus CNRZ1066]
gi|23464987|ref|NP_695590.1| integral membrane protein in the upf0059 [Bifidobacterium longum NCC2705]
gi|54026396|ref|YP_120638.1| hypothetical protein nfa44230 [Nocardia farcinicaIFM 10152]
gi|19551586|ref|NP_599588.1| hypothetical protein NCgl0330 [Corynebacteriumglutamicum ATCC 13032]
gi|23464820|ref|NP_695423.1| hypothetical membrane protein with unknownfunction [Bifidobacterium longum NCC2705]
gi|42519452|ref|NP_965382.1| hypothetical protein LJ1578 [Lactobacillusjohnsonii NCC 533]
ref|ZP_00206596.1|  hypothetical protein Blon03000683 [Bifidobacterium longum DJO10A]
gi|23465240|ref|NP_695843.1| dimethyladenosine transferase [Bifidobacteriumlongum NCC2705]
gi|119025571|ref|YP_909416.1| narrowly conserved hypothetical membrane protein [Bifidobacterium adolescentis ATCC 15703]
gi|54293105|ref|YP_125520.1| hypothetical protein lpl0144 [Legionellapneumophila str. Lens]
gi|23466292|ref|NP_696895.1| probable long-chain-fatty-acid--CoA ligase;long-chain acyl-CoA synthetase [Bifidobacterium longum NCC2705]
ref|YP_909028.1|  hypothetical protein BAD_0165 [Bifidobacterium adolescentis ATCC 15703]
gi|119026150|ref|YP_909995.1| possible lipoprotein signal peptidase [Bifidobacterium adolescentis ATCC 15703]
gi|54025888|ref|YP_120130.1| hypothetical protein nfa39180 [Nocardia farcinicaIFM 10152]
gi|23465396|ref|NP_695999.1| possible thioredoxin-dependent thiol peroxidase [Bifidobacterium longum NCC2705]
gi|119025726|ref|YP_909571.1| pullulanase [Bifidobacterium adolescentis ATCC 15703]
gi|119026628|ref|YP_910473.1| beta-glucosidase [Bifidobacterium adolescentis ATCC 15703]
gi|119025072|ref|YP_908917.1| putative exodeoxyribonuclease V [Bifidobacterium adolescentis ATCC 15703]
gi|119026278|ref|YP_910123.1| similar to glutamine ABC transporter (ATP-bindingprotein) [Bifidobacterium adolescentis ATCC 15703]
gi|119026197|ref|YP_910042.1| CRISPR-associated protein Cas2 [Bifidobacterium adolescentis ATCC 15703]
gi|119026198|ref|YP_910043.1| CRISPR-associated DNA polymerase [Bifidobacterium adolescentis ATCC 15703]
gi|119026274|ref|YP_910119.1| putative ABC-type amino acid transport systemperiplasmic component [Bifidobacterium adolescentis ATCC 15703]
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 predicted proteins in B. longum NCC2705 represent the glycobiome consisting of an 
array of glycoside hydrolases (Schell et al., 2002). This indicates that bifidobacterial 
strains can be identified by their specific sugar-degrading abilities and extend 
previous observations from a study on strain-specific sugar-degrading abilities (Ryan 
et al., 2006). According to our findings, another variable section of bifidobacterial 
genomes may encode genes from the replication and repair ontology group, which 
provide resistance against foreign DNA (11%). These include a series of restriction-
modification systems as well as CRISPR-associated functions. The latter group of 
genes provide immunity against foreign genetic elements via a mechanism based on 
RNA interference (Barrangou et al., 2007). The fact that these CRISPR-associated 
gene clusters have often been found on mobile genetic elements (Kunin et al., 2007) 
indicates that their compositions can vary between closely related species. Finally, 
specific housekeeping functions are recognized as species- and strain-specific (11 
%) and may reflect different capacities to produce vitamins, deal with signalling, or 
produce specific metabolites.
In conclusion, the BMS-microarray is a high-resolution diagnostic tool that can 
be used to reveal strain- and species-specific characteristics of bifidobacteria. 
Moreover, its application to cognate Bifidobacterium spp. revealed this genus to 
contain species-specific diagnostic sequences that are mainly predicted to code for 
the glycobiome and functions involving DNA metabolism.
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Analysis of infant isolates of Bifidobacterium breve  by 
comparative genome hybridization indicates the exis-
tence of new subspecies with marked infant-specificity
Rolf J. Boesten, Frank h.J. Schuren, Richèle d. Wind, Jan knol,
and Willem M. de Vos
A total of 20 Bifidobacterium strains were isolated from fecal samples of 4 breast and bottle-
fed infants that were all characterized as B. breve based on 16S rRNA gene sequence 
and metabolic analysis. These isolates were further characterized and compared to the type 
strains of B. breve and 7 other Bifidobacterium spp. by comparative genome hybridization. 
For this purpose we constructed and used a DNA-based microarray, containing over 2,000 
randomly cloned DNA fragments from the B. breve type strain LMG13208. This molecular 
analysis revealed a high degree of genomic variation between the isolated strains and al-
lowed the vast majority to be grouped in 4 clusters. One cluster contained a single isolate 
that was virtually indistinguishable from the B. breve type strain. The 3 other clusters included 
19 B. breve strains that differed considerably from all type strains. Remarkably, each of the 4 
clusters included strains that were isolated from a single infant, indicating a niche adaptation 
may contribute to the variation within the B. breve species. Based on the genomic hybridiza-
tion data, the new B. breve isolates were estimated to contain approximately 60-90 % of the 
genes of the B. breve type strain, testifying for the existence of various subspecies within the 
species B. breve. Further bioinformatic analysis identified several hundreds of diagnostic 
clones specific for the genomic clustering of the B. breve isolates. Molecular analysis of 
representatives of these, revealed the annotated genes from the conserved B. breve core 
to encode mainly house-keeping functions while the strain-specific genes were predicted to 
code for functions related to life style, such as carbohydrate metabolism and transport. This 
is compatible with a genetic adaption of the strains to their niche, a combination of infant and 
diet.
Submitted to Research in Microbiology
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INTROduCTION
The human gut is colonized by a complex community of microorganisms, the 
microbiome, which are known to impact its host (Hooper and Gordon, 2001). One 
group of commensal bacteria, those belonging to the genus Bifidobacterium, is 
considered to play an important role in the development of our microbiome in early 
life, during infancy. This is mainly based on its abundance in our early life and its 
capability to affect our immune system (Boesten and de Vos, 2008; Favier et al., 2002; 
Favier et al., 2003; O’Hara et al., 2006). Representatives of the species B. breve are 
highly abundant in early life and hence received considerable attention because 
of its impact on human health (Haarman and Knol, 2005; MacConaill et al., 2003; 
Margolles et al., 2006; Menard et al., 2005). Bifidobacterium breve is considered to 
be widely distributed irrespective of host age (He et al., 2001; Matsuki et al., 1998; 
Turroni et al., 2009). Bifidobacteria are host specific and different species occupy 
different niches. For example, the most common habitat of B. dentium is the human 
mouth, whereas B. breve has been mainly identified from the human intestinal tract. 
This suggests that these species possess unique characteristics which can be 
applied in a specific niche. Unravelling species-specific characteristics therefore will 
reveal adaptation strategies for survival in specific ecological niches.
Genomic characterization of B. breve is essential to gain more insight in the 
underlying mechanisms involved in the interaction with its human host (Boesten and 
de Vos, 2008). Although detailed studies on the B. breve UCC2003 genome have 
been published (Ventura et al., 2007b), the genome of B. breve UCC2003, with a 
size of 2.4 Mb, is unfortunately not publically available (Leahy et al., 2005). To date 
several Bifidobacterium genomes have been sequenced. Comparing bifidobacterial 
genomes reveals highly interesting information on the divergence of the genes they 
encode (Ventura et al., 2009). This gives clues for the molecular background of their 
species specific characteristics and genetic adaptation to their ecological niches. 
For example, whole genome comparison studies showed that nearly 10% of the 
total bifidobacterial gene content is dedicated to sugar internalization (Ventura et al., 
2007a). This is 30% higher than other intestinal bacteria such as Escherichia coli 
or Enterococcus faecium (Ventura et al., 2007a). Furthermore, a B. breve specific 
operon that encodes for enzymes that are involved in the breakdown of complex 
sugars such as starch, amylopectin and pullulan was identified (Maze et al., 2007). 
Next to the B. breve UCC2003 genome, a CRISPR-related system (CASS), which 
is implicated in the defence against phages and plasmids is identified in most 
sequenced Bifidobacterium genomes (Horvath et al., 2009; Ventura et al., 2009). In 
summary, Bifidobacterium species have specific characteristics which are rooted in 
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its genetic material, which makes genome studies fruitful.
Genome analysis clarifies intraspecies diversity and can indicate for the presence 
of subspecies. The proposition of reclassifying the three biotypes of Bifidobacterium 
longum as three subspecies for example, was mainly based on genomic data 
(Mattarelli et al., 2008). Little variation of 16S rDNA sequences and DNA-DNA 
hybridization similarity levels between 65 – 80% supported the unification in one 
species. One the other hand, genotypic data from recA, tuf, and ldh gene analysis 
next to RAPD-PCR, PCR-DGGE, and BOX-PCR studies provided evidence for 
unification of B. longum, B. infantis, and B. suis in three subspecies (Mattarelli et 
al., 2008). Besides genotypic divergence, phenotypic variation is needed for proof of 
the existence of subspecies. For example, the three subspecies of B. longum reveal 
considerable differences in carbohydrate metabolism (Mattarelli et al., 2008). 
In this study we describe the genetic characterization of a selection of B. breve 
strains isolated from fecal samples originating from three breast- or bottle-fed infants 
using a DNA-based microarray specific for B. breve. The microarray platform serves 
as a tool for comparison of genome contents without the obligation to sequence 
complete genomes. Due to the lack of commercially available Bifidobacterium 
microarrays, we developed a clone-based B. breve microarray (Boesten et al., 
2009). The goal of this study was to screen for possible correlations between the 
host origin, obtained biochemical data and DNA-DNA hybridization patterns of the 
fecal isolates.
MaTeRIalS aNd MeThOdS
Bacterial strains, and culturing
Bifidobacterium breve LMG13208, B. longum biotype longum LMG13197, B. longum 
biotype infantis LMG8811, B. bifidum LMG11041, B. adolescentis LMG10502, 
B. catenulatum LMG11043, B. animalis subsp. animalis LMG10508, and B. 
pseudolongum subsp. pseudolongum LMG11571 strains were obtained from the 
Belgian Co-ordinated Collections of Microorganisms (BCCM), Ghent, Belgium. 
These type strains were used as reference material in this study. All other strains 
were isolated, characterized biochemically and identified by 16S ribosomal sequence 
analysis (Baseclear, Leiden, NL) at Danone Research (Wageningen, NL) (Felske et 
al., 1997; Haarman and Knol, 2005; Nubel et al., 1996). Isolates NR201, NR202, 
NR203, NR204, NR214, NR224, NR226, NR229, NR239, NR240, NR241, NR242, 
and NR243 were isolated from the feces of a healthy bottle-fed human infant 2. 
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Isolates NR231, NR238, NR207, NR212, NR225, and NR232 were isolated from 
two healthy breast-fed human infants, 3 and 4. Isolate NR200 is commercial strain 
isolated from a healthy bottle-fed infant (Danone Research, Wageningen, NL). LMG 
strains were cultured anaerobically in MRS broth (Difco, Detroit, USA) supplemented 
with 0.05% L-cysteine hydrochloride monohydrate (Sigma-Aldrich, Steinheim, D) 
and incubated at 37°C for 16-40 h. Culturing of the fecal isolates was performed at 
Danone Research (Wageningen, NL) according to conditions described by Haarman 
et al. (2005).
Measuring of bile salt hydrolysis activity, and lactic acid, ammonia, 
histamine, and tyramine production
Bile salt hydrolase activity was detected using a plate assay based on Christiaens 
et al. (1992), and Dashkevicz and Feighner (1989). Freshly cultured bacteria were 
preincubated in MRS broth with 2 mM taurodeoxycholic acid (TDCA; Sigma-Aldrich, 
Zwijndrecht, NL) or glycodeoxycholic acid (GDCA; Calbiochem, Merck, Darmstadt, 
G) and incubated for 24 h at 37°C. The bacterial cultures from the TDCA pre-culture 
were streaked on MRS-plates containing 0.5% TDCA and on a control MRS-plate. 
The bacterial cultures from the GDCA pre-culture were streaked on a MRS-plate 
containing 0.5% GDCA and on a control MRS-plate. Plates were incubated for 72 h 
at 37°C. Plates were checked for bile salt hydrolyse-active colonies with precipitates 
around the colonies. 
L-lactate and D-lactate production was analyzed with L-Lactic acid kit (Enzyplus 
EZA-890, Rasio Diagnostics, www.biocontrolsys.com) and D-Lactic acid kit (Enzyplus 
EZA-889, Rasio Diagnostics, www.biocontrolsys.com). Bacteria were cultured in 
MRS-broth for 48 h at 37°C. Cultures were centrifuged (Sorvall RT-7, rotor RTH 750) 
for 10 min at 4000 rpm. The supernatant was diluted 50 times in demineralised water 
and tested for the presence of D- and L-lactate.
Ammonia production was analyzed with a spectrophotometer using 
previously published methods (Di Giorgio, 1974; Lin and Visek, 1991) with some 
modifications.
Strains were cultured anaerobic in 10 ml BHI-broth (37 g/l; Oxoid, Badhoevedorp, 
NL) for 48 h at 37°C. Cultures were centrifuged (Sorvall RT-7, rotor RTH 750) for 
10 min at 4000 rpm. A volume of 100 μl trichloricacid solution (30%) was added to 
900 μl supernatant or to 900 μl BHI-broth. From an ammonia stock solution (5 mM) 
a standard curve (0 – 5 mM) was prepared. 10 μl Standard, sample or blank (all in 
triplicate) was added to a 96 wells plate. Then 75 μl phenol reagent (50 mg/ml phenol 
and 0.24 mg/ml sodium nitroprusside) and 75 μl alkali-hypochlorite reagent (31.2 mg/
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ml NaOH and 2.6 mg/ml sodium hypochlorite) was added. After an incubation at 37°C 
for 20 min, 100 µl demineralised water was added. Subsequently, the extinctions 
were measured at a wavelength of 620 nm using a plate reader (Spectramax 190, 
Molecular Devices, Sunnyvale, USA). 
The production of the biogenic amines histamine and tyramine was detected via 
a pH increase according Le Jeune et al. (1995). 
dNa extraction
DNA was extracted from Bifidobacterium LMG strains according to the following 
protocol earlier described (Boesten et al., 2009). The DNA was quantified using 
the Agilent 2100 Bioanalyser (DNA 2000 kit, Agilent Technologies, Palo Alto, CA). 
Genomic DNA for DNA-DNA hybridization was isolated from fecal bifidobacterial 
isolates according to the isolation procedure described previously (Boom et al., 
1999).
array design and construction
A genomic library was constructed from Bifidobacterium breve LMG13208, which 
was obtained from the Belgian Co-ordinated Collections of Microorganisms (Gent, 
B). The constructed genomic DNA-based microarray was performed as described 
earlier (Boesten et al., 2009). The final array contained 2000 clones which represent 
about 85% (calculated according to Akopyants et al. (2001)) of the genomic material 
of B. breve LMG13208.
Fluorescent labeling and hybridization
Total DNA samples were labeled by random prime labeling. A volume of 1 μl DNA 
sample was diluted in 4.25 μl H2O and mixed with 5 μl of 2.5 x random primer 
(BioPrime Kit, Invitrogen, Breda, NL). The mixture was incubated at 96°C for 5 min. 
After cooling on ice, the samples were shortly centrifuged at maximum speed in an 
eppendorf centrifuge. Subsequently the following components were added while the 
samples were kept on ice: 0.25 μl 50 x AminoAcid-dNTP mix (AA-dNTP) (Invitrogen, 
Breda, NL), 1.75 μl milliQ, and 0.25 μl Klenow fragment (Invitrogen, Breda, NL). 
After addition the samples were incubated at 37°C for 1.5 hours for amplification. 
Unincorporated AA-dUTP and free amines were removed using QIAqiuck columns 
following the protocol described by the supplier (Qiagen Benelux, Venlo, NL). For 
this purpose, five times the reaction volume of PB buffer (Qiagen supplied) was 
added to the samples and the mixture was transferred to a QIAqiuck Spin Column 
that was centrifuged at 20,000 x g for 1 min. To increase the binding efficiency, the 
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flow through was reloaded and the column was centrifuged again at 20,000 x g for 1 
min and the flow through was discarded. To elute the DNA samples from the columns 
they were first washed separately with 500 μl of 80% ethanol and then eluted with 
30 μl of milliQ H2O, a sept that was repeated twice as described by the manufacturer 
(Qiagen Benelux BS, Venlo, NL). The elutate was dried at high temperature in a 
speed vac for about 15-30 min. For coupling of the Cy Dye Esters to the AA-cDNA 
the dried cDNA samples were dissolved in 4.5 μl 0.1 M sodium carbonate buffer 
(Na2CO3), pH 9.0 during 10 min at RT while mixed a few times. Subsequently, 4.5 μl 
of the appropriate NHS-ester Cy Dye (Amersham, Piscataway, USA) were added. 
This reaction mix was incubated for 1 h at room temperature in the dark. After 
incubation, 10 μl of milliQ H2O was added and the samples were centrifuged shortly. 
To remove the unincorporated dyes we used Autoseq G50 (Amersham, Piscataway, 
USA) columns according to the protocol supplied by the manufacturer.
DNA microarrays were prehybridized for 45 min at 42°C in prehybridization 
solution (1% bovine serum albumin, 5xSSC, and 0.1% SDS). Co-hybridizations of 
labeled total DNA samples were performed overnight at 42°C in 40 μl Easyhyb buffer 
(Roche, Almere, NL) according to the manufacturer’s protocol. Slides were washed 
twice in 1 x SSC, 0.2% SDS at 37°C, once in 0.5 x SSC, and twice in 0.2 x SSC at 
RT and dried with N2-flow.
Microarray scan-image and quality analysis 
Performed as described earlier (Boesten et al., 2009). For validation of the labeling 
and hybridization reaction self-self hybridization reactions were performed. 
Normalization, visualization, and data analysis
Genomic DNA samples were hybridized on a microarray. Significance Analysis 
of Microarrays (SAM), Analysis of Variance (ANOVA), and Principle Component 
Analysis (PCA) were performed and visualized using TIGR MeV 3.1 Software (http://
www.tm4.org/mev.html). As a basis for data analysis the 2log values of untreated Cy5 
(sample)/Cy3 (reference LMG13208) signal intensity value ratios (R) were used. 
ANOVA (p-value: 0.01) was used for selecting a set of clones that were specific 
for one genomic cluster (http://www.tm4.org/mev.html). PCA Settings; 100% data 
values, components: 30, covariance, number of neighbours for KNN imputation: 
10. SAM settings; Two-class unpaired, number of permutations: 100, number of 
K-Nearest Neighbours: 10.
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Sequencing of dNa fragments
Plasmid isolation, purification of PCR products and high throughput sequencing was 
performed by GATC Biotech AG, Konstanz, Germany (www.gatc-biotech.com). The 
average clone size was 1.5 kb. All clones were sequenced in parallel using a forward 
(AMPL1) and a reverse (SR2) universal primer. Sequence runs resulted in stretches 
of on average 800 nucleotides. Sequences were compared with public databases 
by using blastn. BLAST analyses were performed against all currently available 
sequenced genomes using the NCBI website (http://www.ncbi.nlm.nih.gov/).
ReSulTS aNd dISCuSSION
Characterization of fecal isolates
Fecal samples were collected from four healthy human infants. Isolate NR200 is 
a commercial strain (Danone Research, Wageningen, NL) isolated from a healthy 
human infant. We want to note that these infants received different diets. Infant 2 
was bottle-fed and infants 3 and 4 were breast-fed (Figure 1). Bacterial strains were 
isolated from these fecal samples, and a set of 19 isolates was characterized as 
Bifidobacterium breve strains, based on 16S rDNA sequencing. Biochemical analyses 
were performed in order to further characterize these isolates. The production of 
ammonia, histamine, tyramine, L-lactate, and D-lactate was measured next to bile 
acid deconjugation activity. These biochemical characteristics were tested because 
of safety criteria (Borriello et al., 2003; FAO/WHO, 2002) on the one hand, and the 
positive effects ascribed to bile salt deconjugation activity on the other hand. Bile salt 
tolerance could contribute to a higher survival in the stomach and small intestine and 
might be necessary for probiotic applications. Based on this biochemical analysis, 
all bifidobacterial isolates showed the ability to deconjugate glycodeoxycholic acid 
(GDCA) and taurodeoxycholic acid (TDCA). Bile salt hydrolase activity is commonly 
found in bifidobacteria and also in the species B. breve. A strong correlation has been 
observed between the habitat and the presence of bile salt hydrolase activity, being 
more often found in fecal isolates compared to other habitats (Tanaka et al., 1999). 
Furthermore, all isolates produced L-lactate but not ammonia, histamine, tyramine, 
or D-lactate. In general bifidobacteria and B. breve are known to produce lactic acid 
in the L-form, which is more easily metabolized by infants compared to the D-form. 
Ammonia is a potentially toxic compound which can be produced in the intestine from 
ureum by bacterial urease activity. Urease activity has been found in bifidobacteria 
but is not very common in the species B. breve (Crociani and Matteuzzi, 1982), which 
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is confirmed in this study. Histamine and tyramine are biogenic amines which can 
irritate the intestinal wall. They are formed from amino acids by the action of bacterial 
decarboxylating enzymes. The presence of this enzyme activity in bifidobacteria is 
not very well studied. Histamine and tyramine are not produced by the B. breve 
isolates tested in this study.
Figure 1. PCA analysis of the samples visualized in a PC1-3 plot which explains 58.5% data variation. 
Settings; 100% data values (1920 clones/sample), components: 30, covariance, number of neighbours 
for KNN imputation: 10. Clusters of B. breve strains and isolates are highlighted by oval shapes and 
coded 1, 2, 3, and 4. Data points are coded by the NR-code of the isolate or the species name, when 
representing a reference strain. When data points overlap, the codes are listed next to the cluster.
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genotyping of human infant fecal b. breve isolates
To gain more insight into the differences in genome content and functional abilities, 
we compared the total genomic material of the Bifidobacterium isolates to eight 
type strains of common human commensal Bifidobacterium species. Total DNA was 
isolated and hybridized on a microarray containing randomly cloned DNA fragments 
of B. breve LMG13208T. The array contained 2000 clones which together represent 
approximately 85% of the B. breve genome. Based on the draft sequence of B. breve 
DSM 20213 (GI:268158265), our array contains about 1975 genes. 2Log (Cy5/Cy3) 
hybridization signal intensity values of the different DNA samples were analyzed by 
principle component analysis (PCA) (Fig. 1). Clones with 100% sample data, 1561 
in total, were selected for PCA analysis in order to have reliable results. PCA plots of 
principle component (PC)1 and 3 (Fig. 1), visualize the variation of the data. PC1, 2, 
and 3, explain 53.9%, 25.9%, and 4.6% of the data variation respectively. Altogether, 
PC1 and PC2 predict 58.5% of the total data variation. Figure 1 shows, that NR200, 
which is a commercial strain, is highly similar to the B. breve type strain. Based on 
PC1 and 2, all fecal isolates cluster together relatively close to the B. breve type (data 
not shown). Interestingly, there seems to be more genetic variation within the genus 
Bifidobacterium than expected. Although all the fecal B. breve isolates cluster together 
in the PC1-2 plot, they can be split up in three groups based on the PC1-3 plot (Fig. 
1). These three clusters correlated exactly with their infant origin. This means that 
although the feces of all studied infants contained B. breve species, each individual 
contained unique strains with significant differences in genomic composition, 30% 
on average (data not shown). Clearly, the genomic clusters of isolates show a large 
genomic diversity. This suggests the presence of possible B. breve subspecies. The 
high correlation of the hybridization patterns within one cluster suggests that the B. 
breve species is represented by one single strain in every infant. These data indicate 
that the population of B. breve within one infant does not always comprise more than 
one strain. Strains with the same characteristics could be competing while focussing 
on the same niche within the gastrointestinal tract of its host.
Our results prove that next to species assignment, the B. breve microarray 
is able to discriminate between isolates within one species. This discriminating 
ability results in generating sets of isolate-specific clones. Significance analysis of 
microarrays (SAM) was used to select 371 specific clones from the whole dataset, 
23% of all clones. To study the functionalities encoded by the DNA fragments that 
are discriminating for the obtained clusters of B. breve strains we selected a subset 
of 43 clones for sequencing (Fig. 2). The major part of the sequenced specific clones 
(n=33) encoded hypothetical sequences (50%), while the rest showed homology 
to genes that encode for ‘life style’ functions (38%), such as membrane transport, 
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signal transduction, and the glycobiome. We have to note that an annotated B. 
breve genome is not available to date. Next to diagnostic clones we included B. 
breve-conserved clones (n=10) in our sequencing experiment. Instead of ‘life style’ 
functions, the conserved clones mainly encoded for genes involved in ‘house-
keeping’ functions (40%), next to hypothetical proteins (40%). From these results we 
concluded that the genomic variation of the different groups of B. breve isolates is 
based on ‘life style’ characteristics. Furthermore, BLAST analysis showed that some 
diagnostic clones had high homology (>95%) to genes present in the genomes of 
other closely related Bifidobacterium spp. (Fig. 2). This could indicate for horizontal 
gene transfer (HGT) events as suggested by Delétoile et al. (2010).
The clones that we describe as discriminating for different strains of B. breve 
(Figure 3), and done not have high homology with other species, could be used as 
molecular markers. The use of molecular markers has shown to be fruitful in relation 
to the genetic characterization of bifidobacteria (Boesten et al., 2009).
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Best BLAST hit (n = 43)
ref|ZP_06595093.1|  beta-galactosidase [Biﬁdobacterium breve DSM 20213]
ref|ZP_06597046.1|  RNA polymerase sigma-E factor [Biﬁdobacterium breve DSM 20213]
ref|ZP_06596521.1|  peptidase, U32 family [Biﬁdobacterium breve DSM 20213]
ref|ZP_06596659.1|  putative tetratricopeptide repeat-containing domain protein [Biﬁdobacterium breve DSM 20213]
ref|ZP_06595280.1|  conserved hypothetical protein [Biﬁdobacterium breve DSM 20213]
ref|ZP_06596810.1|  proteasome ATPase [Biﬁdobacterium breve DSM 20213]
ref|ZP_06595445.1|  ABC transporter, ATP-binding protein Vexp2 [Biﬁdobacterium breve DSM 20213]
ref|ZP_06595218.1|  putative diacylglycerol kinase catalytic domain protein [Biﬁdobacterium breve DSM 20213]
ref|ZP_06595791.1|  mrp protein [Biﬁdobacterium breve DSM 20213]
ref|ZP_06595046.1|  putative PTS system, IIBC component [Biﬁdobacterium breve DSM 20213]
ref|ZP_06595421.1|  putative arylsulfatase-activating protein AslB [Biﬁdobacterium breve 20213]
gb|AE014295.3| C4-dicarboxylate transporter [Biﬁdobacterium longum NCC2705] L
ref|ZP_06596783.1|  C4-dicarboxylate anaerobic carrier [Biﬁdobacterium breve DSM 20213]
ref|ZP_06596780.1|  putative LacI-type transcriptional regulator [Biﬁdobacterium breve DSM 20213]
ref|ZP_03975913.1|  MFS family major facilitator transporter, multidrug:cation symporter [Biﬁdobacterium longum subsp. Infantis ATCC 55813]
ref|ZP_06595331.1|  transposase [Biﬁdobacterium breve DSM 20213]
ref|ZP_06595513.1|  conserved hypothetical protein [Biﬁdobacterium breve DSM 20213]
ref|ZP_06596304.1|  putative two component sensor kinase [Biﬁdobacterium breve DSM 20213]
gi|23465348|ref|NP_695951.1| hypothetical protein BL0772 [Biﬁdobacterium longum NCC2705]L
ref|ZP_06595344.1|  major facilitator superfamily MFS_1 [Biﬁdobacterium breve DSM 20213]
gi|23465798|ref|NP_696401.1| hypothetical protein BL1231 [Biﬁdobacteriumlongum NCC2705]i
ref|ZP_06596390.1|  glycosyl transf rase, group 2 family [Biﬁdobacterium breve DSM 20213]
ref|YP_002323131.1|  hypothetical protein Blon_1677 [Biﬁdobacterium longum subsp. Infantis ATCC 15697]
ref|ZP_06596430.1|  transcriptional regulator, LacI family [Biﬁdobacterium breve DSM 20213]
ref|ZP_06595995.1|  hypothetical protein BIFBRE_03821 [Biﬁdobacterium breve DSM 20213]
ref|ZP_06596330.1|  conserved hypothetical protein [Biﬁdobacterium breve DSM 20213]
ref|ZP_06596330.1|  conserved hypothetical pr tein [Biﬁdobacterium breve DSM 20213]
ref|ZP_06596330.1|  conserved hypothetical protein [Biﬁdobacterium breve DSM 20213]
ref|ZP_06596398.1|  phosphatidylglycerol--membrane-oligosaccharide glycerophosphotransferase [Biﬁdobacterium breve DSM 20213]
ref|ZP_06596395.1|  polysaccharide ABC transporter membrane-spanning protein [Biﬁdobacterium breve DSM 20213]
ref|ZP_06596397.1|  glycosyl transferase, group 2 family [Biﬁdobacterium breve DSM 20213]
ref|ZP_06596263.1|  conserved hypothetical protein [Biﬁd bacterium breve DSM 20213]
ref|ZP_06596146.1|  oxidoreductase, short chain dehydrogenase/reductase family [Biﬁdobacterium breve DSM 20213]
ref|ZP_06597028.1|  phage integrase [Biﬁdobacterium breve DSM 20213]
gb|CP001095.1| conserved hypothetical protein [Biﬁdobacterium longum subsp. infants ATCC 15697]i
ref|ZP_06595984.1|  daunorubicin resistance protein [Biﬁdobacterium breve DSM 20213]
ref|ZP_06596767.1|  putative CoA-substrate-speciﬁc enzyme activase [Biﬁdobacterium breve DSM 20213]
ref|ZP_06597004.1|  conserved hypothetical protein [Biﬁdobacterium breve DSM 20213]
ref|ZP_06597149.1|  conserved hypothetical protein [Biﬁdobacterium breve DSM 20213]
ref|ZP_06596257.1|  macrolide export ATP-binding/permease protein MacB [Biﬁdobacterium breve DSM 20213]
ref|ZP_06595133.1|  glycogen phosphorylase [Biﬁdobacterium breve DSM 20213]
ref|ZP_06595986.1|  putative bacterial regulatory protein [Biﬁdobacterium breve DSM 20213]
ref|ZP_06595986.1|  putative bacterial regulatory protein [Biﬁdobacterium breve DSM 20213]
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Figure 3. The composition of the KEGG orthologies (www.genome.jp/kegg/) of the sub selection of 33 
specific and 10 conserved clones listed in Figure 2, according to their encoding gene homology.
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Chapter 4
Bifidobacterium  population analysis in the infant gut by 
direct mapping of genomic hybridization patterns: 
potential for monitoring temporal development and ef-
fects of dietary regimens
Rolf J. Boesten, Frank h.J. Schuren, kaouther Ben amor, Monique haarman, 
Jan knol, and Willem M. de Vos
A bifidobacterial mixed-species microarray platform was used in a proof-of-principle 
study to address the composition and development of bifidobacteria in DNA extracted 
from fecal samples. These were collected in a time course of two years since birth and 
derived from human infants that were breast-fed, standard formula-fed, or received a 
prebiotic formula during their weaning period. A set of over 50 samples was analyzed, 
testifying for the throughput of the designed platform for multiple genome hybridizations. 
The generated data revealed that fecal samples of breast-fed infants contained a high 
abundance of genomic DNA homologous to Bifidobacterium breve. In contrast, fecal 
samples from standard formula-fed infants lacked detectable amounts of this B. breve 
DNA but contained genes with high similarity to B. longum. Remarkably, infants that 
received breast milk and later a prebiotic formula consisting of a standard formula milk 
containing a mixture of specific galacto- and fructo-oligosaccharides, continued to 
harbor a B. breve-dominant fecal population. One infant that received standard formula 
in combination with the additional B. lactis Bb12 culture, contained significant amounts 
of fecal DNA belonging to Bb12 but only during the period of ingestion. The microarray 
platform showed sufficient sensitivity to analyze the B. breve group at the strain level. 
Overall, the B. breve populations observed in the fecal samples of the studied infants 
showed a stable composition over time and were unique per infant. In conclusion, our 
results show the applicability of comparative genome hybridization to study bifidobacterial 
populations in infant fecal samples without the use of any amplification step.
Microbial Biotechnology, 2010, early view, doi:10.1111/j.1751-7915.2010.00216.x
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INTROduCTION
The human gastrointestinal tract (GIT) is colonized since birth by a complex community 
of microorganisms that is known to impact its host (Hooper and Gordon, 2001; 
Vaughan et al., 2005; Zoetendal et al., 2008). The contribution of the GIT microbiota 
to converting dietary components into short chain fatty acids with significant caloric 
value, vitamins and other health-promoting compounds, has been well established. 
However, the interest in determining the microbial composition and its development 
is growing as it has been shown that the GIT microbiota has developed intimate 
relations with its host, communicates with its immune system, and can be affected 
by specific dietary components or bacteria, such as those marketed as prebiotics 
and probiotics (Ouwehand et al., 2005; Saxelin et al., 2005; van Baarlen et al., 2009; 
Zoetendal et al., 2008).
The microbial composition of the adult human gut has been subject to multiple 
studies and found to consist of an individual core that is relatively stable in time 
(Zoetendal et al., 2008). Moreover, phylogenetic analyses of adult subjects has 
revealed a general core of bacterial representatives shared between multiple 
individuals of different ages (Rajilic-Stojanovic et al., 2009; Tap et al., 2009). This 
was confirmed at the genomic level by recent massive parallel sequence analyses 
of the adult gut microbiome although at a lower level of depth (Kurokawa et al., 2007; 
Qin et al., 2010; Turnbaugh et al., 2009).
 In contrast to the large attention for the adult microbiota, there is only limited 
information on the development of our intestinal microbe in early life. This is partly 
due to the large variability in the microbial colonization that is encountered after birth, 
as was observed in a longitudinal study using culture independent global analyses 
with a limited set of newborns in the Netherlands (Favier et al., 2002). This was 
confirmed in a more recent comprehensive and longitudinal studies with US babies 
(Dominguez-Bello et al., 2010; Palmer et al., 2007). It is likely that the first bacterial 
contact will be different for every individual and in most cases the intestinal inoculum 
for the newborn baby will derive from the mother. Deep genome sequencing studies 
of the mother and child intestinal microbiota appear to confirm this (Turnbaugh et al., 
2009). We hypothesize that depending on the infants’ environmental and host factors, 
certain groups of bacteria will be favored and dominate their intestinal microbiota. 
One group of commensal bacteria, those belonging to the genus Bifidobacterium, 
is found among the first colonizers of the baby intestine, notably when breast-fed 
(Benno et al., 1984; Favier et al., 2002; Harmsen et al., 2000; Penders et al., 2006). 
Remarkably, different results were observed in the recent studies indicating that 
bifidobacteria are present in only a small fraction of infants or are not numerically 
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dominant in babies (Hopkins et al., 2005; Palmer et al., 2007). However, this may be 
due to bias introduced by the methodologies of DNA extraction or PCR detection as 
discussed recently (Salonen et al., 2010). Alternatively, geographic origin (EU versus 
US), diet or both may play a role in explaining this difference that is in particular 
notable in view of the presumed interactions of bifidobacteria and our immune system 
(Boesten and de Vos, 2008; O’Hara and Shanahan, 2006). Data on the compositions 
of bifidobacterial populations in infants show variable results, partly reflecting the high 
variability between the baby microbiota. Overall, B. longum, B. breve, B. infantis, and 
B. adolescentis have been found in fecal samples of healthy human infants (He et al., 
2001b; Matsuki et al., 1998; Turroni et al., 2009a). A broader set of species has been 
described for the ‘adult-like’ bifidobacterial microbiota including additional species 
of B. catenulatum, B. bifidum and B. pseudolongum (He et al., 2001a; Matsuki et 
al., 1998; Turroni et al., 2009a). Moreover, there are indications for a several new 
Bifidobacterium species in the human gut that so far have not been cultured (Ben Amor 
et al., 2005; Turroni et al., 2009b). The development of the infant microbial community 
from the time of birth to the ‘adult-like’ composition often follows the introduction of 
solid foods after weaning and its timeframe is poorly understood. Similarly, the effect 
of diet on the composition of the infant microbiota is also controversial. Numerous 
studies have found a lower abundance of bifidobacteria and a higher abundance of 
aerobic bacteria in the microbiota of formula-fed infants relative to breast-fed infants 
(Harmsen et al., 2000; Hopkins et al., 2005; Penders et al., 2006), yet other reports 
have found no such difference (Penders et al., 2005). An explanation could be that 
these studies have to cope with numerous different parameters such as differences 
between babies, extraction methods, sample storage, and detection platforms. 
Interestingly, bifidobacteria have been detected in breast-milk samples using 
culture-independent molecular techniques (Collado et al., 2009; Gronlund et al., 2007; 
Gueimonde et al., 2007). Although it is not clear how translocation of bifidobacteria 
from intestine to breast-milk occurs within the mother, it has been shown that breast-
milk contains similar bacteria both before and after breast-feeding, rendering the 
possibility of inoculation of the breast-milk by the infant less likely. Recently, it has 
been suggested that the colonization of breast-milk may take place by transfer of 
intestinal bacteria within the phagocytosing cells from the mothers gut to breast-milk 
(Martín et al., 2004; Perez et al., 2007). Interestingly, bifidobacterial translocation 
has recently been shown to occur after oral administration in a particular mouse 
model (Cronin et al., 2010). In addition, DNA from intestinal bifidobacteria was 
detected in human placenta samples. Although no bifidobacteria could be cultured, 
this suggests that horizontal transfer of bacterial DNA from mother to foetus may 
occur via the placenta (Satokari et al., 2009). These results imply that a constant 
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supply of bifidobacteria to the infant’s intestine is thus assured during breastfeeding 
and will affect the development of the intestinal microbiota.
For further studying the impact of bifidobacteria or other bacterial groups, it is 
essential to have reliable, quantitative and identification tools with high discriminating 
abilities. A variety of culturing-independent microbial screening and detection 
techniques have been developed. Small subunit (SSU) ribosomal DNA (rDNA) 
sequence analysis via cloning or pyrosequencing (Andersson et al., 2008; Kwon 
et al., 2005; Matsuki et al., 1998), temperature/denaturing gel electrophoresis (D/
TGGE) (Favier et al., 2002; Zoetendal et al., 1998) and terminal-restriction fragment 
length polymorphism (T-RFLP) (Zoetendal et al., 2008) are useful for identifying the 
dominant members of a population and for discovering new rDNA species (Nagashima 
et al., 2003), but inadequate for detection and quantification of rare species while 
they all rely on PCR amplifications. Other currently available quantitative techniques, 
such as fluorescence in situ hybridization (FISH) (Amann et al., 1990; Amann et al., 
1995; Moter and Gobel, 2000), dot-blot hybridization (Hopkins et al., 2005) and real-
time PCR (Haarman and Knol, 2005; Penders et al., 2005), are not easily applied to 
large numbers of taxonomic groups or also need an amplification reaction. Recently, 
16S rRNA-based phylogenetic microarrays have been developed to study the 
intestinal microbial ecology of different age groups (Claesson et al., 2009; Palmer et 
al., 2007; Rajilic-Stojanovic et al., 2009; Zoetendal et al., 2008). Moreover, a variety 
of genomics approaches including comparative genome hybridization have been 
developed to study the functionality of bifidobacteria (Ventura et al., 2009). Previously, 
we described the development and application of comparative genome hybridization 
approach involving a Bifidobacterial Mixed-Species (BMS)-microarray platform, 
consisting of genomic DNA fragments that are specific for Bifidobacterium species 
and phylogenetic groups of bifidobacteria (Boesten et al., 2009). Here, we expand 
the use of this BMS-microarray to analyze complex Bifidobacterium communities in 
fecal samples that were obtained from six healthy human infants that were either 
breast-fed, standard formula-fed, or fed with probiotic of prebiotic formulas. From 
every infant ten fecal samples ranging from the first week to 2 years of age were 
analyzed for their Bifidobacterium DNA content and composition. Specific patterns 
were observed that showed the impact of the diet notably on the development of 
B. breve communities. This proof of principle study illustrates the potential of using 
comparative genome hybridization in fecal samples and shows population shifts at 
the strain level obviating the need for cultivation and amplification procedures.
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ReSulTS
Analysis of the bifidobacterial community based on genomic 
hybridization patterns
We designed a culture-independent tool for analyzing the composition of 
bifidobacterial communities within complex microbial samples on species and strain 
level by generating and mapping of genomic hybridization patterns. This tool is based 
on a random clone microarray containing total DNA of those bifidobacterial species 
that have been found in the human intestinal tract. DNA from collected fecal samples 
was extracted to test the applicability of the microarray platform as a molecular tool 
in a proof-of-principle study (Fig. 1). Fecal samples were obtained from six healthy 
human infants who received different diets during their weaning period. Two infants 
were breast-fed, two were fed with a standard formula – one of them received 
an additional supplement of viable B. lactis Bb12 cells, and two were fed with a 
formula containing a prebiotic mixture of galacto- and fructo-oligosaccharides (GOS 
and FOS, respectively). In order to study the temporal development and changes 
of the bifidobacterial composition, a total of 10 samples were analyzed per infant 
and the first sample was obtained at day 5 and the final sample at an age of 25 
months (Fig. 1). The microarray results show that most fecal samples of each of the 
infants turned out to be Bifidobacterium-positive (Fig. 2). Furthermore, we generally 
observed a drop in hybridization signals, in general the majority (over 90 %) of the 
signals disappeared, from the moment the infants reached the age of 1 year. In most 
cases, this time-point correlates with the change of diet. Overall, during the period 
between 6 and 12 months of age the infants received a mixed diet. This means that 
next to their weaning they started to ingest solid food. This obviously affects the 
composition of their intestinal microbiota. To verify whether there was any effect 
on the total community and that of bifidobacteria in particular, we performed qPCR 
amplification of strategic phylogenetic groups (see below). In line with the array data 
the bifidobacteria qPCR values also dropped, indicating that the absolute amount of 
Bifidobacterium DNA was decreased (Fig. 2). 
The presented microarray data showed that the samples from two infants who 
were breast-fed for at least one year, infant A and B, showed presence of DNA 
fragments that are highly homologous to B. breve DNA (Figs. 2A and 2B). The DNA 
samples originating from infants C and D, who were fed a standard formula, showed 
abundance of bifidobacterial DNA which was highly homologous to DNA of B. longum 
subsp. longum (Figs. 2C and 2D). Additionally, the samples isolated from the feces of 
infant D contained DNA that hybridized also with marker clones for the B. animalis/B. 
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lactis group. This latter observation is in concordance with the feeding trial of the 
viable B. lactis Bb12 supplement, which started from birth and ended of 12 months. 
The infants that received a prebiotic mixture showed a shift in the bifidobacterial 
composition (Figs. 2E and 2F). This shift was observed between week 8 and week 
12. Interestingly, this correlates with the start of the prebiotic mixture feeding trial 
at week 10. From week 12, DNA homologous to B. breve becomes more abundant 
whereas DNA of other Bifidobacterium species disappears (Fig. 2).
Validation by qpCR analysis
To support the microarray results and to gain information on the quantitative amounts 
of Bifidobacterium species present in the fecal samples, a series of qPCR analyses 
were performed as summarized in heat maps (Fig. 2). Although it is a totally different 
approach based on specific ribosomal RNA sequences, the qPCR results were in 
line with the data obtained by the microarray platform. This means that when the 
microarray detected DNA homologous to the DNA of a specific Bifidobacterium 
species, the qPCR platform detected the presence of DNA originating from that same 
species. Differences between qPCR and microarray results can be explained by the 
fact that qPCR is a more quantitative measurement than the microarray platform. The 
dynamic ranges of the platforms are quite comparable and the microarray platform 
could detect as little as 0.1% of the DNA isolated from the fecal samples (data not 
shown). However, the microarray platform provided detailed information on the 
genetic content and shifts within one species or phylogenetic group of bifidobacteria 
that goes beyond the detection capacity of qPCR (see below).
Screening for genomic shifts within one Bifidobacterium species group 
in time
Due to its high resolution output, the microarray platform does not only give 
information on shifting of bifidobacterial species but also enables to zoom in at the 
strain level. Comparison of hybridization signals, results in detailed information on 
the shifting of bifidobacterial genomic material even within a single species, which 
suggests succession of strains. Using this principle, we analyzed the DNA samples 
and zoomed in on the composition of the B. breve species group of each infant (Fig. 
3). We concluded that every infant contained a unique B. breve community, with the 
exception of the fecal samples of infants C and D that did not contain any B. breve 
related DNA (Fig. 3). This was observed earlier as visualized in Fig. 2. The B. breve 
populations were generally stable in time. Concentrating on the differential markers 
within the B. breve set, we detected a shift in time in the hybridization pattern of 
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Figure 2. Heat map visualization of the microarray- and qPCR-based screening of the Bifidobacterium 
composition of fecal samples of six infants who received three different diets (Fig. 1). Time-course samples 
are indicated by the age of the infant (D=day, W=week, M=month). The microarray data are presented 
as the percentage of marker-clones, per species or species group (Table 1), that give a significant 
hybridization. The percentages are visualized according to the colour-bar above the heat map. The qPCR 
results are presented as DNA concentrations (nanograms of DNA per sample) of the different species and 
visualized according to the colour-bar above the heat map.The asterisk (*) indicates data not available.
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Figure 3. Hierarchical clustering (Pearson correlation) of the hybridization signals of genomic DNA 
fragments within the B. breve marker set for all fecal samples in time-course order. Signal intensities 
are indicated by a black-white color gradient. On the X-axis the sample codes are presented (D=day; 
W=week; M=month). Samples from one infant are highlighted by the bars above the codes as indicated 
in Figure 1.
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infant B (Fig. 3). We conclude that the B. breve group of this infant gained and lost 
specific B. breve-specific DNA fragments at approximately 12 weeks of development. 
However, a core B. breve genome seemed to be present in both situations. We 
hypothesize that a B. breve population always contains the B. breve core genome 
plus B. breve strain-specific genomic fragments. To gain more insight in the genes 
encoded by these fragments we have sequenced a subset of 11 genomic B. breve 
markers (Fig. 4). Fragments 1 and 2 are present in all samples that are known to 
contain B. breve, based on the qPCR results. We suggest that they belong to the 
B. breve ‘core-genome’ (Fig. 4). Fragments 5 and 6 (Fig. 4) seem to appear in the 
later time-samples in infant B but were present in all time-samples of infant A. These 
fragments must be strain-specific. The best BLASTx hits all showed more than 
98% sequence homology to genes in the published B. breve DSM 20213 genome 
(ACCG02000000) and had E-values close to zero. Fragments 9, 10, and 11 are not 
specific for any of the fecal isolates but only for the B. breve type strain that was used 
for defining the species-specific marker fragments (Table 1). Inspection of the other 
fragments showed them to code for stress related functions, proteins involved in cell 
envelope integrity or location hypothetical proteins. Remarkably, fragment 1 and 4 
coded for a potential sugar-specific PTS transport component and a β-glycosidase 
that were both almost or completely absent in the babies that received standard 
formula. It is tempting to speculate that the used formula product lacks the sugars 
present in the breast milk and prebiotic FOS/GOS mixture that was used to feed the 
other babies.
dISCuSSION
In this study we showed that comparative genome hybridization using a bifidobacterial 
mixed species microarray platform can be applied as a culture-independent tool to 
analyse the composition and development of Bifidobacterium populations in fecal 
samples from human infants. Using this microarray platform we obtained a high 
resolution data output which enabled us to zoom in towards the species and strain 
level of the bifidobacterial population. An advantage of our approach is that we did 
not need to enrich our DNA samples for bifidobacterial DNA. While qPCR is more 
quantitative than the microarray platform, both approaches have similar sensitivity 
and dynamic range. Our observations showed differences in composition of fecal 
bifidobacterial communities in developing infants. As this study serves as a proof of 
principle, we want to stress that these results are based on a limited set of infants. 
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Nevertheless, the data suggests an obvious 
link between diet and Bifidobacterium 
population. Moreover, our results indicate 
that the prebiotic formula applied in this 
study affects the composition of the 
intestinal Bifidobacterium population. As 
indicated previously (Bakker-Zierikzee et 
al., 2005), the composition of the infants 
who received the FOS/GOS mixture 
seems to be shifted towards the direction 
of the Bifidobacterium community as found 
in infants who were breast-fed, in contrast 
to the standard-formula diet (Fig. 2). In line 
with other studies no B. pseudolongum 
homologous DNA was detected in the 
fecal samples tested (Benno et al., 1984; 
Favier et al., 2002; Favier et al., 2003; 
Haarman and Knol, 2005; Harmsen et al., 
2000; Matsuki et al., 1999). In conclusion, 
we expect that in combination with a large 
well-defined sample set, the described 
comparative hybridization approach with 
the microarray platform will contribute to 
a better understanding of our intestinal 
microbial ecology. Furthermore, this 
application could be combined with next 
generation sequencing to generate a pan-
genomic Bifidobacterium screening tool.
expeRIMeNTal pROCeduReS
Sample collection, dNa isolation 
and qpCR analysis
A selection of fecal samples, collected 
during the study described by Bakker-
Zierikzee et al. (2005), formed the basis 
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of this study (Bakker-Zierikzee et al., 2005). Detailed information on the samples is 
visualized in Figure 1.
For the total DNA isolation from fecal samples, a 96 wells plate (Axygen, VWR, 
Amsterdam, NL) was filled with 250 μl 0.1 mm zirconium beads (Brunschwig Chemie, 
Amsterdam, NL) washed in lysis buffer without detergents (Agowa, Berlin, D), 200 
μl phenol solution (Tris pH 8.0), and 250 μl lysis buffer without detergents (Agowa 
GmbH, Berlin, D). Subsequently, per well a volume of a fully loaded inoculation loop, 
(Greiner Bio One, Alphen a/d Rijn, NL), resembling 10 μl of fecal sample was added 
to the mixture. After 2 min of bead beating (Mini Beadbeater, Biospec Products, Lab 
Services, Breda, NL) the plate was cooled on ice. Then the plate was centrifuged for 
10 min at 1,700 x g and 20°C. The supernatant, about 175 μl, was transferred into 
a 0.5 ml 96 wells plate (Axygen, VWR, Amsterdam, NL) and 100 μl phenol solution 
(in Tris pH 8.0) was added. After 10 min of centrifuging at 1,700 x g and 20°C the 
supernatant, per well approximately 150 μl, was transferred into a 96 wells PCR plate 
(Bioplastics, Landgraaf, NL). The DNA was extracted by magnetic beads using the 
Agowa DNA extraction kit (http://www.lgc.co.uk/divisions/life__food_sciences.aspx) 
according to the protocol supplied by the manufacturer. The supernatant, containing 
the DNA, was stored at -20°C.
qPCR analysis was performed as described by Haarman and Knol (2005). Finally, 
the qPCR data was visualized using TIGR MeV 3.1 Software (http://www.tm4.org/
mev.html).
array design and construction
A genomic library was constructed from seven strains representing seven different 
Bifidobacterium species as described previously (Boesten et al., 2009) with the 
difference that the B. pseudolongum library has been replaced by two single 
strain libraries of B. breve LMG 13208T (BRE) and B. catenulatum LMG 11043T 
(CAT). These strains were obtained from the Belgian Co-ordinated Collections of 
Microorganisms (BCCM), Ghent, B. In total this microarray contains four different 
libraries. The libraries of BRE and CAT were constructed from genomic material and 
contain 2000 clones which represent about 85% (calculated according to Akopyants 
et al. (2001)) of the genomes. Except for the fragmentation of the total DNA of B. 
catenulatum, the construction of the BRE and the CAT libraries was performed 
as previously described in Boesten et al. (2009). The B. catenulatum DNA was 
fragmentized by blunt-ended partial digestion using Hae III (New England Biolabs, 
Westburg, Leusden, NL). 10 μl total DNA (~600 ng/ μl) was combined with 9 μl 
reaction buffer 2 (New England Biolabs, Westburg, Leusden, NL), 1 μl HaeIII, and 80 
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μl milli Q water and subsequently incubated at 37°C for 20 min. After incubation the 
DNA samples were loaded in 1.5% agarose/1 x TAE gel. Samples sized from 1 to 2 
kb were isolated from gel during electrophoresis using Takara Recochips (TaKaRa 
Bio, Lonza Verviers, Verviers, BE) according to the protocol provided by the supplier. 
Due to the blunt-end restriction of HaeIII, end-repair as described in Boesten et al. 
(2009) was not necessary.
Fluorescent labeling and hybridization
Total DNA samples were labeled by random prime labeling. A volume of 1 μl DNA 
sample was diluted in 4.25 μl H2O and mixed with 5 μl of 2.5 x random primer 
(BioPrime Kit, Invitrogen, Breda, NL). The mixture was incubated at 96°C for 5 min. 
After cooling on ice, the samples were shortly centrifuged at maximum speed in an 
eppendorf centrifuge. Subsequently the following components were added while the 
samples were kept in ice: 0.25 μl 50 x AminoAcid-dNTP mix (AA-dNTP) (Invitrogen, 
Breda, NL), 1.75 μl milliQ, and 0.25 μl Klenow fragment (3-9 U/μl) (Invitrogen, Breda, 
NL). After addition the samples were incubated at 37°C for 1.5 hours for amplification. 
Unincorporated AA-dUTP and free amines were removed using QIAqiuck columns 
following the protocol described by the supplier (Qiagen Benelux BS, Venlo, NL). 
For this purpose, five times the reaction volume of PB buffer (Qiagen supplied) was 
added to the samples and the mixture was transferred to a QIAqiuck Spin Column 
that was centrifuged at 20,000 x g for 1 min. To increase the binding efficiency, the 
flow-through was reloaded and the column was centrifuged again at 20,000 x g for 1 
min and the flow through was discarded. To elute the DNA samples from the columns 
they were first washed separately with 500 μl of 80% ethanol and then eluted with 
30 μl of milliQ H2O, a step that was repeated twice as described by the manufacturer 
(Qiagen Benelux, Venlo, NL). The elutate was dried at high temperature in a speed 
vac for about 15-30 min. For coupling of the Cy Dye Esters to the AA-cDNA the dried 
cDNA samples were dissolved in 4.5 μl 0.1 M sodium carbonate buffer (Na2CO3), 
pH 9.0 during 10 min at room temperature while mixed a few times. Subsequently, 
4.5 μl of the appropriate NHS-ester Cy Dye (Amersham, Piscataway, USA) were 
added. This reaction mix was incubated for 1 h at room temperature in the dark. After 
incubation, 10 μl of milliQ H2O was added and the samples were centrifuged shortly. 
To remove the unincorporated dyes we used Autoseq G50 (Amersham, Piscataway, 
USA) columns according to the protocol supplied by the manufacturer.
DNA microarrays were prehybridized for 45 min at 42°C in prehybridization 
solution (1% bovine serum albumin, 5 x SSC, and 0.1% SDS). Co-hybridizations 
of labeled DNA samples were performed overnight at 42°C in 40 μl Easyhyb buffer 
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(Roche, Almere, NL) according to the manufacturer’s protocol. Slides were washed 
twice in 1 x SSC, 0.2% SDS at 37°C, once in 0.5 x SSC, and twice in 0.2 x SSC at 
RT and dried with N2-flow.
Microarray scan-image and quality analysis were performed as described 
previously (Boesten et al., 2009).
diagnostic clone selection, visualization, and clustering analysis
For the selection of diagnostic clones we normalized the obtained hybridization data 
as described previously (Boesten et al., 2009). For each Bifidobacterium species we 
defined diagnostic clones. A diagnostic clone has a ‘high homology’ classification for 
a specific Bifidobacterium species and a ‘low homology’ classification for all other 
species. Due to the genetic variation between species and the different sizes of the 
libraries printed on the array the numbers of markers vary per species of species 
group. The number of diagnostic clones for every species or group of species is 
listed in Table 1.
For visualization of the produced hybridization values, the data was converted into 
percentages of marker clones that show significant hybridization signals (Boesten et 
al., 2009). This was performed for every marker group on the microarray (Table 1). 
The percentages give an indication for the rate of similarity of the genomic DNA 
fragments for each Bifidobacterium group, present in the total DNA sample isolated 
from the fecal sample. Finally, this data was visualized using TIGR MeV 3.1 Software 
(http://www.tm4.org/mev.html).
The hierarchical clustering of untreated Cy5 signal intensity data, based on a 
Pearson correlation, was performed and visualized with TIGR MeV 3.1 Software 
(http://www.tm4.org/mev.html).
Sequencing of dNa fragments
Plasmid isolation, purification of PCR products and high throughput sequencing 
were performed by GATC Biotech AG, Konstanz, Germany (www.gatc-biotech.com). 
Sequences were compared with public databases by using BLASTx and BLASTn. 
Blast analyses were performed against all sequenced genomes in the database 
using the NCBI website (http://www.ncbi.nlm.nih.gov/).
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Table 1. Marker groups, the number of marker clones they include, and the strains of origin.
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B. adolescentis *           141 
B. animalis/B.lactis  * *         68 
B. bifidum    *        49 
B. breve     * *      227 
B. breve/B. infantis     * * *     129 
B. breve/B. infantis/
B.longum
     * * * * *   204 
B. infantis/B. longum       * * *   127 
B. longum        * *   167 
B. catenulatum          *  1348 
B. pseudolongum           * 103 
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Mixed-species genomic microarray analysis of fecal 
samples reveals differential transcriptional response of 
bifidobacteria in breast- and formula-fed infants
eline S. klaassens, Rolf J. Boesten, Monique haarman, Jan knol, 
Frank h.J. Schuren, elaine e. Vaughan, and Willem M. de Vos
Although their exact function remains enigmatic, bifidobacteria are among the first colonizers 
of the intestinal tract of newborn infants, and further develop to abundant communities, notably 
in response to the diet. Therefore, the transcriptional response of bifidobacteria was studied 
in rapidly processed fecal samples from young infants that were fed either breast milk or a 
formula containing a mixture of galacto- and fructoligosaccharides were studied. The presence 
and diversity of the bifidobacterial fecal communities were determined using PCR-denaturing 
gradient gel electrophoresis and quantitative real-time PCR for specific species. Changes in total 
number of bifidobacteria as well as in species diversity were observed, indicating the metabolic 
activities of bifidobacteria in the human gut. In addition, total RNAs isolated from infant feces 
were labeled and hybridized to a bifidobacterium-specific microarray comprising approximately 
6,000 clones of the major bifidobacterial species of the human gut. Approximately 270 clones 
that showed the most prominent hybridization with the samples were sequenced. Fewer than 
10% of the hybridizing clones contained rRNA genes, whereas the vast majority of the inserts 
showed matches with protein-encoding genes predicted to originate from bifidobacteria. 
Although a wide range of functional groups was covered by the obtained sequences, the largest 
fraction (14 %) of the transcribed genes assigned to a functional category were predicted to 
be involved in carbohydrate metabolism, while also some were implied in exopolysaccharide 
production or folate production. A total of three of the above-described protein-coding genes 
were selected for quantitative PCR and sequence analysis, which confirmed the expression of 
the corresponding gene and the expected nucleotide sequences. In conclusion, the results of 
this study show the feasibility of obtaining insight into the transcriptional responses of intestinal 
bifidobacteria by analyzing fecal RNA and highlights the in vivo expression of bifidobacterial 
genes implicated in host-related functions.
Applied Environmental Microbiology, 2009, 75 (9); p.2668-2676
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INTROduCTION
Following birth, the virtually sterile gastro-intestinal tract of neonates become rapidly 
colonized by microbial communities, collectively know as microbiota, which rapidly 
increase in complexity (Favier et al., 2002)). The vast majority reside in the colon, 
where densities approach 1011–1012 cells per gram, the highest recorded for any 
microbial habitat (Whitman et al., 1998). Here, hundreds of bacterial species form a 
bacterial community in which bifidobacterial species can constitute up to 60 % of the 
total population in infants (Harmsen et al., 2000). It has been shown previously that 
various environmental factors affect the microbiota development, including the feeding 
regimen of the infant (Harmsen et al., 2000). Bifidobacteria are heterofermentative, 
non-motile, non-spore forming rods; these gram-positive bacteria have high G+C 
contents in their genomic DNA and belong to the Actinobacteria phylum, within 
which they form a distinct order (Biavati and Mattarelli, 2001). At present, the genus 
Bifidobacterium includes 32 species and 9 subspecies, many of which have been 
isolated from fecal sources (Ventura et al., 2007a). The species mostly isolated from 
samples obtained from breast-fed or formula-fed infants is Bifidobacterium breve, 
followed by B. longum ssp. infantis, B. longum and B. bifidum (Marteau et al., 2001). 
In addition, B. catenulatum, B. adolescentis, B. pseudolongum, and B. dentium have 
been detected but less frequently (Haarman and Knol, 2005). It has been reported that 
the postnatal maturation of a balanced immune system requires a constant microbial 
stimulation from the developing intestinal microbiota (Cebra, 1999; Hooper, 2004). 
Moreover, the intestinal microbiota has been claimed to have many beneficial effects, 
and specifically, the bifidobacteria that have been implicated in protection against 
pathogens (Gibson and Wang, 1994), the normal development and maintenance of 
a balanced immune system (Cebra, 1999; Hooper, 2004; Schiffrin and Blum, 2002), 
and the exertion of positive nutritional effects for the intestinal cells and the host 
(O’Sullivan, 2001). In spite of the numerous studies on the diversity of bifidobacteria 
in the human intestine, insight in the specific activity and function of bifidobacteria 
in the gastrointestinal tract remains very sparse. Most studies have focused on 
molecular techniques targeting the 16S rRNA genes, such as PCR-denaturing 
gradient gel electrophoresis (PCR-DGGE) (Satokari et al., 2001), fluorescent in situ 
hybridization (FISH) (Harmsen et al., 2002),  quantitative real-time PCR (qPCR) 
(Haarman and Knol, 2005), and more recently, DNA microarrays (Zoetendal et al, 
2008), to identify and quantify the different intestinal inhabitants of the gut. However, 
a new era has started with the sequence characterization of bifidobacterial genomes 
(Ventura et al., 2009). In silico analysis of the total genome sequence of B. longum 
NCC2705 predicted this bacterium to be adapted to a special colonic niche (Schell 
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et al., 2002). Several genes are predicted to encode for transcriptional regulators, 
which allow quick and stringent responses to environmental changes. Moreover, 
some genes are predicted to code for proteins that show homology to glycoprotein-
binding fimbriae, structures that may be involved in adhesion and persistence in 
the gastrointestinal tract (Schell et al., 2002). Unfortunately, only a few complete 
bifidobacterial genomes have been reported, and only the full annotation of B. longum 
NCC2705 (Schell et al., 2002), B. longum DJO10A (Lee et al., 2008), B. adolescentis 
ATCC15703 (Ventura et al., 2007a), B. longum ssp. infantis ATCC15697 (Sela et al., 
2008), and Bifidobacterium animalis ssp. lactis (Kim et al., 2009) have been made 
publicly available. A significant portion of the B. adolescentis genome differs from 
the B. longum genome, reflecting the evolutionary difference between these species 
based on 16S rRNA genes. Genes coding for lacto-N-biose  (LNB) phosphorylase, 
1,2-α-L-fucosidase and endo-α-N-acetyl galactosamidase, which are associated with 
host-bacterial interaction, were absent in the B. adolescentis genome, suggesting an 
alternative strategy for this species to interact with the host (Ventura et al., 2007a). 
Genomic sequences, however, only provide a static view, and insight in the 
expression levels of the predicted genes in the intestinal tract is not yet available. 
In the present study we investigated the feasibility of using rapidly processed 
fecal samples of infants to determine the bifidobacterial transcriptome with a DNA 
microarray based on 6,000 clones from a shotgun library, hereby bypassing the 
need for genome sequence information (Parro and Moreno-Paz, 2003). This mixed 
species microarray was recently developed and used to study the transcriptome of 
B. longum grown in vitro in the presence of human milk (Gonzalez et al., 2008). To 
improve our understanding of the interaction between bifidobacteria and the host, 
fecal microbiota of infants receiving solely human breast milk and those receiving an 
infant formula containing a mixture of galacto-oligosaccharides (GOS) and fructo-
oligosaccharides (FOS) (Arslanoglu et al., 2007; Moro et al., 2006), were studied at 
the transcriptional and diversity level. The results reveal the expression of a selection 
of genes that may be related to the adaptive responses of these species to the 
physiological gastrointestinal conditions.
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MaTeRIalS aNd MeThOdS
Subjects
In a preliminary study, the transcriptome of fecal microbiotas from four infants ranging 
in age from 1 week to 10 months was evaluated to test the feasibility of the selected 
approach for the detecting the expression of protein-encoded genes with the clone-
based microarray described previously (Boesten et al., 2009). High-quality RNA 
preparations obtained from infants of various ages contained only a low number of 
sequences complementary to rRNA (less than 10% of the total hybridizing clones; 
data not shown). Hence, we systematically monitored two breast-fed infants (infants 
1 and 2) and three formula-fed infants (infants 3 to 5) over time in a controlled dietary 
intervention. During the trial, the formula-fed infants received a milk-based formula 
containing a mixture of GOS and long-chain FOS (lcFOS) (9:1 [wt/wt]) (Arslanoglu 
et al., 2007; Moro et al., 2006) that was provided by Danone Research, Centre 
for Specialised Nutrition, Wageningen, The Netherlands. All infants were healthy 
Caucasians delivered normally. Their ages at the start of the intervention were on 
average 8 months (breast-fed infants 1 and 2 were between 6 and 7 months old, and 
formula-fed infants 3, 4 and 5 were between 6 and 10 months old). They received 
solely breast or formula milk prior to and during the sampling, in addition to small 
amounts of solid food after 6 months, as is common practice in The Netherlands. 
The formula-fed infants received a standard formula without GOS-lcFOS prior to the 
trial. The infants were monitored for up to 8 weeks, and periodically, fecal samples 
were collected and processed as described below. Written consent was obtained 
from parents of each infant.
pCR-dgge analysis and qpCR
DNA was isolated from mechanically disrupted cells (Yaeshima et al., 1992) from 
stool samples stored at -20°C and was purified using the QIAamp DNA stool minikit 
(Qiagen Sciences, Maryland, USA). PCR and DGGE analysis of the V6-to-V8 regions 
of the 16S rRNA genes of the total microbial community were performed as described 
previously using 16S rRNA gene-targeted primers 968-f/1401-r (Nubel et al., 1996). 
The V6-to-V8 regions of the 16S rRNA genes of the bifidobacterial population were 
targeted using Im26-f/Im3-r, followed by Bif164-f/Bif662-rGC (Satokari et al., 2001; 
Zoetendal et al., 2001).
qPCR analysis of DNA extracts was performed in triplicate as described previously 
(Haarman and Knol, 2005) to obtain percentages for the total bifidobacterial 
community as well as specifically B. adolescentis, B. angulatum, B. animalis, B. 
bifidum, B. breve, B. catenulatum, B. dentium, B. infantis, and B. longum. 
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Total RNa isolation
Fecal samples were collected at three time points and immediately mixed with 
RNAlater (Ambion, Austin, TX, USA) at a ratio of 1:2 [wt/vol], and the mixtures were 
incubated overnight at 4°C and stored at -20°C until further processing as described 
previously (Zoetendal et al., 2006).
design and fabrication of a clone library-based dNa microarray
Glass spotted microarrays were constructed as described previously (Boesten et 
al., 2009) and contained approximately 5,000 spots of 1- to 2-kb PCR amplicons 
that were derived from plasmid inserts in genomic libraries of B. longum LMG 13197 
(Reuter, 1963), B. pseudolongum subsp. pseudolongum LMG 11571 (Yaeshima et al., 
1992), B. adolescentis LMG 10502 (Reuter, 1963), B. animalis subsp. animalis LMG 
10508 (Mitsuoka, 1969), B. bifidum LMG 11041 (Orla-Jensen, 1924), B. catenulatum 
LMG 11043 (Scardovi and Crociani, 1974). Slides were stored in the dark under 
dust-free conditions until further use. Before the addition of the hybridization mix, 
the slides were prehybridized for 45 minutes at 42°C in a solution of 5 x SSC (1 x 
SSC is 0.15 M NaCl plus 0.015 M sodium citrate) containing 0.1% sodium dodecyl 
sulfate and 10 mg/ml bovine serum albumin, washed in milliQ water and isopropanol, 
and then dried. Labeling, hybridization, and washing were performed as described 
previously (Boesten et al., 2009). In all instances, Cy3-labeled DNA sequences from 
the bifidobacterial strains used to create the clone  library employed as a reference.
Microarray analysis
The hybridized microarrays were analyzed with a ScanArray Express 4000 scanner 
(Perkin-Elmer, Wellesley, USA). Fluorescent images were captured in a  multi-
image-tagged image file format and analyzed with ImaGene software (BioDiscovery, 
Marina del Rey, USA). As expected, labeled chromosomal DNA of all bifidobacterial 
species on the microarray showed hybridization to virtually all spots on the array. 
Spots that were flagged by the ImaGene software (BioDiscovery) were not included 
in the data analysis. In total, 5,314 spots met the set quality criteria and were included 
in the analysis. For each spot, the mean signal intensity was divided by the local 
background intensity and considered to indicate positive hybridization when it was at 
least 1.25 times higher than the background. The hybridization intensity values were 
normalized to the total intensity to enable the comparison of results from different 
microarrays. Spots that did not show positive hybridization to any of the cDNA samples 
were removed for further analysis. Approximately 500- to 800-bp regions of both the 
3’ and 5’ ends of the inserts in selected clones were subsequently sequenced using 
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primers SL1 and SR2, based on pSMART (GATC Biotech, Germany) (Gonzales et 
al., 2008). The Smith and Waterman algorithm (Smith and Waterman, 1981) was 
applied to evaluate the sequences against different data sets. All sequences were 
analyzed against the complete protein and nucleotide sequences for all genomes 
with complete sequences present in the NCBI repository (as of February 2009). In 
addition, specific searches were performed using the complete genome sequences 
of B. longum NCC2705, B. adolescentis ATCC 15703, B. longum subsp. infantis, and 
B. animalis subsp. lactis. Following these searches, all matches with the genome 
sequences were analyzed for annotated features by using the protein and RNA 
annotation files for the genomes.
principal Component analysis 
Principal component analysis was performed using Canoco software package 4.5 
(Biometris, Wageningen, The Netherlands) to assess the impact of the diet on the 
hybridization of the total RNAs isolated from the fecal microbiotas. Redundancy 
analysis (RA) was applied in specific cases to  explain the contribution of the diet 
(breast milk or formula) to the hybridization data (calculated as the hybridization 
intensity divided by the local background intensity for each clone). Community 
similarities were graphed by using ordination plots with scaling focused on the 
dietary difference. The ordination plot of species and environmental variables is 
characterized by biplots that approximate the weighed averages of each species 
with respect the environmental variable (a diet of either breast milk or formula). 
To test significance of the relationship of the hybridization results with the dietary 
group, unrestricted Monte Carlo permutation tests were performed with 499 random 
permutations and significance level (P value) of 0.05.
qpCR
Primers were designed using Primer express 1.5a (Applied Biosystems, Nieuwerkerk 
aan den Ijssel, The Netherlands), which also takes the presence of secondary 
structures, including possible primer-dimer, into account. All primers were designed 
to have melting temperatures of 60 to 70°C and amplicon sizes between 70 and 130 
bp. The specificities of the primers to bifidobacteria were evaluated by nucleotide 
similarity searches with the BLAST algorithm for short, nearly exact matches at the 
NCBI website (http://www.ncbi.nlm.nih.gov) (McGinnis and Madden, 2004). In silico 
comparisons and PCR amplification products confirmed that primer sets were specific 
for both B. longum NCC2705 and B. longum LMG 13197 but did not target other 
organisms, including Lactobacillus plantarum WCFS1 1 and Escherichia coli (data 
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not shown). Target genes were LNB phosphorylase (BL1641) gene, with primerset 
5’-AACCGTACAAGGACGGATTCG-3’/5’-CGGAATATCGGCGATCATGC-3’; α-L-
arabinosidase (BL1665) gene, with primer set 5’-TACACGCAACGGCCAAGG/5’-
CCAGCAGGACCATCTGACC-3’; and the thymidylate synthase (BL0544) 
gene, with primer set 5’-CACGTGCATATTTGGGATGAGTG-3’/5’-
CCAGGAACGCCACTGCAC-3’. iQ Sybr green supermix (Bio-Rad) was used in all 
reactions. iQ5 real-time PCR detection system (Bio-Rad) was used for all qPCR 
analyses. Each reaction was carried out in a solution containing 5.0 µl of cDNA, 
12.5 µl power Sybr green master mix (Applied Biosystems), the forward and reverse 
primers (2 µM each), and 6.5 µl distilled water. The PCR thermal protocol applied 
consisted of a 2-min 95°C denaturation step, followed by 45 repeats of a 15-sec 
95°C denaturation step, a 30-sec annealing step (at a temperature defined for each 
primer set), and a 30-sec extension step at 72°C. A melting curve analysis was 
performed after final amplification period via a temperature gradient from 60 to 95°C. 
Standard curves for quantification were based on dilution series of DNA of B. longum 
NCC2705. PCR products were sent to GATC Biotech (Germany) for purification and 
sequencing to confirm specific amplification of the target gene.
ReSulTS aNd dISCuSSION
Temporal stability and diversity of the predominant bacterial community 
as determined by pCR-dgge
The fecal microbiotas of infants is influenced by transitions between breast milk, 
formula and solid foods (Benno et al., 1984; Favier et al., 2002; Harmsen et al., 
2000). Hence, prior to gene expression studies, we compared the diversities of the 
microbiotas, including bifidobacteria, in five partly age-matched infants that were 
breast-fed (infants 1 and 2) or subjected to a diet of formula containing prebiotic 
oligosaccharides (infants 3, 4 and 5). Both the expression of bifidobacterial genes 
(see below) and the bacterial diversity were analyzed over a period of 2 to 7 weeks, 
and samples were taken periodically.
The diversities of the total fecal microbiotas and the bifidobacterial population was 
determined by DGGE analysis of the 16S rRNA amplicons. Analysis of the diversities 
of the bifidobacterial communities revealed relatively simple and stable patterns both 
for breast- and formula-fed infants.This finding is illustrated for representative infants 
2 and 5, of the same age (6 to 7 months), who received breast milk and formula, 
respectively, and showed the same dominant bifidobacterial species for several 
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weeks (Fig. 1). In contrast, the DGGE profiles representing the diversities of the total 
bacterial communities from the breast-fed infants were much more stable than those 
from the formula-fed infants. This finding is illustrated ifor the same infants whose 
results are presented in Fig. 2. This stability is especially notable when the sample 
time is considered, as the community in the formula-fed infant fluctuated considerably 
in a period of two weeks while that in the breast-fed infant showed virtually the same 
microbial composition for 6 weeks. Similar observations were made with the fecal 
samples from the other infants (data not shown).
As DGGE analysis of PCR amplicons is qualitative rather than quantitative 
(Zoetendal et al., 2008), a qPCR approach was used to determine the temporal 
development of the total number of bifidobacteria (Fig. 3). This analysis showed 
that the total bifidobacterial numbers in the breast-fed infants were higher than 
than those in the formula-fed infants at the start of the intervention but that the 
numbers in the formula-fed infants increased significantly over time, due possibly 
to the intake of the oligosaccharide-containing formula (Fig. 3). qPCR analyses of 
specific Bifidobacterium species indicated that there were few significant differences 
between breast- and formula-fed infants and that numbers of these species in 
the breast-fed infants were initially higher (Fig. 3). In samples from all infants, B. 
animalis and B. dentium were not detectable and B. angulatum was present in very 
low numbers. In addition, B. longum subsp. infantis, B. breve, B. bifidum, and B. 
longum subsp. longum were detected in samples from all infants, with B. longum 
subsp. infantis being the major species found. Bifidobacterium adolescentis, which 
is most commonly found in adults, was detected at a low proportion in samples from 
the formula-fed infants but not at all in those from infants receiving breast milk. In 
conclusion, these analyses indicated that the samples from the formula-fed infants 
contained fewer bifidobacteria than those from the breast-fed infants but showed 
higher levels of diversity among bifidobacterial species. During the period in which 
the infants received the oligosaccharide-containing formula, the fecal bifidobacterial 
diversities and quantities changed and approached those in the samples from the 
breast-fed infants, which is in line with previous findings (Knol et al., 2005; Moro et 
al., 2006).
Transcriptome of the fecal bifidobacterial population
To gain insight in the activity of the bifidobacterial population within the fecal microbiota, 
transcripts were profiled using a mixed-species microarray of bifidobacteria (Boesten 
et al., 2009). In parallel to the fecal microbial diversity analysis, samples from the 
same five partly age-matched infants (infants 1 to 5; see Materials and Methods) with 
specifed diets (breast milk or formula) were compared using the microarray at three 
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time points in a 2- to 7-week peroid. A total 
of 4,524 clones showed positive hybridization 
of cDNA to at least one of the samples on 
the microarray, and the total sums of the 
fluorescent signals were comparable between 
arrays (data not shown).  A selection of the 
positively hybridized clones was sequenced 
and showed a wide range of protein-encoding 
genes, indicating the metabolic activities of 
the fecal bifidobacterial communities and the 
power of this mixed-species clone library-
based microarray.
It is important that the microarray consists 
of cloned genomic fragments derived from a 
mixture of six Bifidobacterium spp. and that 
the hybridization took place under stringent 
conditions – hence, the expression of only 
the cloned genes of these specific strains or 
genes that share significant (generally more 
than 80%) sequence similarity and, therefore, 
are predicted to have the same function as 
their cloned homolog could be monitored.
Statistical analysis, performed with Canoco 
Figure 1. DGGE profiles of the fecal 
bifidobacteria from breast-fed infants 2 (A) 
and formula-fed infant 5 (B) at different time 
points (sampling days are indicated at the 
top).
Figure 2. DGGE profiles of the fecal 
microbiotas of breast-fed infant 2 (A) and 
formula-fed infant 5 (B) at different sample 
points (sampling days are indicated at 
the top). The arrow identifies bands in the 
gel that correspond to the bifidobacterial 
populations.
software package, was performed to identify whether host, environment, or stochastic 
effects explained grouping of the studied samples. The RA showed that 44% of the 
difference could be explained significantly (P-value of 0.004) by the difference in 
diet, either breast milk or formula. The RA ordination plot for the hybridizations of 
the three samples from infants 2 to 5 visualizes the effects of the different diets (Fig. 
4). The formula-fed infants differed from each other more than the breast-fed infants 
differed from each other, possibly because one of the formula-fed infants was 3 
months older than the other infants in the group. However, all individuals within one 
diet group did not differ significantly from each other (P values above 0.05).
A set of approximately 250 significantly hybridizing clones was selected for 
sequencing to predict the functional identities of the genes carried on the inserts. Most 
of the sequences obtained (500-800 bp) did not include complete genes, but the vast 
majority of the inserts (90%) matched closely (E value ≤10-4) to already described 
bifidobacterial genes, and all ribosomal genes matched closely to bifidobacterial 
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rRNA genes. Less than 1% of the sequences were predicted to be noncoding or could 
not be identified (data not shown). The sequences appeared to encode a wide range 
of functions, such as those of components of transport systems, energy metabolism, 
and carbohydrate metabolism (Fig. 5). Like the taxonomic assignments, the identities 
of transcripts were inferred from the closest matches. These assignments are only 
as good as the existing database, and genes that are rare in genomes because they 
code for unusual or specialized traits are particularly susceptible to poor database 
coverage. The largest fraction of transcripts (31%) was categorized as hypothetical, 
and these transcripts were partly unclassified (typically having known functions but 
not readily placed into a role category during annotation). Among the corresponding 
genes may be those, encoding novel factors that allow the colonization of the human 
intestine by bifidobacterial species.
The inserts’ sequences present in the hybridizing clones on the microarrays 
were functionally annotated and grouped according to the contribution of the gene 
expression values (signal over background) to the RA, as a measure for the impact 
Figure 3. Total percentage of bifidobacteria in fecal samples from infants who were breast-fed (infants 
1 and 2) or fed a standard formula supplemented with GOS/ lcFOS (infants 3, 4 and 5) as determined 
by qPCR. The bars represent the standard errors of the means. The percentage of bifidobacteria in the 
formula-fed but not in the breast-fed group increased significantly as compared to baseline over time (t1 
start of analysis, t2 approximately 3 weeks later for breast-fed and 1 week later for formula-fed infants; 
and t3, an additional 1-2 weeks later) as determined by Student’s t Test (* p<0.05).
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of each gene on the difference between the dietary groups (see the supplementary 
material). The clones are listed in order of importance for the clustering of the 
transcriptome of the infants’ microbiota according to diet (formula or breast milk) by 
using the hybridization signals for samples from infants 1 to 5 (Table 1). This means 
that the list starts with genes that have a large influence on the deviation of the 
infants’ samples according to the dietary group. The signals for the hybridization to 
Figure 4. RA ordination plot comparing the total hybridization patterns of fecal bifidobacterial transcriptomes 
from breast-fed infants ((○); infant 1 and 2) and formula-fed infants ((□); infants 3, 4 and 5) at different time 
points. Each sample is labeled with the identification number of the infant followed by the day of sampling. 
The vector represents the diet variable.
the clones at the end of the list do not indicate any impact on the difference between 
the two dietary groups.
active carbohydrate metabolism
The genome of B. longum NCC2705 includes numerous genes for carbohydrate 
transport and metabolism (Schell et al., 2002). These are collectively termed the 
glycobiome and show a preference for metabolism of di-, tri-, and oligosaccharides, 
pointing towards a biased utilization for complex oligosaccharides complemented 
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with transporters for a variety of disaccharides and oligosaccharides (Parche et al., 
2007). The importance of carbohydrate metabolism for the activity of bifidobacteria 
in the intestinal tract is also evident from this study, as carbohydrate functions are the 
most important category of predicted functions (Fig. 5), corresponding  to 14% of the 
genes, a proportion greater than that determined by the sequence-based classification 
of carbohydrate-active enzymes (8%) (Ventura et al., 2007a). Here, the most salient 
features of the predicted bifidobacterial genes involved in intestinal carbohydrate 
metabolism (the glycobiome) are discussed briefly with specific attention for those 
that are highly expressed, have the greatest impact the RA analysis, or are organized 
into coexpressed operons (Table 1).
Figure 5. Classification of the predicted functions of the 250 sequenced bifidobacterial inserts present on 
the microarray and showing significant hybridization to the labeled total RNAs extracted from infant fecal 
samples. KEGG, Kyoto Encyclopedia of Genes and Genomes.
Taking the RA into account, the DNA fragment that had the greatest impact on the 
difference between the two diet groups included the B. longum lacZ gene (BL0978) 
that shows significant homology to the B. longum subsp. infantis HL96 gene 
encoding β-galactosidases I, which degrades lactose and other sugars containing 
a β-D-anomer-linked galactoside (Hung et al., 2001). Recent growth studies with 
laboratory media showed induction of the B. longum lacZ gene by lactose, maltose 
and FOS (Parche et al., 2007). In the present study, the lacZ-like gene showed 
greater expression in breast-fed infants, though a clone with a very similar gene, 
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BAD_1605, shows much lower hybridization signals than those for the lacZ-like 
gene, indicating the significance of the encoded β-galactosidase in intestinal sugar 
degradation. Similarly, the RA value for the fragment including BL0597 (coding for a 
glycogen phosphorylase) is high and this gene is involved in the breakdown of starch 
into glucose units. The α-1,6 bonds in amylopectin and pullulan can be hydrolyzed 
by so-called pullulanases (encoded by BAD_0708), which were previously shown 
to be expressed in several bifidobacterial species growing on these sugar polymers 
in laboratory media (O’Connell Motherway et al., 2008; Ryan et al., 2006). These 
latter genes show higher hybridization levels in breast-fed infants than in formula-fed 
infants. 
A bifidobacterial α-L-arabinosidase-like gene (BL0544, or abfB) was found to be 
expressed in all of the infants. The abfB gene encodes a hemicellulose-degrading 
enzyme that hydrolyzes terminal α-L-arabinofuranosyl groups from arabinose-
containing oligosaccharides and polysaccharides such as arabinans, arabinoxylans, 
and xylans, major components of plant cell walls (Saha and Bothast, 1998). It is 
known that α-arabinofuranosidases, together with other hydrolases with endo- and 
exo-activities, are required for the complete degradation of polymeric carbohydrates. 
These substrates are poorly digested by the host or other intestinal microbes. The 
sequencing of the B. longum genome (Schell et al., 2002) allowed the annotation of 
at least 14 different enzymes with a hypothetical role in the catabolism of arabinose-
containing polymers, which corroborated the importance of this type of enzymes 
and polysaccharides in the metabolism of some bifidobacteria. The expression of 
the abfB-like gene and the influence of inducers and repressors in B. longum NIZO 
B667 have been studied, and the findings have indicated transcriptional regulation. 
Degenerate primers revealed widespread presence of the α-arabinofuranosidase 
enzym family (family 51 of glycoside hydrolases) in B. longum, B. infantis, B. animalis 
and B. bifidum (Gueimonde et al., 2007). A different gene, possibly coding for an 
arabinosidase (BL0146), was found to have hybridization levels similar to those of 
the abfD-like gene, and may also be involved in breakdown of arabinose-containing 
saccharides. AbfB activity indicates a selective advantage for bifidobacteria for 
nutritional competition and colonization of the human gastrointestinal tract as 
arabinose-containing polymers are abundant in the diet and known to reach the 
colon. The expression of arabinosidases by the bifidobacterial community could 
give these species an advantage to survive and colonize the human colon. As the 
infants that received a breast milk-based diet also showed the expression of an 
abfB-like gene, it is possible either that breast milk contains arabinose-like sugars 
or arabinose-decorated glycoproteins or that it contains related sugars that act as 
inducers of abfB-like expression. An alternative explanation is that milk serves a 
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substrate for the growth of microbes that produce arabinose-like compounds. 
The novel putative operon for galactose metabolism (BL1638-BL1644) was 
detected in the B. longum clone library by hybridization of RNAs from both breast-
fed and formula-fed infants. This operon is involved in the breakdown of structures 
present in mucin sugars (Derensy-Dron et al., 2010; Nishimoto et al., 2007; Wada et 
al., 2008), indicating a way for bifidobacteria to colonize the intestine. Additionally, 
the complex mixture of human milk oligosaccharides contains LNB structures 
(Kitaoka et al., 2005; Ward et  al., 2008) broken down by the products of genes 
in this operon. BL1638 to BL1640 genes are annotated as encoding component 
proteins of the ABC-type sugar transporter, and BL1641  gene is annotated as 
encoding LNB phosphorylase. The cluster of BL1642,  BL1643, and BL1644 genes, 
which were annotated as encoding mucin desulfatase, galactose-1-phosphate 
uridylyltransferase, and UDP-glucose 4-epimerase, respectively, likely codes for a 
metabolic pathway for mucin sugars, because galacto-N-biose is the core structure 
of mucin-type sugars (Derensy-Dron et al., 2010). In this pathway, galactose 1-P, 
formed by the phosphorolysis of LNB/ galacto-N-biose, is converted into UDP-
glucose. Other genes involved in carbohydrate metabolism are predicted to encode 
α-1,4-glucosidase (BL0529) and α-galactosidase (BL1518), both both of which are 
expressed to a greater degree in formula-fed infants than in breast-fed infants. 
Finally, a lactate dehydrogenase (BL1308), involved in the final step in anaerobic 
glycolysis and formation of lactate, was found to hybridize to RNAs isolated from 
both in formula- and breast-fed infants, reflecting the activity of bifidobacterial sugar 
metabolism.
An endo-1,4-β-xylanase (BAD_1527) and a hypothetical gene involved in xylan 
degradation (BL0421) may be involved in breakdown of xylans by hydrolysis of 
1,4-β-D-xylosidic linkages in xylans. The two genes are detected in samples from all 
infants and show similar hybridization signals. BAD_1412 product, a probably sugar 
kinase, has high levels of similarity to xylose kinases and may be involved in the 
breakdown of xylans as well. Sucrose phosphorylase (encoded by BL0536 gene) 
breaks down sucrose and is involved in energy metabolism.
Overall, the expression of the glycobiome (Table 1), especially the genes 
encoding pullulanes, α-1,4-glucosidase, and the glycogen phosphorylase, indicates 
a higher potential for carbohydrate metabolism in breast-fed infants than in formula-
fed infants. This finding may very well be explained by the high diversity of complex 
oligosaccharides in human milk (Boehm and Stahl, 2007) that activate and/or 
increase the abundance of species expressing these genes.
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Colonization factors
Streptococcus mutans 20381 is known to use glycosyltransferases to form 
polysaccharides, which are involved in the formation of biofilms and have been shown 
previously to be the major contributor to adherence (Wiater et al., 1999). In this 
study, the expression of two putative glycosyltransferases, the BL1104 and BL1674 
products, was detected in most of the samples, suggesting the in vivo production of 
polysaccharides that may also play a role in biofilm formation and the colonization of 
the host’s intestiine by bifidobacteria. A possible penicillin-binding protein (encoded 
by BAD_1336) is predicted to be involved in synthesis of peptidoglycan, is the major 
component of bacterial cell walls (Lovering et al., 2007), and may be involved in the 
recognition of the bacteria by the host of the bacteria. Only samples from formula-fed 
babies show hybridization to the clone containing BAD_1336 (see Supplementary 
material).
Activity of bifidobacteria within the human intestine
Several other genes and operons are worth mentioning, as these are biologically 
relevant and may explain functions in the intestinal bifidobacteria related to host 
interaction and colonization and competition within the intestinal microbiota. The 
gene for transaldolase (BL0715), which takes part in the non-oxidative phase of the 
pentose phosphate route, was expressed in all infants. Its translation product was 
also detected in the metaproteome of infant feces (Klaassens et al., 2007) and the 
proteome of B. longum subsp. infantis BI07 grown in a laboratory medium (Vitali 
et al., 2005). The gene for transketolase (BL0716), also involved in the pentose 
phosphate route characteristic of bifidobacterial metabolism, was expressed at lower 
levels than the gene for transaldolase. 
Hybridization to the clone containing BTH_II0919, coding for a glutamine-
dependent NAD+ synthetase (EC 6.3.5.10), indicates the presence of a glutamine-
rich substrate. A previous study showed increased intestinal bifidobacterial numbers 
upon intake of prebiotics containing glutamine-rich protein by healthy adults 
(Kanauchi et al., 1999). Glutamine is known to be among the nutrient requirements 
for the infant gut maturation as the endogenous capacity to synthesize glutamine 
from glutamate is not fully developed. The lower hybridization levels for samples 
from formula-fed infants may be due to lower glutamine levels in the formula than in 
breast milk (Agostoni et al., 2000).
Several genes predicted to be involved in folate biosynthesis pathways were 
found to be expressed, namely, those encoding dihydrofolate reductase (BL1666) 
and thymidylate synthase (BL1665), involved in the last step of the production 
of folate. Folate is involved in many metabolic pathways, such as methyl group 
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biogenesis and synthesis of nucleotides, vitamins, and some amino acids. It has 
been demonstrated that folate synthesized by bacteria in the human intestine is 
absorbed and used by the host (Said and Mohammed, 2006). Moreover, several 
bifidobacterial species have found to produce folate in laboratory media (Pompei et 
al., 2007). The expression of folate genes in the infants’ intestinal tract indicates the 
in vivo production of this vitamin, which is beneficial to the host and can be absorbed 
through the large intestine (Pompei et al., 2007). Remarkably, the hybridization of 
folate biosynthesis-like genes was found to be slightly higher in formula-fed than 
breast-fed infants 
The gene for a putative copper-transporting ATPase (BL0409) was expressed 
mostly in samples from formula-fed infants, and its translation product was also found 
in the proteome of B. longum subsp. infantis (Vitali et al., 2005). In a recent study, a 
transcriptome analysis of L. plantarum indicated significant expression of a gene for 
an orthologous putative copper-transporting protein in intestinal samples of human 
(De Vries, 2006) and mice (Bron et al., 2004), but the function is not confirmed.
qpCR and sequencing analysis
Using the clone insert sequences and matching sequences in the database, primers 
sets for qPRC were designed to target the thymidylate synthase (BL1665) gene, 
(BL1641), and the α-L-arabinosidase (BL0544) gene, and qPCR analysis of cDNAs 
was performed to confirm the specific hybridization of transcripts to the microarray. 
Melting curves showed specific amplification of one product for each sample primer 
set combination (data not shown). 
The quantification of gene activity can be complicated because it is not known 
how many active bifidobacteria with sequences that match the amplicons spotted 
onto the microarray are present in the samples. The yield of RNA per sample unit 
was found to differ among samples and individuals because of transit time, diet, and 
other host-related conditions. The size of the gene fragment on the microarray can 
also cause variability in hybridization of samples from different origins. However, the 
relative copy numbers obtained with qPCR showed a similar trends similar to those 
demonstrated by the relative signal-to-background ratios obtained with the micro 
array hybridizations, confirming the presence of target mRNA (data not shown). 
Moreover, sequence analysis of the amplicons of qPCR confirmed amplification from 
the target genes BL1665, BL1641, BL0544.
Concluding remarks
This study revealed that bifidobacterial species undergo dynamic changes in infant 
feces on the level of persistence as well as their functional complement. To aid the 
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detection of the gene transcript, the number and diversity of bifidobacteria in the 
infants’ feces was determined using molecular tools. This was complemented by 
transcriptome analysis using mixed-bifidobacterial species microarrays that showed 
a significant impact of diet on the transcriptional response of bifidobacteria in breast- 
and formula-fed infants. 
Genome-wide transcript analyses using DNA microarrays provide opportunities 
for comprehensive and integrative views of bacterial activities occurring within the 
intestinal tract. The potential of this approach was exemplified by previous studies 
reporting full-genome transcriptome profiles for Bacteroides thetaiotaomicron 
and B. longum residing in the ceca of germ-free mice (Sonnenburg et al., 2005; 
Sonnenburg et al., 2006), as well as for L. plantarum in conventional mice (Marco 
et al., 2007). In the present study, the hybridization profile could be used to assess 
the influence of the diet on the transcriptome of fecal bifidobacterial communities 
from infants. Particularly, the use of a mixed-species microarray made it possible to 
simultaneously target several bifidobacterial species in the complex fecal microbial 
ecosystem. By using this array it was possible to compare fecal bifidobacterial gene 
expression profiles for individuals despite unique fecal microbial compositions.
Samples from breast-fed infants with stable total microbiotas and bifidobacterial 
populations showed variety in transcripts at different time points indicating active 
bifidobacterial populations. As expected, the transcriptomes of microbiotas in the 
formula-fed infants, with more unstable microbial diversity, also showed differences 
in time. The observed differences have been caused by the variation of activities of 
individual bifidobacterial species and/ or environmental factors such as diet. Possibly, 
host factors and the addition of solid food to the milk also had influence, and hence, 
more individuals should be compared. It is likely that specific bifidobacterial species 
may be a target of modulation by prebiotics, but this study did not reveal a direct link 
between the expressed genes and the species. The genome sequence of B. longum 
NCC2705 revealed that the chromosome includes numerous genes for carbohydrate 
utilization, specifically those for over 30 glycosyl hydrolases that are predicted to be 
involved in the degradation of higher-order oligosaccharides (Schell et al., 2002) 
and 19 carbohydrate transport systems were proven to be active in laboratory media 
(Parche et al., 2007). Bifidobacterium adolescentis MB 239 preferred lactose, FOS 
and raffinose over glucose and fructose in laboratory media, which was explained 
by α-galactosidase, β-galactosidase, and β-fructofuranosidase activities (Amaretti et 
al., 2006). The findings of this study show that at least a portion of these genes are 
being transcribed in vivo in the infant intestinal tract. This gene expression may give 
these bifidobacteria advantages in colonizing the infant gut and explains the growth-
promoting effect of oligosaccharides which are described as prebiotics. 
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The sequencing of an extensive metagenomic library from the human distal 
gut revealed a high degree of diversity in bifidobacterial genes compared to the 
B. longum NCC2705 genome (Gill, 2006). This finding suggests the presence of 
multiple and related bifidobacterial strains. The present and expected sequences 
of several bifidobacterial genomes will open up a new era of comparative genomics 
and provide a basis for the setup of a molecular model that can predict the 
bifidobacterial-host interaction. This progress will improve the molecular studies of 
the functional complement with tools such as transcriptomics, described here, as well 
as metaproteomics (Klaassens et al., 2007) and metabolomics (Goodacre, 2007). 
The  further development of high-throughput sequencing techniques will allow the 
detection and quantification of total cDNAs without the limitation of relevant probes 
on a microarray (Marioni et al., 2008; Wang et al., 2009).
Ultimately, this advancement will lead to a detailed understanding of the nutritional 
lifestyle of bifidobacteria and its impact on the host. Linking functional activities of 
intestinal bifidobacteria to specific groups of healthy or diseased individuals or special 
diets opens up leads for modulation of the intestinal bifidobacterial community, 
exerting health benefits.
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Supplementary Material
appendix 1. Identified clones, listed in order of % RA. RA could explain the grouping of the samples 
from infants by the difference in diet, being either breast- or formula-fed.
% Rda library locustag function kO
90,9 M BL0978 glycosyl hydrolase (LacZ) C
86,1 M BL0597 glycogen phosphorylase C, PS
81,2 P BAD_0376 lysyl-tRNA synthetase 1 A
78,2 M BAD_1319-20 DNA-directed RNA polymerase β chain; HP GI, FU
76,3 P BAD_0470 probable solute binding protein of ABC transporter system MT
75,9 P BAD_1130 DNA polymerase III a subunit GI
72,9 L BL0307-08 possible Rim-like protein involved in efficient processing of 
16S rRNA; inosine-uridine preferring nucleoside hydrolase
GI, FU
69,6 L BL0694-95 possible ABC transporter permease for cobalt; narrowly 
conserved protein with unknown function
T, FU
64,7 L LSA0594 hypothetical prophage lsa1protein (Lactobacillus sakei ssp. 
sakei)
FU
64,3 P BTH_II0919 glutamine-dependent NAD+ synthetase A, CV
62,6 P BAD_1423-24 possible secreted peptidyl-prolyl cis-trans isomerase protein; 
HP
FU
62,2 P BAD_0708 pullulanase M
52,7 L BL1197 large HP FU
51,9 M BL0337 HP possibly in TetR transcriptional regulator family FU
51,7 M BL0440-41 glucose-6-phosphate 1-dehydrogenase; narrowly conserved 
HP
C, FU
50,1 P BL1057 argininosuccinate lyase A
49,3 L BL0356-57 ATP synthase epsilon chain; ATP synthase subunit B EM
49,2 M BL0395 valyl-tRNA synthetase GI
48,2 L BL1275-76 possible homoserine kinase; HP with MutT domain A, FU
48 M BAD_0914 tyrosyl-tRNA synthetase A, GI
46,1 P BAD_1575-76 possible NagC/XylR-type transcriptional regulator; a-
galactosidase
C, GB
44,1 L BL1450/ BL0527 leucyl-tRNA synthetase; 4-a-glucanotransferase A, C
43,5 M BL1429 DNA gyrase subunit B GI
43,5 P BAD_1336 possible penicillin-binding protein FU
42,5 L BL1307 GTP-binding protein FU
42,4 L BL1204 DNA-directed RNA polymerase β-subunit GI
41 P BL1664 widely conserved protein in universal stress protein family FU
40 L BL0422 narrowly conserved HP FU
39,64 L BAD_1295 aminopeptidase N; cystathionine gamma-synthase; ATP-
dependent DNA helicase RecQ
M
37,55 P BAD_0341-42 preprotein translocase SecY subunit; adenylate kinase N, GI
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% Rda library locustag function kO
35,85 M BAD_0702 putative DNA methyltransferase FU
35,58 P BAD_1013 probably bifunctional short chain isoprenyl diphosphate 
synthase
LM
35,28 M BL0409 copper-transporting ATPase EM
35,28 L BL0353-54 HP; possible secreted peptidyl-prolyl cis-trans isomerase 
protein
FU, GI
34,87 L BL0197-98 possible ATP binding protein of ABC transporter; hypothetical 
membrane protein with unknown function
MT
33,84 L BL0722 narrowly conserved HP FU
32,3 L BL1251 probable glutamyl-tRNA synthetase A
31,6 P BAD_0061 probable ferredoxin/ferredoxin-NADP reductase M
31,59 M BL1435 narrowly conserved HP FU
31,55 M  LJ1578 HP (Lactobacillus johnsonii NCC 533) FU
31,1 L BL1251 probable glutamyl-tRNA synthetase A
30,84 L LVIS_2267 ATP-dependent exoDNAse (exonuclease V) β subunit FU
30,63 L BL0726 widely conserved hypothetical transport protein FU
30,54 L BL0919-20 possible efflux transporter protein MT
30,31 L BL0976 galactoside symporter (lacS) T
29,99 L BL1117 narrowly conserved HP FU
29,72 M BAD_0833-37 HP FU
28,8 L BL1518 a-galactosidase C
28,13 P SCO7398 membrane transport protein MT
27,31 L BL1169-70 probable permease of ABC transporter system for sugars MT
27,08 L BL0674 possible cell surface protein with gram positive anchor 
domain; probable permease of ABC transporter system for 
sugars
FU
26,29 L BL1164 probable solute binding protein of ABC transporter system 
for sugars
MT
25,79 M BAD_1191-92 ABC transporter; ATP-binding protein of ABC transporter MT
25,72 L BL1673 possible lactaldehyde reductase C
24,44 M BAD_1132 possible lipoprotein signal peptidase GI
24,4 L BL0544 a-L-arabinosidase C
24,4 L BL0917-18 HP with possible helix turn helix motif; HP with probable 
serine/threonine-protein kinase domain
FU
23,42 L BL0962 hypothetical membrane protein with possible acetylase 
function
C
23,37 M BAD_1257-60 HP; similar to glutamine ABC transporter (ATP-binding 
protein)
FU, MT 
22,86 M BL1170 probable permease of ABC transporter system for sugars MT
22,79 L BL0529 probable a-1,4-glucosidase; maltase-like enzyme C
22,25 L BL0871-72 possible ABC transporter component MT
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22,06 L BL1757-60 BglX; HP; HP with possible nucleotidyltransferase domain; 
HP possibly involved in exopolysaccharide production
C, FU
21,71 M BAD_1445 HP FU
21,05 P BL0662 HP FU
19,79 P BL0009 HP FU
19,66 L  EF2229 HP FU
19,31 M BL1498 HP FU
19,05 L BL0268 ATP binding protein of ABC transporter similar to Vex1 
(VexP1) of S. pneumoniae
MT
18,44 L BL1280-81 succinyl-diaminopimelate desuccinylase; ribonuclease G A, GI
18,16 L BL1291 50S ribosomal protein L1 GI
17,86 M BL1148-50 deoxyguanosinetriphosphate triphosphohydrolase-like pro-
tein; alanine racemase; probable amino acid transporter
N, A, MT
17,59 L BL0837-38 HP; LacI-type transcriptional regulator FU, C
17,41 P BP1364 putative amino-acid ABC transporter, periplasmic amino acid-
binding protein
MT
16,96 M BL0196-98 HP; possible ATP binding protein of ABC transporter FU, MT 
16,58 M BAD_0490-92 cystathionine β-synthase EM, A, GI
16,35 L BL0951-53 formate acetyltransferase; HP; glutamine-dependent NAD(+) 
synthetase
C, FU,A
16,22 L BL1571-73 50S ribosomal protein L13; 30S ribosomal protein S9; prob-
able glycogen operon protein GlgX
GI, C
16,17 M BAD_0525-26 probable phosphoribosylglycinamide formyltransferase 2; 
possible glycosyltransferase
C, N
16,11 L BL1069-70 possible permease protein of ABC transporter for cobalt; ATP 
binding protein of ABC transporter
MT
15,84 L BL0850-51 conserved hypothetical transmembrane protein with un-
known function; conserved HP similar to MazG
MT, FU
15,59 L DIP1756 Putative DNA methyltransferase (Corynebacterium diphthe-
riae NCTC 13129)
FU
15,24 P BAD_0262 HP FU
14,37 L BL1639 permease of ABC transporter for sugars MT
14,25 L BL1534 hypothetical integral membrane with weak similarity to pro-
teins in BioY family
FU
14,02 M BL0485 DNA topoisomerase I GI
13,46 L BL0435-36 possible ammonium ion transporter; FtsY signal recognition 
particle
MT, GI
13,43 L BL1287-90 preprotein translocase SecE subunit; probable transcription 
antitermination protein; HP; 50S ribosomal protein L11
GI, FU
13,17 L BL1114-15 DNA polymerase V; S-adenosyl-L-homocysteine hydrolase GI, A
12,89 M BL1292 morphine 6-dehydrogenase M
12,81 L BL0421 narrowly conserved HP possibly involved in xylan degrada-
tion
C
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12,77 L BL1104 possible glycosyltransferase C
12,74 M BL1251-52 probable glutamyl-tRNA synthetase; possible phosphodi-
esterase
A
12,66 L BL1665-66 thymidylate synthase; dihydrofolate reductase CV
12,39 L BL0146 possible arabinosidase C
12,38 M BAD_1556-58 LacI-type transcriptional regulator; putative ABC transport 
system membrane protein; haloacid dehalogenase-like 
hydrolase
C
12,35 L BL1026 peptidyl-tRNA hydrolase MT
12,25 P BAD_1412 probable sugar kinase C
12,16 M BAD_1188 galactoside symporter T
12,07 M RHA1_ro03515 possible transcriptional regulator (Rhodococcus spp. RHA1) FU
12 M nfa39180 HP (Nocardia farcinica IFM 10152) FU
10,93 L BL1127-29 HP; probable metal uptake regulator similar to ferric uptake 
regulator protein; phosphoribosylaminoimidazole carboxylase 
ATPase subunit
FU, GI, N
10,77 M BAD_0956-57 probable aminotransferase; similar to Mycobacterium tuber-
culosis polyphosphate glucokinase
A, C
10,71 P BL1695-96 ATP binding protein of ABC transporter for pentoses; prob-
able ABC transport system permease protein for sugars
FU
10,71 L BL0158 very narrowly conserved HP MT
10,65 P BL0067-68 carbamoyl-phosphate synthase small subunit; CarB N, A
10,33 L BL1068-69 possible rRNA methylase; possible permease protein of ABC 
transporter for cobalt
GI, MT
10,25 L BL1549-50 50S ribosomal protein L10; 50S ribosomal protein L7/L12 GI, PM
10,24 L BL1616 translation initiation factor IF-2 GI
10,23 L BL0012-13 HP weakly similar to putative transcriptional regulator from 
Streptomyces; proline/betaine transporter
FU, T
10,23 L BL0033-34 ATP binding protein of ABC transporter; probable solute 
binding protein of ABC transporter system possibly for sugars
MT
10,18 L BL0820-21 HP; possible thioredoxin-dependent thiol peroxidase FU, GI
10,04 L Francci3_4210 Integrase GI
9,89 M BL0417 HP FU
9,84 M BL0630 glutamate dehydrogenase A, EM
9,74 L BAD_1527 endo-1,4-beta-xylanase C
9,27 L BL0342-43 possible permease of ABC transporter; possible permease 
protein of ABC transporter system
MT
9,11 L BL0592-93 narrowly conserved HP FU
8,83 M BAD_1124 1-(5-phosphoribosyl)-5- [(5-phosphoribosylamino) methylide-
neamino] imidazole-4-carboxamide isomerase
A
8,58 L BAD_0608/ 
BL0338
pyrroline-5-carboxylate reductase; aspartate ammonia-lyase A
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8,51 L BL1772 sugar kinase in PfkB family C
8,5 M BH1867 HP (Bacillus haloduransC-125) FU
8,4 L BL1673-74 possible lactaldehyde reductase; probable glycosyltrans-
ferase
C
8,26 M BAD_1179 CRISPR-associated protein Cas2 FU
8,22 M BAD_0210 HP FU
8,18 L BL1276 HP with MutT domain FU
8,05 L BL0450-51 ATP binding protein of ABC transporter; possible permease 
protein of ABC transporter system
MT
7,91 M BAD_0708 pullulanase M
7,85 M DVU2019 HP FU
7,78 L Lxx04970 rhamnosyltransferase (Leifsonia xyli subsp. xyli CTCB07) C
7,75 P APECO1_536 putative tail component of prophage FU
7,47 L BL1732 methionine aminopeptidase GI
7,41 L BL1164-65 probable solute binding protein of ABC transporter system 
for sugars; 
MT
6,86 P BAD_0254-55 JadJ; propionyl-CoA carboxylase beta chain A, C
6,58 L BL0771-72 HP FU
6,48 P BAD_0746-47 GTP-binding protein lepA; probable oxygen-independent 
coproporphyrinogen III oxidase
C
5,86 M SAV7543 helicase FU
5,77 L BL1396-97 probable cation-transporting ATPase; aconitate hydratase FU, C, 
EM
5,76 L BL1169-70 probable permease of ABC transporter system for sugars; 
probable permease of ABC transporter system for sugars
MT
5,75 L BL0716 transketolase C
5,71 L BL0552 probable ferredoxin/ferredoxin-NADP reductase M
5,66 L BL0163-64 HP related to thiamine biosynthesis lipoprotein ApbE; prob-
able permease protein of ABC transporter system
CV, MT
5,63 M BAD_1120 ATP-dependent helicase GI
5,61 L BL1641 Lacto-N-biose phosphorylase C
5,32 M BL1230 HP FU
5,1 L BL1126-27 probable solute binding protein of ABC transporter system; 
HP
MT, FU
4,97 M BAD_0267 possible protease EM
4,93 P BAD_0470-71 probable solute binding protein of ABC transporter system; 
probable permease protein of ABC transporter system
MT
4,76 L BL0466-67 HP FU
4,76 L Reut_B4371 AMP-dependent synthetase and ligase C, EM
4,76 M BL0206 hypothetical membrane protein with unknown function FU
4,76 M AAur_3512 bacterioferritin comigratory protein (thioredoxin reductase) GI
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4,76 L BL0099-100 HP with possible acylase domain; DNA repair protein RecO FU, GI
4,76 L BL0992 30S ribosomal protein S1 GI
4,76 M BL1804 HP FU
4,76 L BL0604 phosphoenolpyruvate carboxylase FU
4,7 L BL0675 possible cell surface protein similar toFimA fimbrial subunit FU
4,62 L BL0157-58 narrowly conserved HP FU
4,36 L BL0795-96 glutamate-ammonia-ligase adenylyltransferase; choloylgly-
cine hydrolase
A, LM
4,34 L Lxx04950  glycosyl transferase (Leifsonia xyli ssp. xyli CTCB07) C
4,28 L BL1638 solute binding protein of ABC transporter for sugars MT
4,23 L BL0092 probable DNA helicase II C
4,04 M BAD_1512 putative cell wall-anchored protein FU
3,75 L BL0387 HP FU
3,74 L FN0557 HP FU
3,37 L BL1537 Fas LM
3,22 P BAD_1612 widely conserved protein with eukaryotic protein kinase 
domain
FU
3,18 P BL0670-71 ribonucleotide-diphosphate reductase alpha subunit; 
ribonucleotide-diphosphate reductase beta subunit
N
3,11 M BCE_1227 S-layer protein, putative (Bacillus cereus ATCC10987) FU
3,09 L BL1148 deoxyguanosinetriphosphate triphosphohydrolase-like 
protein
N
3,07 L BL0655-56 HP; 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase; Cmk; 
4-(cytidine-5’-diphospho)-2-C-methyl-D-erythritol kinase
FU, LM
3,05 L BL1134-35 HP; ATP binding protein of ABC transporter FU, MT
3,01 L BAD_1605 β-galactosidase C
2,81 L CE1244 putative transposase FU
2,71 M BAD_1200 HP FU
2,71 L BL0116 glycyl-tRNA synthetase C
2,59 L BAF40155 IS3 family transposase FU
2,54 L BL1692-93 ATP binding protein of ABC transporter for pentoses; prob-
able repressor protein in (NagC/XylR) family
MT
2,37 L BL1276-77 HP with MutT domain; ATP-binding protein of ABC trans-
porter system
FU
2,25 L BL0485 DNA topoisomerase I GI
2,14 P BAD_1412 probable sugar kinase FU
2,13 L BAD_0708 pullulanase M
2,05 L BL1732 methionine aminopeptidase GI
2,01 M BAD_1230-32 helicase; HP; probable type II restriction enzyme similar to 
Sau3AI
FU
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1,99 L BL1319-20 UDP-N-acetylmuramoylalanyl-D-glutamyl-2, 6-diaminopime-
late--D-alanyl-D-alanyl ligase; phospho-N-acetylmuramoyl-
pentapeptide-transferase
A
1,97 P AAur_1329 putative dolichyl-phosphate-mannose-proteinmannosyltrans-
ferase family protein
FU
1,95 M BL0387 HP FU
1,92 L BL1110-11 HP; possible Na(+)/H(+) antiporter FU
1,79 L BL1220-21 narrowly conserved HP; glycine cleavage system H protein FU
1,76 L BL1674 probable glycosyltransferase FU
1,73 L BL1723-24 oligoribonuclease; possible helicase FU
1,7 P BL0141 possible solute binding protein of ABC transporter FU
1,56 L BL0529 probable a-1,4-glucosidase; maltase-like enzyme C
1,55 L BL1647-48 HP FU
1,52 M BAD_0972 possible solute binding protein of ABC transporter FU
1,48 L BL0284 FemAB-like protein possibly involved in interpeptide bridge 
formation in peptidoglycan
GB
1,4 M BL1422 anthranilate phosphoribosyltransferase 1 A
1,37 M BAD_0054-56 putative exodeoxyribonuclease V; response regulator of two-
component system; queuine tRNA-ribosyltransferase
EP
1,34 M nfa44220 HP (Nocardia farcinica IFM 10152) FU
1,28 P BAD_0858-59 probable ribosomal-protein-alanine N-acetyltransferase; HP GI
1,23 L BL0715 Transaldolase C
1,23 L BL1535-36 JadJ; propionyl-CoA carboxylase beta chain LM
1,19 L NTHI1839 putative type I restriction enzyme HindVIIP specificity protein 
(Haemophilus influenzae 86-028NP)
M
1,18 P BAD_1120 ATP-dependent helicase GI
1,11 P BAD_1016 HP FU
1,1 M BL0027-28 narrowly conserved HP; probable DEAD box-like helicase FU
1,07 M BAD_1614-15 dimethyladenosine transferase; HP GI
1,06 L BL1752 anaerobic ribonucleoside triphosphate reductase N
1 L BL0111 hypothetical metabolite transport protein possibly for a sugar FU
0,96 P BL0143-44 permease of ABC transporter possibly for oligosaccharides MT
0,91 L BL1152-53 S-ribosylhomocysteinase; ATP-dependent DNA helicase 
RecQ
A
0,89 M BL0934 possible pyridoxine kinase CV
0,87 P BL1455 HP FU
0,85 L BL1098 elongation factor G GI
0,84 L BL0949-50 narrowly conserved HP; pyruvate formate-lyase 1 activating 
enzyme
FU
0,8 L BL0613 probable integral membrane transporter FU
0,74 L BAD_1065 putative ABC transport system integral membrane protein FU
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0,74 L BAD_1177 putative transposase FU
0,73 M BAD_0243 glutamate 5-kinase A
0,68 L BL0768-70 HP FU
0,61 L BL1532-33 HP FU
0,58 L BL1002-04 HP with similarity to ImpA of Salmonella involved in UV 
protection and mutation; HP with phosphoribosylpyrophos-
phate transferase domain and similarity to OrfS annotated 
as putative ComF protein; HP with similarity to eukaryotic 
phosphomannomutase
FU
0,57 M BAD_0315 probable repressor in the Rok (NagC/XylR) family FU
0,57 L BL1443 HP FU
0,53 L BL1523 sugar permease of ABC transporter system MT
0,48 M BL0006-07 cold shock protein; histidine kinase sensor of two-component 
system
GI, EP
0,44 L BL0157 narrowly conserved HP FU
0,42 L BL1643-44 galactose-1-phosphate uridylyltransferase; UDP-glucose 
4-epimerase
C
0,41 L BAD_1188 galactoside symporter T
0,39 L BL0092-93 probable DNA helicase II; narrowly conserved HP C
0,37 L BL0901-02 probable ATP binding protein of ABC transporter; histidine 
kinase sensor of two-component system
MT
0,33 L BAD_0181 HP FU
0,32 L BL1377-78 possible pyridoxal-phosphate-dependent aminotransferase; 
probable sugar transporter
CV, T
0,31 M BAD_1028 DP-diacylglycerol--glycerol-3-phosphate 3- phosphatidyl-
transferase
LM
0,21 L BL0675 possible cell surface protein similar to FimA (fimbrial subunit 
of Actinomyces naeslundii)
FU
0,2 L BL1518 a-galactosidase C
0,19 L BL0418-20 ribose-phosphate pyrophosphokinase; HP in upf0001; 
probable extracellular protein possibly involved in xylan or 
arabinan degradation
N
0,17 L LSL_1522 HP FU
0,17 P BL1308 lactate dehydrogenase C
0,16 L BL0619 HP FU
0,16 L BL1181-82 HP with weak C-terminal similarity to TraG; FtsX-like protein 
involved in cell division
FU
0,16 M BL1803-04 HP FU
0,14 P BL0995 ATP binding protein of ABC transporter MT
0,13 L BL1246 hypothetical membrane protein with unknown function FU
0,12 L BL0949-50 narrowly conserved HP; pyruvate formate-lyase 1 activating 
enzyme
FU
0,1 P  BL0536 sucrose phosphorylase C
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0,1 L BL1795 hypothetical proteasome-associated protein; GI
0,1 L BL0617-18 widely conserved HP with duf21 and CBS domains; HP in 
DPS family
FU
0,07 L BL1679-80 hypothetical secreted protein with D-Ala-D-Ala carboxypepti-
dase 3 (S13) domain; narrowly conserved HP similar to MesJ
FU
0,05 P BL0536 sucrose phosphorylase C
0,05 L BL0950-51 pyruvate formate-lyase 1 activating enzyme; formate acetyl-
transferase
GI
0,05 L BL1795-96 hypothetical proteasome-associated protein; possible inositol 
monophosphatase
FU
0,03 L BL0059-60 narrowly conserved HP; HP with limited similarity to C-
terminal part of trans-aconitate methyltransferase
FU
0,01 L BL0072 HP FU
0 L BL0457-58 narrowly conserved HP; narrowly conserved HP with duf24 FU
0 L BL0146 possible arabinosidase C
appendix 1. Continued.
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Bifidobacterium breve  ─  HT-29 cell line interaction: 
modulation of TNF-α  induced gene expression
Rolf J. Boesten, Frank h.J. Schuren, linette Willemsen, 
aldwin Vriesema, Jan knol, and Willem M. de Vos
To provide insight in the molecular basis for intestinal host-microbe interactions, we 
determined the genome-wide transcriptional response of human intestinal epithelial 
cells (HIECs) following exposure to cells of Bifidobacterium breve. To select an 
appropriate test system reflecting inflammatory conditions, the responsiveness to 
TNF-α was compared  of T84, Caco-2 and HT-29 cells. The highest TNF-α response 
was observed in HT-29 cells and this cell line was selected for exposure to the 
B. breve strains M-16V, NR 246 and UCC2003. After one hour of bacterial pre-
incubation followed by two hours of additional TNF-α stimulation, B. breve M-16V 
(86%), but to a much lesser extent strains NR246 (50%) or UCC2003 (32%), showed 
a strain-specific reduction of the HT-29 transcriptional response to the inflammatory 
treatment. The most important functional groups of genes that were transcriptionally 
suppressed by the presence of B. breve M-16V, were found to be involved in immune 
regulation and apoptotic processes. About 54% of the TNF-α induced genes were 
solely suppressed by the presence of B. breve M-16V. These included apoptosis-
related cysteine protease caspase 7 (CASP7), interferon regulatory factor 3 (IRF3), 
amyloid beta (A4) precursor protein-binding family A member 1 (APBA1), NADPH 
oxidase (NOX5), and leukemia inhibitory factor receptor (LIFR). The extracellular 
IL-8 concentration was determined by an immunological assay but did not change 
significantly, indicating that B. breve M-16V only partially modulates the TNF-α 
pathway. In conclusion, this study shows that B. breve strains modulate gene 
expression in HT-29 cells under inflammatory conditions in a strain-specific way.
Thesis-Rolf-v3.indd   93 2-1-2011   23:33:22
Chapter 6
94
INTROduCTION
It has been well established that our body is a natural habitat for numerous microbes. 
Its barrier with the surrounding environment, the surface ectoderm, is a common site 
for colonization. The abundant presence of microbes results in a molecular interplay 
with the epithelial cells. A major site of microbial interaction is our intestinal tract. 
Besides its tremendous surface this is due to the unique environmental conditions 
within. Notably bacteria but also other commensal microbes are able to colonize 
this unique location and together form our intestinal microbiota (Eckburg et al., 
2005; Rajilic-Stojanovic et al., 2009; Zoetendal et al., 2006). There is considerable 
interest in the understanding the mechanisms involved in beneficial host-microbe 
interactions and an increasing number of studies are underpinning the effects of the 
commensal microbes (Boesten and de Vos, 2008; Guarner and Malagelada, 2003; 
Ouwehand et al., 2002).
To sustain homeostasis in the gut, discrimination between pathogenic and 
commensal microbes by our immune system is of vital importance. To facilitate this, 
the human host contains two types of defense, the innate and adaptive immune 
systems (for a recent review see Medzhitov, 2007). In short, the innate immune 
recognition is germ-line encoded and mediated by pattern recognition receptor (PRR) 
systems (Janeway, 1989). The adaptive system enables immunological memory 
and is mediated by antigen receptors (Schatz et al., 1992). The development of 
highly specific antibodies by the assembling of genes encoding antigen receptors 
is stimulated by the activated innate system (Schatz et al., 1992). Basically, the 
initial recognition of pathogens is performed by the innate immune system. Via the 
PRRs, it screens for foreign material by searching for microorganism-associated 
molecular patterns (MAMPs). Examples of bacterial MAMPs are specific cell-
envelope components, such as lipopolysaccharides (LPS), peptidoglycan and 
lipotechoic acids, as well as cell-envelope proteins. Pathogenic bacteria are known 
to induce inflammatory reactions in human host cells, in contrast to commensals that 
are recognized as self. As both pathogenic and commensal bacterial cells contain 
MAMPs, the final outcome of a host-response relies on multiple distinct interactions 
between PRRs and MAMPs, in combination with associated co-receptors.
The detailed analysis of MAMP-PRR interactions contributed to the present insight 
in the underlying molecular mechanism of this system. The best characterized class 
of PRRs are TLRs and their interactions with bacterial surface molecules have been 
well-documented and include LPS signaling via TLR4 (Akira et al., 2006; Takeda et 
al., 2003). Under homeostatic conditions, the expression and signaling of an epithelial 
PRR system may be suppressed. However during inflammation or infection, apical 
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TLR expression will be induced, enabling bacterial signaling (Abreu et al., 2002). 
Many of the host inflammatory responses are controlled by the transcription factor 
nuclear factor (NF-)κB (O’Hara and Shanahan, 2006). Upon activation, through a 
wide range of stimuli such as TNF-α, IL-1β, or Escherichia coli LPS that signals via 
TLR-4, NF-κB translocates to the nucleus (Hayden and Ghosh, 2004; Li and Verma, 
2002). At that place, it controls the transcription of a series of genes involved in 
acute responses to tissue damage and in chronic intestinal inflammation (Riedel et 
al., 2006). TNF-α is an important player in the innate and adaptive immune defense. 
It controls cellular functions at multiple levels. TNF-α signaling leads to diverse 
downstream events, such as the regulation of NF-κB, MAPK, Jun N-terminal kinase 
(JNK) and caspases, which in turn influence cell-death and cell-survival decisions 
(as reviewed by Mathew, 2009). TNF-α mediated functions that have been best 
characterized are related to apoptosis and inflammation (Aggarwal, 2003). 
The vast majority of intestinal commensals are Gram-positive bacteria that do 
not contain LPS but may affect epithelial activation and TLR signaling via other 
PPR systems than TLR4. This includes TLR2 that recognizes lipoproteins and 
lipoteichoic acids, which are integrated in a peptidoglycan layer of Gram-positive 
bacteria (Schwandner et al., 1999; Vizoso Pinto et al., 2009; Yoshimura et al., 1999). 
In contrary to the LPS receptor TLR4, TLR2 induces both pro-inflammatory and 
anti-inflammatory cytokine synthesis (Netea et al., 2004). Interestingly, many PRR 
ligands are expressed by commensal bacteria, yet the healthy gut does not evoke 
inflammatory responses to these gut inhabitants. This can be explained by the ability 
of these bacteria to inhibit translocation of NF-κB to the nucleus and thereby prevent 
the induction of inflammatory responses. Several different mechanisms to prevent 
this translocation have been elucidated (O’Hara and Shanahan, 2006). These include 
inhibition of epithelial proteasome function, stabilization of NF-κB counter-regulatory 
factor IκBα or prevention of nuclear export of the NF-κB subunit, p65, through a 
peroxisome proliferator-activated receptor (PPAR)γ-dependent pathway (Kelly et al., 
2004; Neish et al., 2000; Petrof et al., 2004).
A number of studies have described the ability of commensal bacteria to modulate 
the inflammatory response of its host. Common model systems for interaction studies 
are human intestinal epithelial cell (HIEC) lines. HIECs are considered to form an 
integral part of the innate immune system, constituting important targets for bacteria 
and cytokines. Using such a cell line model, it was demonstrated that Lactobacillus 
rhamnosus GG and L. reuteri are able to modulate the TNF-α induced release of 
IL-8 in Caco-2 and in T84 and HT-29 intestinal epithelial cells, respectively (Ma et al., 
2004; Zhang et al., 2005). Similarly, Bifidobacterium bifidum and B. longum showed 
the capacity to inhibit the LPS-induced NF-κB activation in HIECs (Riedel et al., 
Thesis-Rolf-v3.indd   95 2-1-2011   23:33:22
Chapter 6
96
2006). Several comprehensive overviews of the studies on the induction of immune 
modulation molecules and effector substances by lactic acid bacteria have recently 
been published (Winkler et al., 2007). The effects on immune modulation molecules 
have been described as strain- and species-specific and are executed via several 
different mechanisms (Candela et al., 2008; Sonnenburg et al., 2006). 
In summary, many studies indicate that commensal bacteria are capable of 
modulating the host response under basal or inflammatory conditions. In this study 
we exploited a global transcriptomics approach in HIECs to provide a molecular 
basis for the interaction of human epithelial cells with B. breve strains that included 
the model strain UCC2003 (Ventura et al., 2009) and two industrially-relevant strains, 
M16-V and NR264. TNF-α stimulation was used to generate an NF-kB dependent 
inflammatory response in the HIEC lines. The results indicate significant but strain-
dependent modulation of gene expression in HT-29 cells under inflammatory 
conditions. 
MaTeRIalS aNd MeThOdS
Bacterial strains, culturing, and co-incubation
All Bifidobacterium strains, B. breve UCC2003 (Cork University, IR), B. breve M-16V 
(Morinaga Milk Industry Co., Ltd., Zama, JP), and B. breve NR264 (Numico Research 
Culture Collection) were grown anaerobically in MRS broth (Difco, Detroit, USA) 
supplemented with 0.05% L-cysteine hydrochloride monohydrate (Sigma-Aldrich, 
Steinheim, G) and incubated at 37°C for 16 – 40 h. Human intestinal epithelial cell 
lines (HIECs), Caco-2 cells (ATCC destination HTB 37, Manassas, USA ), T84 (ATCC, 
Manassas, USA; passages 57-64), and HT-29 (HTB-38; ATCC, Manassas, USA; 
passages 136-150) were grown in T75 Falcon flasks (Becton Dickinson, Franklin 
Lakes, USA) respectively on MEM/NEAA, McCoy’s 5a Medium or DMEMF12 
glutamax (Invitrogen, Breda, NL), supplemented with 10% Fetal Bovine Serum 
(Greiner Bio-One, Longwood, USA) and penicillin (100 IU/ml) and streptomoycin 
(100 µg/ml) (Invitrogen, Breda, NL) (pen/strep) in a humidified incubator at 37°C 
under 5% CO2 and 95% air. Cells were grown to confluency. Co-incubations of HIECs 
and bifidobacteria were performed with supplemented medium without pen/strep. 
Bacterial cultures were washed in cell line culture medium prior to the co-incubation 
with the HIECs. A volume of 10 ml bacterial culture (5 x 107/ml) was added to the 
T75 flasks that contained a monolayer of HIECs and 10 ml of supplemented medium 
without pen/strep. Negative controls, without bacteria, were included in this study. 
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After one hour of pre-incubation, inflammatory conditions were induced by addition 
of human recombinant TNF-α (10 ng/ml) (Endogen, Perbio Science, Ettenleur, NL) 
to the co-culture of HIECs and bacteria and subsequent incubation for 2, 4 and 
6 hours. Negative controls, without TNF-α, were included in this study. For ELISA 
analysis, 24-wells plates were used instead of T75 Falcon flasks (0.5 ml bacterial 
suspension per well). Prior to and after co-incubation bacterial culture samples were 
inoculated on MRS (0.05% L-cysteine hydrochloride monohydrate) agar plates for 
determination of bacterial numbers. After 40 h of anaerobic incubation at 37°C, CFUs 
were counted.
Immunological assay of Il-8
IL-8 was quantified in supernatants with the Human IL-8 CytoSetsTM (Biosource, 
Invitrogen, Breda, NL), performed as per the vendor’s instructions (Biosource) with 
the following adaptations: a complete TMB solution (Pierce, Thermo Fisher Scientific, 
Etten-Leur, NL) was used instead of the one described in the protocol.
RNa isolation from hIeCs
Cells were harvested by scraping after adding 2 ml of Trizol (Invitrogen, Breda, NL) 
to the cell monolayer. After scraping the cells were collected in a 2 ml Eppendorf 
tube, snap-frozen in liquid N2 and stored at -80°C. Before RNA isolation the cell 
mixture was defrosted by incubation at room temperature (RT).  The thawed cell 
suspension was homogenized by pipetting and vortexing and incubated at RT for 5 
min. Subsequently, 1:5 volumes of chloroform were added at RT and the mixture was 
shaken vigorously for 15 seconds. Then the samples were cooled on ice for 5 min 
and centrifuged at 18,000 x g and 4°C for 15 min. After centrifuging the water phase 
was transferred into a new 1.5 ml Eppendorf tube and placed on ice. The samples 
were purified and DNase treated using an RNeasy kit (Qiagen, Venlo, NL) according 
to the protocol of the supplier. Subsequently, the RNA samples were concentrated 
and purified using Vivaspin500 concentrator tubes (VivaScience, Sigma-Aldrich, 
Steinheim, G) according to the protocol of the manufacturer. 
labeling
An amount of 25 μg of total RNA was pipetted in an Eppendorf tube and dried down 
in a Speed Vac at low temperature. Subsequently, 3 μl of oligo (dT) 15primer (50 
μM) was added. A volume of 15.5 μl 10U RNasin containing milliQ H2O was added 
and the samples were put on ice for 10 min while mixed by vortexing a few times. 
Subsequently, the samples were incubated at 70°C for 10 min. After cooling at room 
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temperature for 10 min the samples were centrifuged. Subsequently, per sample 
the following reagents were added on ice: 6.0 μl 5 x First Strand buffer, 3.0 μl 0.1 
M DTT, 0.6 μl 50 x AA-dNTP mix (25 mM dATP, dCTP, dGTP, 15 mM dTTP, 10 mM 
AA-dUTP), 2.0 μl Superscript II RT enzyme (200 U/μl). The reaction mix was mixed 
well and incubated for 3 h at 42°C. The RNA template material was hydrolyzed by 
addition of 3 μl of 2.5 M NaOH. The mixture was mixed well and incubated at 37°C 
for 30 min. After the incubation 3 μl of 2.5 M HAc was added to neutralize the pH. 
Unincorporated AA-dUTP and free amines were removed using QIAquick columns 
(QIAgen Benelux BS, Venlo, NL). Five times the reaction volume of PB buffer 
(QIAgen supplied) was added to the samples and the mixture was transferred to a 
QIAqiuck Spin Column. Then the column was centrifuged at 18,000 x g for 1 min. 
The flow through was reloaded and the column was centrifuged again at 18,000 x g 
for 1 min. After centrifuging, the flow through was discarded. To wash the samples 
500 μl of 80% ethanol was added to the column and they were centrifuged at 18.000 
x g for 1 min. After centrifuging, the flow through was discarded and the washing with 
80% ethanol was repeated for two more times. Subsequently, the empty collection 
tubes were dried by centrifuging an additional 1 min at 18,000 x g. For elution of the 
sample material, 30 μl of milliQ H2O was carefully added to the centre of the columns 
after they were transferred to a new 1.5 ml Eppendorf tube. These were incubated 
for 1 min and centrifuged at 18,000 x g for 1 min. The elution step was repeated and 
the total volume of 60 μl of purified sample was dried at high temperature in a Speed 
Vac for about 15-30 min. For coupling of the Cy Dye Esters to the AA-cDNA the dried 
cDNA samples were dissolved in 4.5 μl 0.1 M sodium carbonate buffer (Na2CO3), pH 
9.0 during 10 min at room temperature while mixed a few times. Subsequently, 4.5 μl 
of the appropriate NHS-ester Cy Dye in dimethylsulfoxide (Amersham, Piscataway, 
USA) were added. This reaction mix was incubated for 1 h at RT in the dark. After 
incubation 10 μl of milliQ H2O was added and the samples were centrifuged shortly. 
To remove the unincorporated dyes we used Autoseq G50 columns (Amersham, 
Piscataway, USA) according to the protocol supplied by the manufacturer.
Microarray design and construction
The human microarray slides used contain 19,200 spots (16,659 70-mers, Operon 
human version1 (Operon Biotechnologies, G), and 2541 control spots). The 
microarrays were printed (Genomics Laboratory, UMC Utrecht, Department for 
Physiological Chemistry, Stratenum, Utrecht, NL) onto Corning UltraGAPS slides 
(Corning Incorporated, USA). Scanning of the slides was performed at 10 micron 
resolution. Array layout: 48 subgrids of 20 x 20 spots.
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prehybridization
The slides were washed at room temperature in a washing buffer containing 2*SSC 
and 0.05% SDS by shaking vigorously for about 1 min. After washing, the slides were 
blocked in at 42°C preheated borohydride buffer containing 2 x SSC, 0.05% SDS and 
0.25 sodium borohydride (Sigma-Aldrich, Steinheim, G) for 30 min. Subsequently, 
the slides were washed by dipping 5 times in room temperature milliQ H2O. After 
blocking the slides were prehybridized for 45 min at 42°C in prehybridization buffer 
containing 5 x SSC, 25% formamide (Merck, Darmstadt, G), 0.1% SDS and 1% 
bovine serum albumin (Sigma-Aldrich, Steinheim, G). After prehybridization the slides 
were washed by dipping five times in room temperature milliQ H2O. Subsequently, 
the slides were blow dried using compressed nitrogen.
hybridization
Per six slides 250 μl of 0.22 filter sterile 2 x hybridization buffer containing 50% 
formamide, 10 x SSC and 0.2% SDS, was mixed with 10 μl Salmon sperm DNA 
(5 mg/ml) and 4 μl Yeast tRNA (25 μg/ul; Invitrogen, Breda, NL) and preheated. A 
volume of 55 μl of preheated 2 x hybridization buffer was combined with 23 μl Cy3 
labeled cDNA, 23 μl Cy5 labeled cDNA and 9 μl milliQ H2O. This probe mixture was 
incubated at 95°C for 5 min, centrifuged and placed at 42°C. A volume of 110 μl 
of the probe was transferred to the slide by pipetting and covered with a LifterSlip 
(VWR, Soulbury, UK). Finally, 20 μl of milliQ H2O was added to each well in the 
hybridization chamber. The chamber was closed and placed in a water bath at 42°C 
for 16-20 h.
Washing of the slides
Before washing the LifterSlip was removed from the slide in low-stringency washing 
solution containing 1 x SSC and 0.2% SDS. Subsequently, the slides were incubated 
for 4 min in this low-stringency washing buffer. For the following high-stringency 
wash, the slides were transferred to a high-stringency washing buffer containing 0.1 
x SSC and 0.2% SDS and incubated for 4 min. The slides were finally washed in 0.1 
x SSC for 4 min to remove remnants of SDS. This step was repeated once, but the 
second time they were shaken vigorously for 1 min. The slides were blow dried using 
compressed nitrogen.
Microarray scan-image and data pre-processing
After washing and drying, slides were scanned with a ScanArray Express 4000 
scanner (Perkin-Elmer Nederland, Groningen, NL). The obtained images were 
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analyzed using Imagene 5.6 software (BioDiscovery, Marina del Rey, CA). A gene 
identification file was constructed  using CloneTracker software (www.biodiscovery.
com). Spots were quantified using ImaGene 5.6 software (www.biodiscovery.com).
During quantification, the ImaGene 5.6 software determined the average spot 
quality. Spot parameters such as shape regularity of the spots (threshold 0.4), spot 
size and background signals (signal intensity >2 x background signal) were used 
for flagging poor and empty spots. For validation of the labeling and hybridization 
reaction self-self hybridization reactions were performed
data analysis
Microarray data (Cy5/Cy3 ratios) were LOWESS normalized using ArrayNorm 1.7.2 
Software (http://genome.tugraz.at) (default settings). A 80% data filter was used as 
a cut-off criterion for further analysis. Principal Component Analysis (PCA) (default 
settings), Hierarchical Clustering Analysis (HCA) by determining the Euclidean 
Distances in the complete linkage clustering, Significance Analysis for Microarrays 
(SAM) (Two-class unpaired) and Analysis of Variance (ANOVA) (critical P value of 
0.01) of the normalized data was performed using TIGR MeV 3.1 Software (www.
tm4.org/mev.html).
ReSulTS
Comparison of TNF-α induced global transcriptional responses in 
intestinal cell lines
In a pilot experiment to select the most responsive model system, different confluent 
monolayers of T84, Caco-2 and HT-29 cells were stimulated with TNF-α. These 
three HIECs were selected as they represent the most commonly used intestinal 
cell lines with different degree of differentiation. Subsequently, after two and 
six hours of incubation, these HIECs were harvested for RNA extraction and the 
sample transcripts were determined by hybridization to genome-wide microarrays. 
Hierarchical clustering analysis (HCA) and principle component analysis (PCA) of 
the generated data, indicated that the parameter ‘cell type’ predicted most of the 
gene expression values subsequently followed by the ‘time of harvest’ and finally 
‘TNF-α stimulation’ (data not shown). Although the overall gene expression showed 
extensive variation between the cell types, these results confirm the difference in 
sensitivity to TNF-α. The HCA enabled us to identify sub-clusters of genes that were 
up-regulated by TNF-α stimulation. Based on significance analysis of microarray data 
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(SAM) analysis, 25 genes showed differential expression after stimulation with the 
cytokine. PCA analysis clearly visualized these differences with the responsiveness 
of  HT-29 being the highest, followed by that of Caco-2 cells, while T84 cells were 
the least responsive and only showed increased gene expression after 6 hours of 
incubation (Figure 1).
To confirm functional activation of the nuclear factor kappa-B (NF-κB) signalling 
pathway, IL-8 mRNA and protein concentrations in the supernatant were measured. 
After two and six hours respectively 16.0 and 1.96 fold up-regulation of IL-8 mRNA 
expression was observed in HT-29 cells compared to non in T84 and Caco-2 cells. 
Figure 1. PCA-plot (PC2-3) based on expression data of inflammatory genes (n=25) after in vitro 
stimulation of Caco-2 (Caco), HT-29 (HT-29), and T84 (T84) cell line monolayers with TNF-α (TNF-) 
for two (2h) or six (6h) hours. Genes were selected by SAM analysis (TNF-stimulated versus non-TNF-
stimulated cells) based on a total of 4710 genes (80% data filter). PC1, PC2, and PC3 explain 28.9%, 
26.2%, and 13.9% of the data variation respectively.  Settings; components: 25, covariance, number of 
neighbours for KNN imputation: 10
Caco 6h
HT29 6h
T84 6h
T84 2h
HT29 2h
Caco 2h
T84 6h TNF
T84 2h TNF
Caco 6h TNF
Caco 2h TNF
HT29 2h TNF
HT29 6h TNF
59.21
47.37
35.53
23.69
11.84
-11.84
-23.69
-35.53
-47.37
-59.21
6.68 13.36 20.04 26.71 33.39-6.68-13.36-20.04
PC 2 (26.2%)
PC 3 (13.9%)
This was in line with the concentrations of extracellular IL-8 protein detected in their 
supernatant. After two, six, and 24 hours respectively 500, 2000, and 15000 pg/ml 
IL-8 protein was measured in HT-29 cells. The extracellular IL-8 level of T84 reaches 
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its maximum of 120 pg/ml after 24 hours. No extracellular IL-8 was measured in the 
supernatant of the Caco-2 cells.
Caco-2 cells were responsive to TNF-α but only a few inflammatory genes were 
differently expressed in comparison to the control situation. Mainly, NF-κB was up-
regulated after two hours of stimulation with TNF-α. On the other hand, the HT-29 
and T84 cells showed much more interesting gene expression patterns. T84 cells 
showed up-regulated expression of NF-κB genes and interferon-gamma (IFN-γ) 
receptor. The expression levels were changed after two hours and more increased 
after six hours of TNF-α stimulation. MAPK genes were up-regulated at 6 hours 
of stimulation. However, IL-8 expression was not induced. Obtained ELISA data 
determined a slide increase of extracellular IL-8, but only 24h after the stimulation. 
This could be an cumulative effect of either active secretion or passive leakage of 
IL-8 proteins from the T84 cells. 
HT-29 cells showed a strong induction of NF-κB, IL-8, and IFN-γ genes after two 
hours of stimulation. At six hours of TNF- α stimulation this up-regulation of NF-κB 
and IL-8 gene expression was decreased compared to the situation after two hours 
of stimulation, but MAPK signal transduction routes were activated. At two hours of 
stimulation with TNF-α there were more genes differently expressed than after six 
hours. In conclusion, HT-29 are more early responsive than the other two cell lines 
and show an pro-inflammatory gene expression pattern after stimulation with TNF-α. 
Therefore, the HT-29 cells were used for the inflammatory host-microbe interaction 
model. 
Transcriptome analysis of modulating effect of b. breve M-16V
Using TNF-α stimulated HT-29 cells as a test system, we studied whether B. breve 
strains were capable of immune-modulating HIECs. For this purpose, a confluent 
monolayer of HT-29 cells was pre-incubated for one hour with either B. breve 
UCC2003, B. breve M-16V, or B. breve strain NR246 followed by an additional 
TNF-α stimulation of two hours. Subsequently, the global transcriptional response 
was determined by hybridizing isolated RNA to genome-wide microarrays. Using an 
80%  data cut-off filter, 5461 genes were selected for further analysis. SAM analysis 
was applied in order to select genes that were affected by TNF-α stimulation of the 
HT-29 cells. The data showed that the transcription of 107 genes was differently 
regulated in the tested conditions and with the applied selection criteria (Table 1). 
HCA enabled clustering of these genes in three main groups. One group contained 
15 genes that were upregulated in all conditions, either bacterial presence, TNF-α 
stimulation, or both. A second group contained  58 genes  that were characterized 
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by an upregulation in all TNF-α stimulated conditions except for the coincubation 
with bacterial M-16V cells. Furthermore, a third group included 34 genes that 
showed solely upregulation when stimulated with TNF-α and could be suppressed 
by all three B. breve strains. This microarray dataset confirmed the pilot study by 
showing that TNF-α stimulation resulted in the upregulation of a pro-inflammatory 
gene repertoire in the HT-29 cells (Table 1). Evidence of activation of chemokine 
signaling, apoptotic, and MAPK pathways was found. IL-8 gene expression was up-
regulated by TNF-α stimulation, but the presence of bifidobacteria up to two hours of 
coincubation did not reduce the IL-8 transcription. Hence, we determined the level of 
extracellular IL-8 by an immunological assay and observed that the TNF-α induced 
secretion of IL-8 was also unaltered in the two hour presence of bacteria. TNF-α 
stimulation resulted in 7000 (SD=63), 12000 (SD=736), and 19000 (SD=233) pg/ml 
extracellular IL-8 protein after respectively two, four, and six hours of incubation. In 
comparison, TNF-α stimulation in presence of B. breve M-16V showed extracellular 
concentrations of 8000 (SD=135), 13000 (SD=1307), and 22000 (SD=50) pg/ml, 
after the same time of incubation, indicating no significant difference. Also the two 
other strains did not alter the TNF-α induced IL-8 secretion by HT-29 cells while 
the bifidobacterial cells alone, in absence of TNF-α stimulation, did not induce IL-8 
secretion by epithelial cells (results not shown). The colony forming units (CFU) of 
the bifidobacterial strains during the incubation with the HT-29 cells were determined 
as an indication for the bacterial viability. At time-point zero and after three hours of 
incubation, the average number of CFU/ml was stable (approximately  5.0 x 107), 
indicating that the treatments did not affect viability in this time frame.
Despite the lack of effect of the Bifidobacterium strains on the amount of 
extracellular IL-8 protein, HCA in combination with SAM of the obtained gene 
expression data showed divergent modulating effects of the B. breve strains on 
gene expression of HT-29 cells upon the TNF-α stimulation. Based on the earlier 
described  TNF-α  affected genes (Table 1), a PCA plot was constructed to visualize 
the effects of the different B. breve strains on the expression of these genes (Figure 
2). The PCA plot clearly showed that the gene expression patterns of the HT-29 cells 
incubated with B. breve M-16V, NR246, UCC2003 were relatively close to that of 
the negative control. Furthermore, the TNF-α stimulated HIECs displayed a totally 
different pattern characteristic of an inflammatory reaction. The gene expression of 
the TNF-α stimulated HT-29 cells co-incubated with UCC2003 cells and those solely 
stimulated with TNF-α were highly similar, indicating that there was little effect of the 
UCC2003 cells. The HT-29 cells that were co-incubated with NR246 and stimulated 
with TNF-α were found on a significant distance from the controls in the PCA plot. This 
suggests a mild suppression of the gene expression induced by TNF-α. Remarkably, 
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Figure 2. PCA-plot (PC1, 2) based on average expression data (n=2) of genes selected as described 
in the legend of Figure 2. PC1, PC2, and PC3 explain 60.1%, 12.5%, and 10.5% of the data variation 
respectively.  Settings; components: 107, covariance, number of neighbours for KNN imputation: 10
the TNF-α stimulated HIECs co-incubated with M-16V were not located close to 
the other TNF-α stimulated samples in the PCA but revealed an expression pattern 
overlapping with that of the control incubation without TNF-α. This is indicative of the 
suppression of the effect induced by TNF-α-by these cells. These results indicate 
that the expression of a cluster of genes that is affected by TNF-α stimulation, is 
modulated by the presence of B. breve M-16V, but not by B. breve NR246 or B. 
breve UCC2003. This provides support for the existence of strain-specific effects of 
bifidobacteria on HT-29 cells.
analysis of functional groups that are modulated
All genes that are found to be affected by TNF-α including their KEGG orthology 
grouping, are listed in Table 1. Remarkably, the transcriptional regulation of a subset 
of 58 genes could be influenced by the presence of M-16V. Some genes that were 
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clearly influenced can be linked to inflammation and apoptosis. B. breve M-16V, 
and not the other two strains, prevented TNF-α induced up regulation of apoptosis-
related cysteine protease caspase 7 (CASP7), interferon regulatory factor 3 (IRF3), 
NADPH oxidase (NOX5), and amyloid beta (A4) precursor protein-binding family A 
member 1 (APBA1), genes which are involved in activation of apoptotic and immune 
regulatory pathways (Chenevier-Gobeaux et al., 2006; Korfali et al., 2004; Palmerini 
et al., 2001; Park et al., 2006; Reimer et al., 2008). Furthermore B. breve M-16V 
suppressed the induction of leukemia inhibitory factor receptor (LIFR), involved in 
cell cycle arrest (Tomida, 2000) and IL-6ST, which was also suppressed by NR246 
and UCC2003, involved in pro-inflammatory cytokine signaling (Radtke et al., 2010). 
Notably, The TNF-α induced gene, TRAIL receptor 2, was one of the few genes to 
be suppressed by NR246. According to its KEGG orthology this gene is involved in 
TNF-related apoptosis.
dISCuSSION
In this study we determined the genome-wide transcriptional response of human 
epithelial intestinal cells (HIECs) following exposure to cells of Bifidobacterium breve. 
TNF-α stimulated HT-29 cells were selected for exposure to the B. breve strains 
M-16V, NR246 and UCC2003. After one hour of bacterial pre-incubation followed by 
two hours of additional TNF-α stimulation, B. breve M-16V, to a much lesser extent 
strain NR246, but not UCC2003, showed a strain-specific reduction of the HT-29 
transcriptional response to the inflammatory treatment. The results underline the 
complexity of the cell-cell signalling interaction network between intestinal epithelial 
cells and bifidobacteria. Bifidobacterium breve M-16V selectively prevented TNF-α 
induced gene expression of HT-29 human intestinal epithelial cells. Bifidobacterium 
breve NR246 and B. breve UCC2003 were less effective and showed  little or no 
specific modulation. Although 86% of the TNF-α induced genes were suppressed by 
B. breve M-16V, transcription of general NF-κB signalling molecules and IL-8 was 
not affected. Bifidobacterium breve M-16V however interfered with specific TNF-α 
induced genes involved in immune regulation, and apoptosis. Bifidobacterium 
breve M-16V has been described as a potential anti-allergic strain with respect to 
ovalbumin-allergic asthma and food allergy in mice (Hougee et al., 2010; Schouten 
et al., 2009). In similar experiments, no anti-allergic effect of B. breve NR246 could 
be observed (L.E.M. Willemsen, personal communication), supporting our present 
findings that this strain showed a mild anti-inflammatory effect. We could not 
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detect a clear effect of the presence of bifidobacteria on HIEC gene expression 
under non-inflammatory conditions. Next to HT-29 cells, incubation of Caco-2 cells 
with bifidobacteria did not result in a significant change of gene expression in the 
HIECs data (not shown). Even not a light inflammatory response was measured as 
described previously for a set of Lactobacillus strains (Vizoso Pinto et al., 2009). 
We suggest that under stress-free conditions the bifidobacteria did not modulate 
the HIECs as there was no need change their local environment. As inflammatory 
conditions might provoke them to perform immune-modulating activities, TNF-α 
induced immune stress was used to study the effect of three different bifidobacterial 
strains on HIEC in an inflammatory host-microbe interaction model. TNF-α induces 
an inflammation reaction in the HIECs in vitro and also is known to affect epithelial 
signalling and integrity in patients affected with inflammatory bowel disease (Riedel 
et al., 2006; Weber et al., 2010). To mimic the in vivo situation of a colonized intestinal 
tract, the HIECs were pre-incubated with bacteria before stimulation with TNF-α. 
A pre-incubation period of one hour is long enough to enable the HIECs to adapt 
to the presence of the bacteria and sufficiently short to prevent acidification of the 
culture medium. While gene-expression is regulated within seconds, the subsequent 
two hour additional stimulation with TNF should result in a measurable effect on 
transcriptome level. It is described that the sensitivity of HIECs to cytokines differs 
per cell type (Schuerer-Maly et al., 1994). Therefore, we screened the three most 
commonly used HIECs ─ Caco-2, HT-29 and T84 - for their sensitivity for TNF-α. Our 
results indicated a clear response of HT-29 cells to extracellular TNF-α stimulation 
of the IL-8 secretory pathway in correspondence with increased IL-8 transcription 
strongly present after 2 hr of incubation. This was less prominent for Caco-2 and 
T84 cells and IL-8 secretion was very low or not observed. In the HT-29 most genes 
were differentially expressed after two hours of stimulation. HT-29 showed a strong 
induction of NF-κB genes which was tightly regulated since it was decreased after 
six hours of stimulation while MAPK signal transduction routes were activated at this 
time point. This correlates with the described response of HT-29 to TNF-α, which 
triggers inflammatory pathways (Gross et al., 1995). From our results, we concluded 
that TNF-α stimulated HT-29 cells gave a clear response on transcription, which is 
measurable by microarray analysis and correlated with IL-8 protein secretion. Based 
on this characteristic of a rapid response, the HT-29 cell line was chosen as model 
cell line in co-incubation experiments with the set of bifidobacteria.
It has been described that inflammation or infection can induce apical TLR 
expression in HIECs (Muzio et al., 2000). Bifidobacteria may affect NF-κB signalling 
amongst others by binding to these TLR receptors. Stimulation of HT-29 cells with 
TNF-α followed by co-incubation with B. longum Bar33 whole cells was found to 
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decrease of IL-8 production, although this response was dose-independent (Candela 
et al., 2008). In contrast L. rhamnosus GG and not B. breve M-16V was found to 
enhance the pro-inflammatory immune response in a trans-well coculture model of 
HT-29 and activated PBMC (Hoffen et al., 2010). However, B. breve M-16V and not 
B. infantis NR251, B. animalis NR252, B. animalis NR253, L. plantarum NR8, or 
L. rhamnosus NR6 effectively decreased ovalbumin-sensitization in mice (Hougee 
et al., 2010). Overall, these experiments suggested that commensal microbes are 
strain-specific in their ability to regulate the delicate balance between necessary 
and excessive immune responses (Winkler et al., 2007). This is supported by 
our observations in which B. breve M-16V, NR246, and UCC2003 were able to 
subsequently suppress 86%, 50%, and 30%  of the TNF-induced set of genes 
(Table 1). No clear pathways could be identified from the set of genes suppressed 
by UCC2003 and NR246. M-16V on the other hand showed suppression of encoded 
proteins involve apoptotic and immune activation pathways. Dampening of these 
pathways by B. breve M-16V may help to regulate the inflammation. Interestingly, the 
TNF-α signaling was only partially influenced since transcription of NFκB and MAPK 
signaling proteins and IL-8 transcription and translation remained unaffected.
In conclusion, B. breve M-16V was found to partially modulate the TNF-α induced 
inflammation of HIEC. These modulating abilities were strain-specific since two other 
B. breve strains were ineffective. Overall, these findings will contribute to a better 
understanding of the underlying mechanisms of interaction between bifidobacteria 
and HIECs. Moreover, genomic comparison of the B. breve genomes with that of 
the model strain UCC2003 will advance further insight in the molecular determinants 
involved in this strain-specific signalling.
aCkNOWledgeMeNTS
We would like to thank Arjan Duivelshof and Menno-Jan van den Brink for their 
excellent technical support. This study was financially supported by the Dutch 
Ministry of Economic Affairs through the Innovation Oriented Research Program on 
Genomics (IOP Genomics: IGE01016).
Thesis-Rolf-v3.indd   109 2-1-2011   23:33:28
Thesis-Rolf-v3.indd   110 2-1-2011   23:33:28
Chapter 7
General discussion & concluding remarks
Thesis-Rolf-v3.indd   111 2-1-2011   23:33:29
Chapter 7
112
This thesis combines comprehensive microarray-based studies contributing to 
a better understanding of the role of bifidobacteria in relation to the human host. 
An general overview on the described modes of interaction between bifidobacteria 
and human gastrointestinal cells is presented in Chapter 1. It focuses on the 
unique characteristics of the genus Bifidobacterium in comparison with that of 
the genus Lactobacillus that are indicative for the role of their members in our 
intestines. Chapter 2 describes the development of a microarray platform that 
enables genomic comparison of Bifidobacterium species originating from our 
gastrointestinal tract (GIT). Based on the obtained high-resolution data, species-
unique genomic sequences could be identified. The ability to zoom in on strain level, 
using this platform, was tested in Chapter 3. This work showed a relatively high 
genomic variation between the different B. breve isolates, using direct mapping 
of genomic hybridization patterns. Clustering of hybridization patterns resulted in 
clear grouping of isolates originating from the same infant. The predicted difference 
in gene content between the new isolates was approximately 60-90%, testifying 
for the existence of various subspecies within the species B. breve, or even for 
new Bifidobacterium species. Analysis of the bifidobacterial genomic variation was 
studied in a broader sense in Chapter 4. This Chapter describes the analysis of 
genomic variations between total Bifidobacterium populations from different infant 
fecal samples. The applied microarray platform showed the potential to monitor 
temporal development and effects of dietary regiments. The observation of different 
compositions of bifidobacterial populations could be linked to dietary effects. Mapping 
of the hybridization patterns enabled monitoring shifts in genomic content within 
one bifidobacterial species in time. Sequence analysis of DNA fragments showing 
discriminating hybridization characteristics resulted in a selection of genes that are 
conserved or strain-specific within the species B. breve. Next to studying genomic 
variation, transcript profiling experiments in both bifidobacterial cells and human 
intestinal epithelial cell lines were performed (Chapters 5 and 6). Clear proof of 
transcriptional activity in bifidobacterial cells isolated from infant feces was presented 
in Chapter 5. To the best of our knowledge, this is the first demonstration of in situ 
activity of bifidobacteria in the human GIT. Furthermore, our results indicate a link 
between transcription patterns and the infants diet. Bifidobacteria in breast-fed infants 
showed differential transcriptional responses in comparison those in formula-fed 
infants. Additionally, transcript sequence analysis revealed the expression of genes 
that are homologous to genes that are known to be involved in folate production, 
testifying for the production of this important vitamin in early life. A view from the 
other side was presented in Chapter 6. This transcriptomics study focused on the 
effect of different B. breve strains on HT-29 human intestinal epithelial cells (HIECs). 
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An inflammatory environment was mimicked by stimulating the HT-29 cells with the 
pro-inflammatory cytokine TNF-α. Co-incubation of HIECs with bifidobacterial cells 
during TNF-stimulation resulted in the observation of an species-specific suppression 
of genes upregulated by TNF-α. Although we did not observe complete suppression 
of the TNF effect, we could show that apoptotic and immune regulatory pathways 
were affected by incubation with cells of B. breve M-16V.
 In the following sections the relations between the work presented in this thesis 
and other relevant studies and recent publications will be discussed in more detail. 
The bifidobacterial taxonomy will be summarized and used as reference for the 
interpretation of the observed genomic variation between new B. breve isolates 
and the results of the genomic comparisons. It will be discussed how the species-
specific DNA fragments may contribute to an improved understanding of species-
specific characteristics and effects. Moreover, an overview of various observations 
on bifidobacterial populations in both infants and adults will presented and linked to 
our own data. Furthermore, the new insights in the bifidobacterial effects discovered 
in the present work will be compared to recent findings in other interaction studies 
(such as reviewed in Chapter 1). Finally, an overview of the recently completed 
and currently ongoing genome projects, together with a general comparison of next-
generation sequencing platforms summarizes the current state of the art and provides 
new avenues for studying the functionality of bifidobacteria and other microbes in the 
human GIT. 
The geNuS bifidobacterium
An exhaustive overview of the history and phenotypic characteristics of the genus 
Bifidobacterium has been recently published (Lee and O’Sullivan, 2010). Currently, 
around 31 species have been assigned to this genus including recent additions 
such as B. denticolens and B. inopinatum isolated from human dental caries and B. 
psychraerophilum, originating from pig intestines. Different phylogenetic analyses 
using different methods and models, affirm that the genus Bifidobacterium contains 
different groups of species (Favier et al., 2002; Ventura et al., 2006). These have 
been named based on the first described species in the group and include the 
following groups: the B. adolescentis group, the B. pullorum group, the B. asteroids 
group, the B. boum group, the B. pseudolongum group (for a detailed overview see 
Fig. 1). The species B. breve and B. longum form a couple, as well as B. minimum 
and B. psychroaerophilum, although the latter grouping is less well supported. 
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Bifidobacterium bifidum, B. magnum, B. scardovii and B. subtile form distinct branches 
(Fig.1). Recently, a phylogenetic re-analysis was reported by using a multilocus 
sequencing approach (Ventura et al., 2006). This confirmed the phylogenetic structure 
of the genus at almost all levels and improved the discrimination of related species. 
Other molecular methods addressed taxonomic issues in the genus Bifidobacterium 
concerning the species B. longum and B. infantis. These are now considered to 
belong to one of the three biotypes of B. longum that include the infantis type, the 
longum type, and the suis type (Sakata et al., 2002). Another debated issue is the 
relationship between B. animalis and B. lactis, and the latter was recently reclassified 
as B. animalis subsp. lactis. This had an impact on the taxonomic position of the 
frequently used probiotic Bifidobacterium strain Bb12 that systematically correct 
should be termed B. animalis subsp. lactis Bb12.  Finally, a further  differentiation 
was made between B. indicum, B. coryneforme and B. asteroids. While B. indicum 
and B. asteroids could be easily distinguished, B. indicum and B. coryneforme could 
not (Felis and Dellaglio, 2007). Detailed DGGE analysis of 16S rRNA amplicons 
confirmed the high relatedness of these species (Temmerman et al., 2002). However, 
multilocus sequence analysis has shown to successfully differentiate B. indicum and 
B. coryneforme (Ventura et al., 2006).
With the exception of species isolated from human dental caries, sewage or 
insects, the majority if bifidobacteria species are found in the GIT of mammals. 
Bifidobacteria are known to be host-specific. Species found in the human GIT are 
highlighted in Figure 1 (Leahy et al., 2005). Other Bifidobacterium species have 
been isolated from pig, honeybees, chicken, lamb, calf, rabbit and rat intestinal tracts 
(Leahy et al., 2005). 
Bifidobacteria are likely to owe their specific ecological success to their capacity to 
metabolize complex carbohydrates. It therefore comes as no surprise that genes for 
complex sugar metabolism are abundantly present in the genomes of B. breve and 
B. longum biotype longum (Ventura et al., 2007). According to the sequence-based 
classification of carbohydrate-active enzymes (CaZy), over 8% of the annotated 
genes of these bifidobacterial genomes are predicted to code for enzymes involved 
in the metabolism of carbohydrates. These include a variety of glycosyl hydrolases 
for utilization of diverse, and in most cases not identified, plant-derived dietary fibers 
or complex carbohydrate structures, such as human milk oligosaccharides (HMOs). 
Relatively few of these glycosyl hydrolases are predicted to be secreted, including 
those that are thought to hydrolyze arabinogalactans and arabinoxylans (Schell et 
al., 2002). Instead, most of the bifidobacterial glycosyl hydrolases are predicted 
to be intracellular, and the genes that encode them are almost without exception 
associated with genes predicted to encode systems for the uptake of structurally 
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Figure 1. Phylogenetic tree of the genus Bifidobacterium, based on 16S rDNA sequence analysis (adapted 
from Ventura et al., 2006). Species that have been isolated from the human GIT are marked by arrows
diverse carbohydrate substrates. Moreover, carbohydrate-modifying enzymes may 
also shape the overall metabolic state of the colon to sustain a microbiota that 
indirectly provides the host with about 10% to 15% of its calories from the degradation 
of complex carbohydrates through short-chain fatty acids (Vaughan et al., 2005). 
Bifidobacteria can also utilize sialic acid-containing complex carbohydrates in mucin, 
glycosphingolipids, and human milk. Some of the details of this important degradation 
pathway have recently been elucidated (Turroni et al., 2010). Thus, the mammalian 
host supplies substrates for intestinal commensals including bifidobacteria, in a 
remarkable symbiotic (or altruistic) relationship (Corfield, 1992; Nakano et al., 2001). 
Starch and amylopectin are other examples of polysaccharides which may escape 
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The ability to degrade these sugars appears to be restricted to certain species or to 
certain strains of a particular species, including B. breve and B. adolescentis (Ryan et 
al., 2006). This is a clear example of adaptation to a specific ecological niche, namely 
that of the human GIT. The potential impact that bifidobacteria may have on human 
health resulted in the recommendation of bifidobacteria as dietary supplements 
already over hundred years ago (Mayer, 1948; Parvez et al., 2006; Saavedra and 
Tschernia, 2002; Tissier, 1906). Freeze-dried bifidobacterial preparations, sometimes 
with in combination with specific lactibacilli such as Lactobacillus acidophilus, have 
been used for the treatment of GIT disorders (Prevot, 1971; Reuter, 1969). Currently, 
bifidobacteria are added to numerous foods and numerous probiotic activities have 
been claimed (Figure 2). In order to confirm these claims and to provide more insight 
in the interaction of bifidobacteria and their human host numerous studies have 
been performed. Chapter 1 summarizes the interaction mechanisms described 
from bifidobacteria. For example, colonization of gnotobiotic mice with bifidobacteria 
and Bacteroides revealed that the presence of bifidobacteria expanded the diversity 
of polysaccharides degraded by Bacteroides, suggesting a synergistic effect of 
digestion in the upper human GIT and which are plant-derived high-molecular-weight 
carbohydrates. 
Suppression of colonization 
of pathogens
Reduction in risk factors 
for colon cancer
Control of irritable 
bowel diseases Alleviate food allergy 
symptoms in infants
Strengthened innate 
immunity
Improved lactose tolerance
Normalised intestinal 
microbiota composition
Immunomodulation
PROBIOTICS
Metabolic effects
Supply of SCFA and vitamins (e.g. 
folate) to the colonic epithelium
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hydrolysis
Bile salt deconjugation 
and secretion
Balanced 
immune 
response
PREBIOTICS
Effects of 
Bifidobacteria
(specific oligo-/polysaccharides)
Lower serum cholesterol 
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 the gut  
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Figure 2. Overview of the effects of bifidobacteria (after Parvez et al., 2006)
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bifidobacteria with other intestinal microbiota on digestion of polysaccharides which 
are indigestible by the host (Sonnenburg et al., 2006). In addition, recently performed 
RNA-based stable isotope probing experiments showed that B. adolescentis is 
actively involved in inulin and lactose metabolism in a human intestinal model system 
(Kovatcheva-Datchary, 2010). Another possible role of bifidobacteria in the large 
intestine is the production of water-soluble vitamins, such as many of the B group of 
vitamins, as shown previously (Deguchi et al., 1985) and also substantiated by genome 
analysis. Additionally, the first study to provide proof of transcriptional activity in fecal 
bifidobacteria (Chapter 5), showed presence of mRNA sequences implicated to be 
involved in folate production. An important role of bifidobacteria in the large intestine 
is believed to be modulation of certain bacterial groups that may be detrimental to 
the host. Numerous studies support their competitive abilities against other intestinal 
microbes (Asahara et al., 2004; Hopkins and Macfarlane, 2003). In addition, in vivo 
studies have shown that bifidobacteria can produce antimicrobial compounds such 
as organic acids (Scardovi et al., 1970), iron-scavenging compounds (O’Sullivan, 
2008), and bacteriocins (Cheikhyoussef et al., 2008; Lee et al., 2008; Yildirim et al., 
1999). An intriguing function of bifidobacteria in the intestine may be in protection 
against some immune-based disorders, as numerous studies have shown them 
to stimulate a host innate immune response (O’Hara et al., 2006; Sonnenburg et 
al., 2006). These inflammatory and immune defense responses are proposed to be 
triggered by recognition of commensal bifidobacteria or its components via Toll-like 
receptors (TLRs) of the host innate immune system (Rakoff-Nahoum et al., 2004). 
In summary, the pivotal role of bifidobacteria in the development of the intestinal 
microbial community in our early life, our immune system, and its involvement in 
maintaining microbial stability within our intestinal tract, has greatly increased the 
interest in  microbe─host interaction studies.
dyNaMICS OF The INTeSTINal BIFIdOBaCTeRIal pOpulaTION 
The dynamics of the bifidobacterial population during human life has received great 
interest (for a summary see Figure 3). Various studies have shown that, on average, 
the Bifidobacterium population of a young infant contributes 40-60% to the total fecal 
microbiota. However, high variations were observed while some formula-fed infants 
contained no detectable fecal bifidobacteria compared to exclusively breast-fed 
infants that showed faecal bifidobacterial populations that constituted 90% of the total 
bacterial load (Harmsen et al., 2000). The most abundant species to be found in the 
Thesis-Rolf-v3.indd   117 2-1-2011   23:33:30
Chapter 7
118
infant intestinal tract are B. breve, B. longum subsp. longum, and B. longum subsp. 
infantis. Next to these three, B. catenulatum, B. adolescentis, and B. bifidum are 
also often detected. Many Bifidobacterium population studies have been performed 
with respect to human fecal samples. The overall bifidobacterial compositions, as 
published by various research groups through different geographical regions, are 
presented in Table 1. Although there is some variation, the three most abundant 
species are consistent throughout the different studies and in line with the work 
presented in Chapter 4. An interesting observation is the difference in breast-fed and 
formula-fed infants. It was recently reported that the average bifidobacterial diversity 
was greater in breast-fed infants in comparison to infants that received a formula 
without additional prebiotic oligosaccharides (Roger et al., 2010). This outcome 
was different from the findings described in Chapter 3 that indicate the opposite. 
This difference could be explained by the nature of the different formulas as the 
formula milk that increased the bifidobacterial diversity (as reported in Chapter 3) 
was supplemented with a mixture of galacto-oligosaccharides (GOS) and fructo-
oligosaccharides (FOS). This is supported by the  data presented in Chapter 4 
that also showed infants that received formula milk supplemented with a FOS/GOS 
mixture to contain a more diverse bifidobacterial populations than those receiving a 
standard formula without these oligosaccharides.
The overview of recent studies on the bifidobacterial development in early life 
revealed the existence of geographical factors (Table 1). Characteristic species in 
adult populations have found to include B. longum subsp. longum, B. catenulatum, 
and B. adolescentis. By comparing the various studies, it appeared that B. 
adolescentis was mainly detected in Japanese subjects. This could be an example 
of a geographic effect based on local diet habits and/or genetic differences.
Individual variation in gut microbiota diversity and functional genome content 
is greater between infants than adults (Kurokawa et al., 2007). These variations 
may be due to random colonization events, differences in immune responses to the 
colonizing microbes, changes in host behavior, or other aspects of host life style 
(Dethlefsen et al., 2006; Palmer et al., 2007). As infant microbiomes are less diverse, 
we hypothesize that differences in composition have a significant impact on the total 
microbial intestinal community. However, detailed information on the development of 
the infant microbiome and the role of the shaping factors mentioned above is lacking. 
Recently, a 2.5 year case study was reported that related life events to microbiome 
composition and functions (Koenig et al., 2010). A gradual over time increase of the 
phylogenetic diversity was observed. Furthermore, major taxonomic groups showed 
abrupt shifts in abundance corresponding to changes in diet or health, such as fever 
and antibiotic treatment. This is not new and has been well documented for several 
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babies for up to a year in the first molecular studies on the infant microbiota (Favier et 
al., 2002; Favier et al., 2003). Similar observations have been described in Chapter 
4, where a more systematic  analysis of six infants for up to a year were monitored 
and correlations between diet and the composition of the intestinal bifidobacterial 
population were observed. In this study, direct mapping of microarray hybridization 
patterns enabled detailed analysis of the bifidobacterial population in the infant gut. 
Obtained findings consolidating with other studies, indicate that diet is an important 
factor with respect to the development, composition, and stability of our microbiome. 
Furthermore, the unexpected hybridization pattern of a sample obtained in week 
16 of infant B, that showed an abrupt drop in Bifidobacterium counts, might be 
also explained by a fever or antibiotic treatment, in line with observations of others 
Figure 3. Schematic representation of the dynamics of the intestinal bifidobacterial population during 
human life
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populations are more
sensitive to this eect 
compared to adult-like
Bidobacterium populations
Senior bidobacterial population
Bidobacterium populations of
seniors show temporal stability
over limited time, but charaterized
by extreme variability
0.4 - 2% of total bacterial population
Abundant species:
- B. adolescentis
- B. angulatum
- B. longum
- B. bidum
- B. breve
Often detected species:
- B. pseudocatenulatum
- B. dentium
The bidobacterial
population is aected
by ageing due to
changes in physiology
of the GI-tract, lifestyle,
nutrition, and the
functionality of the
immune system
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(Koenig et al., 2010). Unfortunately, we did not have access to detailed information 
on the infant’s conditions but it is tempting to speculate that a change in health 
status may have caused the drop of bifidobacterial abundance in this particular 
sample. When the infants changed to  diet of solid foods we observed a 90% drop 
of Bifidobacterium-specific hybridization signals (Chapter 4). This corresponds to 
the change in abundance of Bacteroidetes following the same event (Koenig et al., 
2010). Additionally, direct mapping of hybridization patterns, as described in Chapter 
4, provided highly detailed information on genomic variation within species which 
has not been described in other studies.
Interestingly, in none of the six infant fecal samples that were analyzed in Chapter 
4, we could observe any B. longum subsp. infantis above the detection level of 
around 2 ng DNA. This is remarkable, as this subspecies has been described as 
specialized in human milk utilization (Sela et al., 2008). Several chromosomal loci 
of B. longum subsp. infantis reflect the potential adaption to the infant host. And 
example is the presence of a 43 kbp cluster encoding catabolic genes, extracellular 
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Geographical location NL 
AL
G 
J
P 
J
P 
J
P UK 
UK 
+ 
NZ 
GH UK EST 
J
P 
J
P 
J
P 
J
P 
J
P Geographical location 
B. breve H H L H H H   M M L L L  L B. breve 
B. longum subsp. 
infantis  H H H H H  H   H    L 
B. longum subsp. 
infantis 
B. longum subsp. 
longum  H H  H  H L M H L H H H H 
B. longum subsp. 
longum 
B. adolescentis   L  L H   H H H H H H H B. adolescentis 
B. catenulatum     L  L  H H H H H H H B. catenulatum 
B. bifidum   L H L H L  L L L  L  M B. bifidum 
B. pseudocatenulatum H      L  L       B. pseudocatenulatum 
B. angulatum     L    H   L   L B. angulatum 
B. dentium     L    M L  L L  L B. dentium 
Table 1. Bifidobacterial population composition - the output of various studies . High (H), medium (M), 
low (L) relative % of bifidobacterial population (Favier et al., 2002; Magne et al., 2006; Matsuki et al., 
1999; Matsuki et al., 2004; Mitsou et al., 2008; Roger et al., 2010; Sakamoto et al., 2003; Sakata et al., 
2005; Stsepetova et al., 2007; Woodmansey et al., 2004; Young et al., 2004). Geographical locations; 
The Netherlands (NL), United Kingdom (UK), Japan (JP), Algeria (ALG), New Zeeland (NZ), Ghana (GH), 
Estonia (EST). Generally abundant species in the infant or adult bifidobacterial population are indicated 
(dark and light grey shading, respectively).
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solute binding proteins and permeases predicted to be active on HMOs which are 
abundant in breast-milk (Sela et al., 2008). A phenotypic study underlines these 
findings and illustrates the ability to consume HMOs as a sole carbon source, which 
is a unique property of Bifidobacterium and Bacteroides species (Zivkovic et al., 
2010). However, this ability does not extend to all bifidobacterial isolates. The ability 
to grow vigorously in HMOs is most common in B. bifidum and B. longum subsp. 
infantis strains. Moderate growth has been observed for B. longum subsp. longum 
and B. breve strains and B. adolescentis and B. animalis seem to lack this ability. 
Moreover, these common infant-borne bifidobacteria possess different modes for 
consumption of HMOs. Bifidobacterium longum subsp. infantis strains likely imports 
the lower weight oligosaccharides while B. bifidum exports fucosidases and lacto-N-
biosidase for extracellular hydrolysis to remove lacto-N-biose (LNB) from the HMO 
structure. Bifidobacterium breve on the other hand is suggested to be dependent on 
possible cross-feeding, while it has the ability to consume various liberated monomer 
constituents of HMO and imports them as mono-saccharides, followed by intracellular 
catabolism. These observations are in concordance with the data presented in 
Chapter 4 showing the presence of B. bifidum, B. longum subsp. longum, B. breve, 
and B. adolescentis in the infant intestine. Based on their HMO degrading abilities, 
all of these species showed competence for the occupation of the unique niche found 
within the intestinal tract of a breast-fed infant (Zivkovic et al., 2010). In all infants, 
at least B. breve or B. longum was present, although B. longum subsp. infantis was 
not detected. The sole presence of B. adolescentis was never observed, which can 
be explained by its lacking ability to grow on HMOs. The presence of B. animalis 
correlated with the supplementation of living B. animalis subsp. lactis Bb12 cells to 
the formula diet. Overall, it has been postulated that there are different strategies for 
the use of HMOs suggesting possible niche-specific mechanisms divided among the 
different bifidobacterial species within the developing infant microbiome.
The findings presented in Chapter 5 are the first to show that it is feasible to 
analyze and compare global transcript profiles of bifidobacterial populations isolated 
from infants that received different diets. However, exact quantification can be 
complicated as it is not known how many active bifidobacteria are present in the 
samples. It is evident from the results of this study that carbohydrate metabolism 
is really operating in bifidobacteria derived from the baby GIT. A putative operon for 
galactose metabolism was found to be expressed in both breast-fed and formula-fed 
infants. Products of this operon could be involved in the breakdown of LNB structures. 
The fact that formula-fed infants received an additional mixture of GOS and FOS 
supplements can be the explanation of the activation of galactose metabolism in 
this group. Furthermore, the expression of genes predicted to be involved in folate 
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production was observed, indicating that bifidobacterial cells are actively producing 
folate while colonizing our gut. Overall, it revealed that bifidobacterial species 
undergo dynamic changes in infant faeces at the level of persistence as well as their 
functional complements.
uNRaVelINg The BIFIdO-eFFeCT
Many health benefits of treatment with probiotic bacteria have been described 
(Fig. 1). Numerous studies have been performed to confer these beneficial effects. 
Although some have come with underlining proof, most studies had to cope with 
small sample sizes, non-significant results, or have failed to clarify the underlying 
mechanisms (Lee and O’Sullivan, 2010). Overall, proposed immune-stimulatory 
effects of Bifidobacterium strains are most significant and thus most convincing. In 
comparison to other proposed effects, the molecular mechanism involved in immune 
modulation of bifidobacteria is relatively well studied and characterized. For example, 
a large human study showed reduction of symptom scores and extracellular IL-10/
IL-12 ratios which indicates up-regulation of anti-inflammatory cytokines in human 
subject suffering from irritable bowel syndrome after supplementation with B. longum 
subsp. infantis (O’Mahony et al., 2005). A smaller human study showed some 
increase in the extracellular levels of IFN-γ in their peripheral blood mononuclear cells 
following consumption of milk supplemented with B. animalis subsp. lactis NH019 
(Arunachalam, 1999). Additionally, A mice study showed the anti-inflammatory effect 
of administration of B. animalis subsp. lactis DN173010. This strain showed an 
indirect anti-inflammatory effect on mice suffering from inflammatory bowel disease 
(IBD) by altering a niche for colitogenic microbes (Veiga et al., 2010).  Another small 
human study showed no significant change in symptom scores but some decrease 
in expression of genes encoding human pro-inflammatory cytokines, such as 
TNF-α and IL-1α, in ulcerative colitis (UC) patients who were supplemented with B. 
longum, inulin, and fructooligosaccharides (Furrie et al., 2005). Also mRNA levels 
for human beta defensins 2, 3, and 4 which are strongly up-regulated in active UC, 
were significantly reduced in the test group after treatment (Furrie et al., 2005). A 
small mouse study showed some reduction in the pro-inflammatory cytokines IFN-γ, 
TNF-α, and IL-12 from supplementation with B. longum subsp. infants (McCarthy 
et al., 2003). Other data obtained from a mouse study described a reduction in 
CD4+ T cells in the spleen and colon following supplementation with B. bifidum 
(Kim et al., 2007). Furthermore, in vitro co-culture incubation experiments with B. 
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bifidum performed in this same study showed suppression of MCP-1 and IFN-γ , 
and induction of IL-6 and IL-10 (Kim et al., 2007). All these findings indicate for the 
existence of immune-modulating abilities of some Bifidobacterium strains.
 In Chapter 6, the responsiveness of the different HIECs, Caco-2, T84, and HT-29, 
for TNF-α was tested. Subsequently, the most response cell line, HT-29, was used in 
an co-incubation study with B. breve cells. The goal of the co-incubation experiment 
described in Chapter 6 was to expand the information on the molecular mechanism 
of immune modulation by bifidobacteria. One general conclusion, extracted from 
the co-incubation experiments was that the effects of B. breve strains on HIECs 
are strain-specific. Furthermore, we detected partial suppression of TNF-α induced 
expression in HT-29 cells by B. breve M-16V. Other B. breve strains tested did not or 
on a very low level show the ability to suppress TNF-α induced inflammation under 
the conditions tested. 
A recent study has shed new light on the Bifidobacterium–host interaction 
(Maslowski et al., 2009). It describes the signalling mechanism between short-chain 
fatty acids (SCFAs) and the G-protein-couplet receptor 43 (GPR43). SCFAs, such 
as acetate, are produced by commensal bifidobacteria after utilization of specific 
oligosaccharides (Chapter 1). Particularly acetate and propionate have recently 
been found to bind and activate GPR43. Interestingly, GPR43 gene expression 
showed close regulation with receptors important for innate immunity, such as Toll-
like receptors (TLS2 and TLR4). Furthermore, stimulation of GPR43 by SCFAs 
was necessary for the normal resolution of certain inflammatory responses. Both 
GPR43-deficient and germ-free mice showed dysregulation of certain inflammatory 
responses. In summary, SCFA-GPR43 signalling is one of the molecular pathways 
whereby commensal bacteria regulate immune and inflammatory responses. The 
question rises, whether the strain-specific B. breve effects observed in Chapter 6 will 
be overruled by a more general Bifidobacterium-effect in vivo, based on mechanisms 
like SCFA-GPR43 signalling. In order to answer this question dietary compounds 
should be integrated in future co-incubation experiments. The interaction experiment 
presented in Chapter 6 illustrates the complexity of the dynamic interplay between 
bacteria and human cells. We want to emphasize here that the final outcome of a 
host cell response against a microorganism depends on the combination of distinct 
MAMPs that can interact with the various PRRs and associated co-receptors that fine-
tune signaling, as well as on the concentration of the MAMPs, their accessibility for 
the PRRs and the presence of other microbial effector molecules that can modulate 
host responses (Lebeer et al., 2007).
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The FuTuRe exTeNSION OF The BMS-MICROaRRay
The role of the microarray platform described in Chapters 2, 3, and 4 was to 
circumvent high-cost and time-consuming whole genome sequencing. Arraying 
thousands of DNA fragments enabled high resolution screening for Bifidobacterium 
species unique genes. These were subsequently used for studying the diversity 
of the genus by analyzing pure bifidobacterial cultures. The functionalities of the 
proteins encoded by the marker genes could predict species-specific biochemical 
characteristics. Furthermore, this approach was also suitable for the screening 
complex microbial communities, such as human faecal samples. The observed 
compositions of fecal bifidobacterial populations and genomic shifts within these 
populations in time revealed the flexibility of the population. This indicated that diet 
affects the population. A future alternative of the microarray-based comparative 
hybridizations could be in silico comparison of whole genomes. This will enable fast 
and accurate selection of marker DNA fragments. However the described microarray 
platform represents as a good alternative. It should be stressed that in all cases the 
experiments could be realized without the need for PCR amplification. In view of 
the series of biases such as preferential and non-linear amplification and formation 
of chimers, that can originate from PCR, this is an important and possibly decisive 
advantage. On the other hand, the era of next-generation sequencing (NGS) has 
begun. To date several commercial platforms have been developed, each of which 
is linked to a unique combination of protocols determining the type of data output. 
A technical review, describing the differences with respect to template preparation, 
sequencing and imaging, genome alignment and assembly approaches, and recent 
advantages in current and near-term commercially available NGS instruments, has 
recently been published and include half a dozen different technologies (Metzker, 
2010). NGS technologies clearly have an impressive range of applications and its 
field is still a fast-moving area of research. Commercially available NGS-platforms 
have caused an explosion of sequenced genomes (Chain et al., 2009). Using the 
newest technologies, researchers can process hundreds of millions of base pairs in 
just a few hours (Table 2 and 3). In a short period of time numerous Bifidobacterium 
genomes have been sequenced and many more are in progress or in the planning 
phase (Table 4).  Multiple genome sequences of species and notably strains of 
Bifidobacterium will be generated and NGS also is a powerful tool for genome 
resequencing of mutant or transformed strains. This enables the screening for 
highly discriminatory and unique marker gene sequences. Finally, it contributes to 
the definition of the Bifidobacterium pan-, core-, and species-specific genome and 
allows to link the functionalities to their survival strategies. Another application of 
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NGS can be mRNA detection and sequencing in complex microbial samples, as 
an extension of the microarray-based transcriptome analysis presented in Chapter 
5. Possible problematic features could be abundance of highly expressed genes. 
High abundant mRNA molecules will prevent the detection of low level transcripts. 
Furthermore, in order to obtain a dynamic range of one microarray spot, more than 
105 sequencing reads are needed.
Organism  Size 
(Mb) 
GenBank Sequencing Center 
Bifidobacterium adolescentis ATCC 15703 2.1 AP009256 Gifu University, Life Science Research 
Center, Japan 
Bifidobacterium animalis subsp. lactis AD011 1.9 CP001213 Korea Research Institute of Bioscience 
and Biotechnology 
Bifidobacterium animalis subsp. lactis BB-12 1.9 CP001853 Chr. Hansen A/S 
Bifidobacterium animalis subsp. lactis Bl-04 1.9 CP001515 Danisco USA Inc. 
Bifidobacterium animalis subsp. lactis  
DSM10140 
1.9 CP001606 Danisco USA Inc. 
Bifidobacterium animalis subsp. lactis V9 1.9 CP001892 Southwest Agricultural University, 
China 
Bifidobacterium bifidum S17 2.2 CP002220 Institute of Microbiology and 
Biotechnology, University of Ulm 
Bifidobacterium dentium Bd1 2.6 CP001750.1 University of Parma, Italy [more] 
Bifidobacterium longum DJO10A 2.39 CP000605 University of Minnesota [more] 
Bifidobacterium longum NCC2705 2.3 AE014295 Nestle Research Center, Switzerland 
Bifidobacterium longum subsp. infantis  
ATCC15697 
2.8 CP001095 DOE Joint Genome Institute [more] 
Bifidobacterium longum subsp. longum JDM301
 
2.5 CP002010.1 Genome Sequencing Center (GSC) at 
Washington University (WashU) School 
of Medicine 
Bifidobacterium adolescentis L2-32 2.4 AAXD00000000
 
Washington Univ, USA     
Bifidobacterium angulatum DSM 20098 2 ABYS00000000 Washington Univ, USA     
Bifidobacterium bifidum JCM 1255 2  Japan 
Bifidobacterium bifidum NCIMB 41171 2.2 ABQP00000000
 
Broad Institute, USA     
Bifidobacterium breve DSM 20213 2.3 ACCG00000000
 
Washington Univ, USA     
Bifidobacterium catenulatum DSM 16992 2.1 ABXY00000000
 
Washington Univ, USA     
Bifidobacterium dentium ATCC 27678 2.6 ABIX00000000
 
Washington Univ, USA     
Bifidobacterium dentium ATCC 27679  AEEQ00000000
 
BCM-HGSC, USA     
Bifidobacterium dentium JCVIHMP022  AEHJ00000000
 
J. Craig Venter Institute, USA     
Bifidobacterium gallicum DSM 20093 2 ABXB00000000
 
Washington Univ, USA     
Bifidobacterium longum infantis ATCC 55813 2.4 ACHI00000000
 
BCM-HGSC, USA     
Bifidobacterium longum infantis CCUG 52486 2.5 ABQQ00000000
 
Broad Institute, USA     
Bifidobacterium pseudocatenulatum DSM 20438
 
2.3 ABXX00000000
 
Washington Univ, USA     
Table 2. Completed bifidobacterial genome sequencing projects (modified after Lee and O’Sullivan, 2010) 
and (Fanning, 2010) 
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Table 3. Ongoing or targeted bifidobacterial genome projects(modified after (Lee and O’Sullivan, 2010) 
and (Fanning, 2010) 
Organism Project status Sequencing Center 
Bifidobacterium animalis subsp. lactis HN019 In progress Fonterra Research Center, NZ 
Bifidobacterium angulatum JCM7096 In Progress Japan  
Bifidobacterium animalis ACS-248-V-Col6 Awaiting DNA J. Craig Venter Institute, USA     
Bifidobacterium animalis DN-173010 Awaiting DNA Broad Institute, USA     
Bifidobacterium bifidum DSM 20456 In Progress Washington Univ, USA     
Bifidobacterium bifidum PB2003/035-T3-1 Awaiting DNA J. Craig Venter Institute, USA     
Bifidobacterium breve ACS-071-V-Sch8b In Progress J. Craig Venter Institute, USA     
Bifidobacterium breve EX336960VC18 In Progress Virginia Commonwealth Univ, USA 
Bifidobacterium breve EX336960VC19 In Progress Virginia Commonwealth Univ, USA 
Bifidobacterium breve EX336960VC21 In Progress Virginia Commonwealth Univ, USA 
Bifidobacterium breve EX533959VC13 In Progress Virginia Commonwealth Univ, USA 
Bifidobacterium breve JCM1192 In Progress Japan  
Bifidobacterium catenulatum JCM1194 In Progress Japan  
Bifidobacterium dentium Targeted USA  
Bifidobacterium dentium Targeted USA  
Bifidobacterium dentium Targeted USA  
Bifidobacterium dentium JCM1195 In Progress Japan  
Bifidobacterium lactis Bb-12 Awaiting DNA Broad Institute, USA     
Bifidobacterium lactis Bi-07 Awaiting DNA Broad Institute, USA     
Bifidobacterium longum 3_1_37DFAAB Awaiting DNA Broad Institute, USA     
Bifidobacterium longum FB030-04AN Awaiting DNA J. Craig Venter Institute, USA     
Bifidobacterium longum infantis 157F-NC In Progress Japan  
Bifidobacterium longum infantis JCM 1217 In Progress Japan  
Bifidobacterium longum infantis JCM 1222 In Progress Japan  
Bifidobacterium longum longum F8 In Progress Sanger Institute, United Kingdom 
Bifidobacterium pseudocatenulatum D2CA In Progress Sanger Institute, United Kingdom 
Bifidobacterium scardovii JCM12489 In Progress Japan  
Bifidobacterium sp. 12_1_47BFAA In Progress Broad Institute, USA     
Bifidobacterium sp. FB030-04AN Awaiting DNA J. Craig Venter Institute, USA     
Bifidobacterium sp. HM5 In Progress Japan  
Bifidobacterium sp. JCM15439 In Progress Japan  
When considering other future applications, it can be envisaged that the identified 
species-unique gene sequences form the basis for the design and in vitro synthesis 
of marker oligos. Arrayed, these oligos could form a tool for studying the genomic 
diversity in highly complex microbial populations. Notably, to be successful this future 
platform will not only require complete and reliable whole genome sequence data from 
multiple strains per species but also a well-designed bioinformatics tool together with 
high capacity hardware. Currently, an ongoing initiative of the European Commision, 
called Metagenomics of the Human Intestinal Tract (MetaHIT, www.metahit.eu) 
focusing on defining the human metagenome, is applying this approach.
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Table 4. Overview of currently available next-generation sequencing platforms. * Average read-lengths. 
¥Fragment run. §Mate-pair run. Frag, fragment; GA, genome Analyzer; GS, Genome Sequenser; MP, 
mate-pair; N/A, not available; NGS, next-generation sequencing; PS, pyrosequencing; RT, reversible 
terminator; SBL, sequencing by ligation; SOLiD, support oligonucleotide ligation detection. (according to 
Metzker, 2010)
Platform Library/tem
plate 
preparation 
NGS 
chemistry 
Read 
length 
(bases) 
Run 
time 
(days) 
Gb 
per 
run 
Machine 
cost 
(US$) 
Pros Cons Biological 
applications 
Roche/454's GS 
FLX Titanium 
Frag, 
MP/emPCR 
PS 330* 0.35 0.45 500,000 Longer reads 
improve 
mapping in 
repetitive 
regions; fast 
run times 
High reagent 
cost; high 
error rates in 
homo-
polymer 
repeats 
Bacterial and 
insect genome de 
novo assemblies; 
medium scale (<3 
Mb) exome 
capture; 16S in 
metagenomics 
Illumina/Solexa's 
GAII 
Frag, 
MP/solid-
phase 
RTs 75 or 
100 
4¥, 9§ 18¥, 
35§ 
540,000 Currently the 
most widely 
used platform 
in the field 
Low 
multiplexing 
capability of 
samples 
Variant discovery 
by whole-
genomeresequenci
ng or whole-exome 
capture; gene 
discovery in 
metagenomics 
Life/APG's 
SOLiD3 
Frag, 
MP/emPCR 
Cleavable 
probe SBL 
50 7¥, 14 30¥, 
50§ 
595,000 Two-base 
encoding 
provides 
inherent error 
correction 
Long run 
times 
Variant discovery 
by whole-
genomeresequenci
ng or whole-exome 
capture; gene 
discovery in 
metagenomics 
Polonator G.007 MP 
only/emPCR 
Non-
cleavable 
probe SBL 
26 5§ 12§ 170,000 Least 
expensive 
platform; 
open source 
to adapt 
alternative 
NGS 
chemistries 
Users are 
required to 
maintain and 
quality 
control 
reagents; 
shortest NGS 
read lengths 
Bacterial genome 
resequencing for 
variant discovery 
Helicos BioScience 
HeliScope 
Frag, 
MP/single 
molecule 
RTs 32* 8¥ 37¥ 999,000 Non-bias 
representatio
n of 
templates for 
genome and 
seq-based 
applications 
High error 
rates 
compared 
with other 
reversible 
terminator 
chemistries 
Seq-based methods 
PacificBiosciences 
(target release: 
2010) 
Frag 
only/single 
molecule 
Real-time 964* N/A N/A N/A Has the 
greatest 
potential for 
reads 
exceeding 1 
kb 
Highest error 
rates 
compared 
with other 
NGS 
chemistries 
Full-length 
transcriptome 
sequencing; 
complements other 
resequencing 
efforts in 
discovering large 
structural variants 
and haplotype 
blocks 
TOWaRdS deFININg The CORe-, paN, aNd SpeCIeS-SpeCIFIC 
geNOMe
Recently, a great variety of extended genome sequencing projects have been started 
(see for overview Table 1). A trial analysis was initiated by the Human Microbiome 
Jumpstart Reference Strains Consortium (Nelson et al., 2010). This initiative focuses 
on describing the biodiversity of species within the human microbiome. Hundreds 
of microbe genomes have been sequenced. Among others, genome sequences of 
five different Bifidobacterium longum strains were compared (Nelson et al., 2010). 
Preliminary results of this comparison of B. longum sequences, suggest a core genome 
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size of approximately 1430. Four of the five genomes contribute approximately 
equally to the pan-genome (~50 to 150 genes). The fifth strain (ATCC 15697) was 
special in contributing a much higher number of specific genes (~640). The genomic 
diversity of these strains belonging to the same species was measured by defining 
the average nucleotide identity (ANI), a measure of the evolutionary relatedness 
based on sequence similarity between the set of shared genes (Konstantinidis et al., 
2006). Functional and ecological relatedness was studied by measuring the gene 
content similarity between to strains. Again four strains had pairwise ANI similarities 
at the higher end of the spectrum, ranging between 96 and 98%, but with relatively 
low gene-content similarity (that is, below 82%), indicating a broad range in gene 
complements. One additional strain (ATCC15697) showed an ANI below 95% and a 
gene content similarity below 65%, confirming its unique evolutionary and ecological 
position (Nelson et al., 2010). These findings are in line with the work presented in 
Chapter 2. A hybridization homology, which is comparable to a gene-content similarity, 
of approximately 72% was described for B. longum strains LMG13197 (ATCC15707) 
and LMG8811 (ATCC15697). As mentioned earlier, the core genome of B. longum 
species was predicted to contain around 1430 genes. The question rises whether the 
core genome of the genus Bifidobacterium is much smaller? Interestingly, Chapter 
2 showed a gene-content similarity of B. longum LMG13197 and B. pseudolongum 
LMG11571 of approximately 9%, based on hybridization experiments. Due to the 
relatively large phylogenetic distance of B. longum LMG13197 and B. pseudolongum 
LMG11571, these species might cover most of the genus and therefore this value 
could be an indication for its core genome size. This means that the Bifidobacterium 
core genome consists of roughly 200 genes, based on gene-content similarity. This 
clearly reveals the diversity of this genus. 
Relatively high diversity rates were described within the species B. breve in 
Chapter 3, where 20 fecal isolates of B. breve were compared to the type strain. 
In this study the DNA-based microarray platform served as a comparative genome 
hybridization tool. This approach was fruitful and resulted in a high-resolution 
data set revealing detailed information on the genomic diversity of the different 
isolates. It displayed an overall B. breve isolate gene-content similarity of 60 – 90% 
in comparison to the B. breve LMG13208 type strain. These results testify for the 
existence of various subspecies within the species B. breve. Currently, taxonomic 
research on these strains is ongoing in order to clarify this matter.
Chapters 2, 3, and 4 describe the selection of sets of DNA fragments, showing 
either species-unique, strain cluster-unique, or conserved hybridization characteristics 
on the microarray, for sequence analysis. In order to link these three experiments 
these sets were checked for overlapping DNA fragments or homologies (Table 5). We 
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Table 5. Comparison of the genes identified for their unique hybridization characteristics and selected for 
sequencing analysis in Chapters 2, 3, and 4 of this thesis
# Chapter Specificity Best BLAST hit Remarks 
25 Chapter 2 - Fig 4 
 
B. longum 
spp./INF/BRE 
gi|23465396|ref|NP_695999.1| possible 
thioredoxin-dependent thiol peroxidase 
[Bifidobacterium longum NCC2705] 
Two different sequences with the same 
'best’-BLAST hit, but different e-values 
47 Chapter 2 - Fig 4 
 
CAT gi|23465396|ref|NP_695999.1| possible 
thioredoxin-dependent thiol peroxidase 
[Bifidobacterium longum NCC2705] 
1 Chapter 3 - Fig 2 
 
conserved ref|ZP_06595093.1|  beta-galactosidase 
[Bifidobacterium breve DSM 20213] 
Refer to the same DNA fragment 
originating from one single spot on the 
BMS-microarray. We have to note that 
the specificity, defined in Chapter 3, is 
based on a limited set of B. breve strains, 
which could explain this observation. 
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specific ref|ZP_06595986.1|  putative bacterial regulatory 
protein [Bifidobacterium breve DSM 20213] 
Sequences originate from different clones 
but show similar 'best’-BLAST hit 
results, which indicates high homology 
between the genes they represent. 
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specific ref|ZP_06595986.1|  putative bacterial regulatory 
protein [Bifidobacterium breve DSM 20213] 
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specific ref|ZP_06596330.1|  conserved hypothetical protein 
[Bifidobacterium breve DSM 20213] 
Sequences originate from different clones 
but show similar 'best’-BLAST hit 
results, which indicates high homology 
between the genes they represent. 
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specific ref|ZP_06596330.1|  conserved hypothetical protein 
[Bifidobacterium breve DSM 20213] 
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specific ref|ZP_06596330.1|  conserved hypothetical protein 
[Bifidobacterium breve DSM 20213] 
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specific ref|ZP_06596397.1|  glycosyl transferase, group 2 
family [Bifidobacterium breve DSM 20213] 
Refer to the same DNA fragment 
originating from one single spot on the 
BMS-microarray, which confirms the 
specificity 
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specific ref|ZP_06596398.1|  phosphatidylglycerol--
membrane-oligosaccharide 
glycerophosphotransferase [Bifidobacterium breve 
DSM 20213] 
Refer to the same DNA fragment 
originating from one single spot on the 
BMS-microarray, which confirms the 
specificity 
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conserved ref|ZP_06596810.1|  proteasome ATPase 
[Bifidobacterium breve DSM 20213] 
Refer to the same DNA fragment 
originating from one single spot on the 
BMS-microarray. We have to note that 
the specificity, defined in Chapter 3, is 
based on a limited set of B. breve strains, 
which could explain this observation. 
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specific ref|ZP_06597004.1|  conserved hypothetical protein 
[Bifidobacterium breve DSM 20213] 
Refer to the same DNA fragment 
originating from one single spot on the 
BMS-microarray, which confirms the 
specificity 
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specific ref|ZP_06597149.1|  conserved hypothetical protein 
[Bifidobacterium breve DSM 20213] 
Refer to the same DNA fragment 
originating from one single spot on the 
BMS-microarray, which confirms the 
specificity 
8 Chapter 4 - Fig 4 
 
breve strain-
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ref|ZP_06597149.1|  conserved hypothetical protein 
[Bifidobacterium breve DSM 20213] 
 observed that two DNA fragments, one described to be specific for B. catenulatum 
(#25) and the other for the B. longum group (#47), showed high, but different, 
homologies to an identical gene based on their ‘best’-BLAST hit (highest homology 
% in combination with the lowest E-value of all BLAST hit results). Could they have 
similar ‘best’-BLAST hit results and also represent species-specific sequences? To 
answer this question we analyzed both sequences in more detail. We concluded that 
they had little overlap with each other and that the B. longum specific fragment was 
the only one identical to B. longum NCC2705 genome, which gave the ‘best’-BLAST 
hit. Therefore, we suggest that the difference between the sequences is large enough 
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for the fragments to have species-unique features. Sequenced fragments #42 and 
#43 originated from different clones but represented the same gene. This explains 
their similar hybridization characteristics. The same is true for fragments #26, #27, 
and #, 28.  Several sequences DNA fragments were described to be specific for a 
cluster of strains within the B. breve species in Chapter 3, and showed B. breve 
strain-specific characteristics in Chapter 4 (#31 and #6; #29 and #9; #38 and #10; 
#39 and #8) . These results confirm the uniqueness of the DNA sequences. DNA 
fragments #1 and #4, as well as #6 and #3, are described as conserved in B. breve 
in Chapter 3, but show strain-specific hybridization patterns in Chapter 4. This could 
be explained by the limited number of strains in the set of B. breve isolates analyzed 
in Chapter 3.
geNeRal CONCluSION
In conclusion, the work presented in the thesis, which formed part of a larger IOP 
Genomics project, contributed to an advanced insight in the interaction between 
bifidobacteria and the human host. Furthermore, it resulted in the development 
of genome-based molecular platforms suite for analyzing genomic diversity 
between and within species, as well as population dynamics in complex microbial 
communities. We anticipate that the molecular approaches pioneered in this thesis 
will be instrumental in the further elucidation of the host─microbe interactions in the 
GIT of human an other animals.
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NedeRlaNdSe SaMeNVaTTINg
Dit proefschrift beschrijft een verzameling van, op microarray-technieken gebaseerde 
studies, die bijdragen tot een beter inzicht in de rol van bifidobacteriën in relatie 
tot hun menselijke gastheer. Het behandelt onder andere recent beschreven 
interactiemechanismen tussen bifidobacteriën en humane gastrointestinale cellen. 
Ook belicht het de unieke eigenschappen van het genus Bifidobacterium, die 
essentieel zijn voor hun voortbestaan in het ecosysteem van onze darm. Met behulp 
van een ‘Bifidobacterium mixed-species (BMS)’ microarray-platform is er een middel 
gecreëerd waarmee het genetisch materiaal van verschillende bifidobacteriesoorten, 
die voorkomen in het spijsverteringskanaal van de mens, vergeleken kunnen 
worden. Gebaseerd op gedetailleerde microarraydata, konden soortspecifieke 
genoomfragmenten geïdentificeerd worden. Een groot gedeelte van deze voorspelde 
genen codeerden voor eiwitten die betrokken zijn bij het suikermetabolisme van de 
bifidobacteriën. Een unieke eigenschap van het ontwikkelde microarray-platform is dat 
het de mogelijkheid biedt om tot op stamniveau verschillen in genetische samenstelling 
te meten. Het microarray-platform werd toegepast om de genetische variatie tussen 
verschillende B. breve isolaten in kaart te brengen door de hybridisatiepatronen, 
van de uit de desbetreffende stammen geïsoleerde DNA monsters, te vergelijken. 
Dit onthulde een relatief grote genomische variatie binnen de B. breve soort en 
leverde zelfs bewijs voor het bestaan van verscheidene subsoorten binnen de soort 
B. breve. Uit het clusteren van de hybridisatiepatronen kwam een duidelijk verband 
naar voren tussen het patroon en de baby waar de bacteriën uit geïsoleerd waren. Dit 
was een aanwijzing voor niche-specifieke aanpassing van verschillende stammen 
binnen dezelfde soort. Verder werden in een studie, beschreven in dit proefschrift, 
ook bifidobacteriepopulaties in fecale monsters van verschillende zuigelingen 
geanalyseerd. Totaal DNA extracten werden gehybridiseerd op de ontwikkelde 
BMS microarray. Deze analyses fungeerden als test voor de toepasbaarheid van 
het microarray platform voor onderzoek naar de dynamiek van bifidobacteriële 
populaties in borst- en flesgevoede baby’s. Het microarray-platform bewees zijn 
bruikbaarheid voor het monitoren van de ontwikkeling in de tijd en de effecten van de 
bijbehorende voedingspatronen. De waargenomen verschillen in de bifidobacteriële 
populaties, zowel in de tijd als tussen de individuen, vertoonden een correlatie met 
het dieet van de gastheer. Analyse van de hybridisatiepatronen maakte het in de 
tijd monitoren van de veranderingen in de genetische compositie van het genoom, 
binnen een bifidobacterie soort, mogelijk. Sequentie-analyse van DNA fragmenten, 
die onderscheidende hybridisatiekarakteristieken vertoonde, leverde selecties van 
voorspelde genen op, die of geconserveerd of stamspecifiek zijn binnen de soort B. 
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breve. Naast onderzoek naar genomische variatie, zijn ook transcriptiepatronen van 
zowel bifidobacteriën als humane darmepitheel cellen bestudeerd. Transcriptiegericht 
onderzoek bij bifidobacteriën leverde duidelijk bewijs voor transcriptionele activiteit 
in bifidobacteriecellen door RNA te isoleren uit fecale monsters van baby’s. 
Zover wij weten is dit het eerst beschreven voorbeeld van in situ activiteit van 
bifidobacteriën in het menselijk spijsverteringskanaal. Daarbij geven onze resultaten 
een indicatie voor een verband tussen de genexpressie en het dieet van het kind 
waar het fecale monster vandaan komt. Bifidobacteriën geïsoleerd uit borstgevoede 
kinderen vertonen een ander transcriptionele reactie in vergelijking tot kinderen die 
flesvoeding hebben ontvangen. Sequentie-analyse van de transcripten onthulde de 
expressie van voorspelde genen, die homologie vertonen met genen die betrokken 
zijn bij de productie van folaat. Dit getuigt voor de productie van deze belangrijke 
vitamine door bifidobacteriën, die aanwezig zijn in onze darmen tijdens onze jonge 
jaren. Als laatste laten we, door middel van de analyse van het transcriptome van 
HT-29 cellen (een cellijn van humaan darmepitheel), het soortspecifieke effect van 
de aanwezigheid van de B. breve M-16V stam zien op de expressie van genen die 
in afwezigheid van deze bifidobacterie door TNF-α verhoogd tot expressie werden 
gebracht. Twee andere, parallel geteste, bifidobacteriestammen lieten een extreem 
mild of zelfs onmeetbaar effect zien op TNF-α-gestimuleerde HT-29 cellen. Hoewel 
we geen complete onderdrukking van het TNF-effect waargenomen hebben, konden 
we aantonen dat apoptotische en immunologische regulatoire cascades beïnvloed 
werden door de aanwezigheid van de B. breve M-16V cellen. Samengevat draagt 
dit proefschrift, wat onderdeel was van een overkoepelend IOP Genomics project 
genaamd ‘A genomics approach towards gut health’, bij aan een verbeterd inzicht 
in de interactie tussen bifidobacteriën en de menselijke gastheer. Het heeft 
geresulteerd in de ontwikkeling van een moleculair platform wat toepasbaar is voor 
het onderzoeken van de genomische diversiteit tussen en binnen soorten, naast het 
bestuderen van de populatiedynamiek van complexe microbiële gemeenschappen. 
We verwachten dat de moleculaire aanpakken, aangedragen in dit proefschrift, bij 
zullen dragen aan het in kaart brengen van de interacties tussen de gastheer en het 
micro-organisme in het spijsverteringskanaal van de mens en dier.
Thesis-Rolf-v3.indd   133 2-1-2011   23:33:36
Chapter 8
134
ReFeReNCeS
abreu, M. T., e. T. arnold, l. S. Thomas, R. gonsky, y. Zhou, B. hu, and M. arditi. 2002. 
TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal 
epithelial cells. J. Biol. Chem. 277:20431-20437.
aggarwal, B. B. 2003. Signalling pathways of the TNF superfamily: a double-edged sword. 
Nat Rev Immunol 3:745-756.
agostoni, C., B. Carratu, C. Boniglia, e. Riva, and e. Sanzini. 2000. Free amino acid 
content in standard infant formulas: comparison with human milk. J Am Coll Nutr 19:434-
438.
akira, S., S. uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. 
Cell 124:783-801.
akopyants, N. S., S. W. Clifton, J. Martin, d. pape, T. Wylie, l. li, J. C. kissinger, d. 
S. Roos, and S. M. Beverley. 2001. A survey of the Leishmania major Friedlin strain V1 
genome by shotgun sequencing: a resource for DNA microarrays and expression profiling. 
Mol Biochem Parasitol 113:337-340.
amann, R. I., B. J. Binder, R. J. Olson, S. W. Chisholm, R. devereux, and d. a. Stahl. 
1990. Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for 
analyzing mixed microbial populations. Appl Environ Microbiol 56:1919-1925.
amann, R. I., W. ludwig, and k. h. Schleifer. 1995. Phylogenetic identification and in situ 
detection of individual microbial cells without cultivation. Microbiol Mol Biol Rev 59:143-169.
amaretti, a., e. Tamburini, T. Bernardi, a. pompei, S. Zanoni, g. Vaccari, d. Matteuzzi, 
and M. Rossi. 2006. Substrate preference of Bifidobacterium adolescentis MB 239: compared 
growth on single and mixed carbohydrates. Appl Microbiol Biotechnol 73:654-662.
andersson, a. F., M. lindberg, h. Jakobsson, F. Bäckhed, p. Nyrén, and l. engstrand. 
2008. Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS 
ONE 3:e2836.
arslanoglu, S., g. e. Moro, and g. Boehm. 2007. Early supplementation of prebiotic 
oligosaccharides protects formula-fed infants against infections during the first 6 months of 
life. J Nutr 137:2420-2424.
arunachalam, k. d. 1999. Role of bifidobacteria in nutrition, medicine and technology. Nutr 
Res 19:1559-1597.
asahara, T., k. Shimizu, k. Nomoto, T. hamabata, a. Ozawa, and y. Takeda. 2004. Probiotic 
bifidobacteria protect mice from lethal infection with shiga toxin-producing Escherichia coli 
O157:H7. Infect Immun 72:2240-2247.
Thesis-Rolf-v3.indd   134 2-1-2011   23:33:36
Nederlandse samenvatting, References, Dankwoord, About the author, Publications , VLAG activities
135
Ch
ap
te
r  8
avall-Jääskeläinen, S. and a. palva. 2005. Lactobacillus surface layers and their applications. 
FEMS Microbiol Rev 29:511-529.
Baess, I. 1974. Isolation and purification of deoxyribonucleic acid from mycobacteria. Acta 
Pathol Microbiol Scad Sect B 82:780-784.
Baker, g., J. Smith, and d. Cowan. 2003. Review and re-analysis of domain-specific 16S 
primers. J Microbial Meth 55:541-555.
Bakker-Zierikzee, a., M. alles, J. knol, F. kok, J. Tolboom, and J. Bindels. 2005. Effects 
of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable 
Bifidobacterium animalis on the intestinal microflora during the first 4 months of life. Br J Nutr 
94:783-790.
Barrangou, R., C. Fremaux, h. deveau, M. Richards, p. Boyaval, S. Moineau, d. Romero, 
and p. horvath. 2007. CRISPR provides acquired resistance against viruses in prokaryotes. 
Science 315:1709-1712.
Barrangou, R., e. altermann, R. hutkins, R. Cano, and T. R. klaenhammer. 2003. 
Functional and comparative genomic analyses of an operon involved in fructooligosaccharide 
utilization by Lactobacillus acidophilus. Proc Natl Acad Sci USA 100:8957-8962.
Ben-amor, k., h. heilig, h. Smidt, e. e. Vaughan, T. abee, and W. M. de Vos. 2005. Genetic 
diversity of viable, injured, and dead fecal bacteria assessed by fluorescence-activated cell 
sorting and 16S rRNA gene analysis. Appl Environ Microbiol 71:4679-4689.
Benno, y., k. Sawada, and T. Mitsuoka. 1984. The intestinal microflora of infants: composition 
of fecal flora in breast-fed and bottle-fed infants. Microbiol Immunol 28:975-986.
Biavati, B. and p. Mattarelli. 2001. The family Bifidobacteriaceae, p. 1-70. In M. Dworkin, S. 
Falkow, E. Rosenberg, K. Schleifer, and E. Stackebrandt (eds.), The Prokaryotes. Springer, 
New york.
Boehm, g. and B. Stahl. 2007. Oligosaccharides from milk. J Nutr 137:847S-849S.
Boekhorst, J., M. Wels, M. kleerebezem, and R. J. Siezen. 2006. The predicted secretome of 
Lactobacillus plantarum WCFS1 sheds light on interactions with its environment. Microbiology 
152:3175-3183.
Boesten, R. J. and W. M. de Vos. 2008. Interactomics in the human intestine: lactobacilli and 
bifidobacteria make a difference. J Clin Gastroenterol 42:S163-S167.
Boesten, R. J., F. h. J. Schuren, and W. M. de Vos. 2009. A Bifidobacterium mixed-species 
microarray for high resolution discrimination between intestinal bifidobacteria. J Microbiol 
Meth 76:269-277.
Thesis-Rolf-v3.indd   135 2-1-2011   23:33:36
Chapter 8
136
Boom, R., C. Sol, M. Beld, J. Weel, J. goudsmit, and p. Wertheim-van dillen. 1999. 
Improved silica-guanidiniumthiocyanate DNA isolation procedure based on selective binding 
of bovine alpha-casein to silica particles. J Clin Microbiol 37:615-619.
Borriello, S., W. hammes, W. holzapfel, p. Marteau, J. Schrezenmeir, M. Vaara, and V. 
Valtonen. 2003. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 
36:775-780.
Bron, p. a., C. grangette, a. Mercenier, W. M. de Vos, and M. kleerebezem. 2004. 
Identification of Lactobacillus plantarum genes that are induced in the gastrointestinal tract of 
mice. J Bacteriol 186:5721-5729.
Bron, p. a., M. Meijer, R. S. Bongers, W. M. de Vos, and M. kleerebezem. 2007. Dynamics 
of competitive population abundance of Lactobacillus plantarum ivi gene mutants in faecal 
samples after passage through the gastrointestinal tract of mice. J Appl Microbiol 103:1424-
1434.
Candela, M., F. perna, p. Carnevali, B. Vitali, R. Ciati, p. gionchetti, F. Rizzello, M. Campieri, 
and p. Brigidi. 2008. Interaction of probiotic Lactobacillus and Bifidobacterium strains with 
human intestinal epithelial cells: Adhesion properties, competition against enteropathogens 
and modulation of IL-8 production. Int J Food Microbiol 125:286-292.
Cario, e. 2005. Bacterial interactions with cells of the intestinal mucosa: toll-like receptors and 
NOD2. Gut 54:1182-1193.
Cebra, J. J. 1999. Influences of microbiota on intestinal immune system development. Am J 
Clin Nutr 69:1046S-1051S.
Chain, p. S. g., d. V. grafham, R. S. Fulton, M. g. Fitzgerald, J. hostetler, d. Muzny, 
J. ali, B. Birren, d. C. Bruce, C. Buhay, J. R. Cole, y. ding, S. dugan, d. Field, g. M. 
garrity, R. gibbs, T. graves, C. S. han, S. h. harrison, S. highlander, p. hugenholtz, h. 
M. khouri, C. d. kodira, e. kolker, N. C. kyrpides, d. lang, a. lapidus, S. a. Malfatti, V. 
Markowitz, T. Metha, k. e. Nelson, J. parkhill, S. pitluck, x. Qin, T. d. Read, J. Schmutz, 
S. Sozhamannan, p. Sterk, R. l. Strausberg, g. Sutton, N. R. Thomson, J. M. Tiedje, 
g. Weinstock, a. Wollam, genomic Standards Consortium human Microbiome project 
Jumpstart Consortium, and J. C. detter. 2009. Genome project standards in a new era of 
sequencing. Science 326:236-237.
Cheikhyoussef, a., N. pogori, W. Chen, and h. Zhang. 2008. Antimicrobial proteinaceous 
compounds obtained from bifidobacteria: From production to their application. International 
Journal of Food Microbiology 125:215-222.
Chenevier-gobeaux, C., h. lemarechal, d. Bonnefont-Rousselot, S. poiraudeau, O. 
ekindjian, and d. Borderie. 2006. Superoxide production and NADPH oxidase expression 
in human rheumatoid synovial cells: regulation by interleukin-1b and tumour necrosis factor-a. 
Inflam Res 55:483-490.
Thesis-Rolf-v3.indd   136 2-1-2011   23:33:36
Nederlandse samenvatting, References, Dankwoord, About the author, Publications , VLAG activities
137
Ch
ap
te
r  8
Christiaens, h., R. J. leer, p. h. pouwels, and W. Verstraete. 1992. Cloning and expression 
of a conjugated bile acid hydrolase gene from Lactobacillus plantarum by using a direct plate 
assay. Appl Environ Microbiol 58:3792-3798.
Claesson, M. J., O. O’Sullivan, Q. Wang, J. Nikkilä, J. R. Marchesi, h. Smidt, et al. 2009. 
Comparative analysis of pyrosequencing and a phylogenetic microarray for exploring microbial 
community structures in the human distal intestine. PLoS ONE 4:e6669.
Collado, M., S. delgado, a. Maldonado, and J. Rodriguez. 2009. Assessment of the 
bacterial diversity of breast milk of healthy women by quantitative real-time PCR. Lett Appl 
Microbiol 48:523-528.
Corfield, T. 1992. Bacterial sialidases--roles in pathogenicity and nutrition. Glycobiology 
2:509-521.
Corr, S., y. li, C. u. Riedel, p. W. O’Toole, C. hill, and C. g. M. gahan. 2007. Bacteriocin 
production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. 
Proc Natl Acad Sci USA 104:7617-7621.
Crociani, F. and d. Matteuzzi. 1982. Urease activity in the genus Bifidobacterium. Ann 
Microbiol 133:417-423.
Cronin, M., d. Morrissey, S. Rajendran, S. M. el Mashad, d. van Sinderen, g. C. O’Sullivan, 
and M. Tangney. 2010. Orally administered bifidobacteria as vehicles for delivery of agents to 
systemic tumors. Mol Ther 18:1397-1407.
dashkevicz, M. p. and S. d. Feighner. 1989. Development of a differential medium for bile 
salt hydrolase-active Lactobacillus spp. Appl Environ Microbiol 55:11-16.
de Vos, W. M., p. a. Bron, and M. kleerebezem. 2004. Post-genomics of lactic acid bacteria 
and other food-grade bacteria to discover gut functionality. Curr Opin Biotechnol 15:86-93.
de Vries, M. 2006. Analyzing global gene expression of Lactobacillus plantarum in the human 
gastrointestinal tract. phd Thesis. Wageningen University, Wageningen.
deguchi, y., T. Morishita, and M. Mutai. 1985. Comparative studies on synthesis of water-
soluble vitamins among human species of bifidobacteria. Agric Biol Chem 49:13-19.
delétoile, a., V. passet, J. aires, I. Chambaud, M. Butel, T. Smokvina, and S. Brise. 
2010. Species delineation and clonal diversity in four Bifidobacterium species as revealed by 
multilocus sequencing. Res Microbiol 161:82-90.
derensy-dron, d., F. krzewinski, C. Brassart, and S. Bouquelet. 2010. b-1,3-Galactosyl-N-
acetylhexosamine phophorylase from Bifidobacterium bifidum DSM 20082: characterization, 
partial purification and relation to mucin degradation. Biotechnol Appl Biochem 29:3-10.
dethlefsen, l., M. Fall-Ngai, and d. a. Relman. 2007. An ecological and evolutionary 
perspective on human-microbe mutualism and disease. Nature 449:811-818.
Thesis-Rolf-v3.indd   137 2-1-2011   23:33:36
Chapter 8
138
dethlefsen, l., p. B. eckburg, e. M. Bik, and d. a. Relman. 2006. Assembly of the human 
intestinal microbiota. Trends Ecol Evol 21:517-523.
di Caro, S., h. Tao, a. grillo, C. elia, g. gasbarrini, a. R. Sepulveda, and a. gasbarrini. 
2005. Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa. Dig 
Liver Dis 37:320-329.
di giorgio, J. 1974. Nonprotein nitrogenous constituents, p. 503-563. In R. Henry, D. Cannon, 
and J. Winkelman (eds.), Clinical Chemistry: Principles and Techniques. Harper and Row.
dominguez-Bello, M. g., e. k. Costello, M. Contreras, M. Magris, g. hidalgo, N. Fierer, 
and R. knight. 2010. Delivery mode shapes the acquisition and structure of the initial 
microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 107:11971-
11975.
eckburg, p., e. Bik, C. Bernstein, e. purdom, and l. dethlefsen. 2005. Diversity of the 
human intestinal microbial flora. Science 308:1635-1638.
Fanning, S. 2010. PhD Thesis University College Cork.
FaO/WhO. 2002. Report of a joint FAO/WHO working group on drafting guidelines for the 
evaluation of probiotics in food. Joint FAO/WHO Working Group Meeting.
Favier, C. F., W. M. de Vos, a. d. l. and akkermans. 2003. Development of bacterial and 
bifidobacterial communities in feces of newborn babies. Anaerobe 9:219-229.
Favier, C. F., e. e. Vaughan, W. M. de Vos, and a. d. l. akkermans. 2002. Molecular 
monitoring of succession of bacterial communities in human neonates. Appl Environ Microbiol 
68:219-226.
Felis, g. and F. dellaglio. 2007. Taxonomy of lactobacilli and bifidobacteria. Curr Issues 
Intest Microbiol 8:44-61.
Felske, a., h. Rheims, a. Wolterink, e. Stackebrandt, and a. d. akkermans. 1997. 
Ribosome analysis reveals prominent activity of an uncultured member of the class 
actinobacteria in grassland soils. Microbiology 143:2983-2989.
Fujiwara, S., h. hashiba, T. hirota, and J. F. Forstner. 1997. Proteinaceous factor(s) in 
culture supernatant fluids of bifidobacteria which prevents the binding of enterotoxigenic 
Escherichia coli to gangliotetraosylceramide. Appl Environ Microbiol 63:506-512.
Furrie, e., S. Macfarlane, a. kennedy, J. h. Cummings, S. V. Walsh, d. a. O’Neil, and g. T. 
Macfarlane. 2005. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution 
of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 
54:242-249.
Furrie, e., S. Macfarlane, g. Thomson, and g. T. Macfarlane. 2005. Toll-like receptors-2, 
-3 and -4 expression patterns on human colon and their regulation by mucosal-associated 
bacteria. Immunol 115:565-574.
Thesis-Rolf-v3.indd   138 2-1-2011   23:33:36
Nederlandse samenvatting, References, Dankwoord, About the author, Publications , VLAG activities
139
Ch
ap
te
r  8
gibson, g. and x. Wang. 1994. Regulatory effects of bifidobacteria on the growth of other 
colonic bacteria. J Appl Bacteriol 77:412-420.
gibson, g. R., a. l. McCartney, and R. a. Rastall. 2007. Prebiotics and resistance to 
gastrointestinal infections. Br J Nutr 93:S31-S34.
gill, S. R. 2006. Metagenomic analysis of the human distal gut microbiome. Science 
312(5778):1355-1359.
gonzalez, R., e. S. klaassens, e. Malinen, W. M. de Vos, and e. e. Vaughan. 2008. 
Differential transcriptional response of Bifidobacterium longum to human milk, formula milk, 
and galactooligosaccharide. Appl Environ Microbiol 74:4686-4694
goodacre, R. 2007. Metabolomics of a superorganism. J Nutr 137:259S-266S.
grangette, C., S. Nutten, e. palumbo, S. Morath, C. hermann, J. dewulf, B. pot, T. hartung, 
p. hols, and a. Mercenier. 2005. Enhanced antiinflammatory capacity of a Lactobacillus 
plantarum mutant synthesizing modified teichoic acids. Proc Natl Acad Sci USA 102:10321-
10326.
gronlund, M. M., M. gueimonde, k. laitinen, g. kociubinski, T. gronroos, S. Salminen, 
and e. Isolauri. 2007. Maternal breast-milk and intestinal bifidobacteria guide the compositional 
development of the Bifidobacterium microbiota in infants at risk of allergic disease. Clin Exp 
Allergy 37:1764-1772.
gross, V., T. andus, R. daig, e. aschenbrenner, J. Schölmerich, and W. Falk. 
1995. Regulation of interleukin-8 production in a human colon epithelial cell line (HT-29). 
Gastroenterology 108:653-661.
guarner, F. and J. R. Malagelada. 2003.  Gut flora in health and disease. Lancet 361:512-
519.
gueimonde, M., l. Noriega, a. Margolles, and C. de los Reyes-gavilín. 2007. Induction of 
a-L-arabinofuranosidase activity by monomeric carbohydrates in Bifidobacterium longum and 
ubiquity of encoding genes. Arch Microbiol 187:145-153.
gueimonde, M., k. laitinen, S. Salminen, and e. Isolauri. 2007. Breast milk: a source of 
bifidobacteria for infant gut development and maturation? Neonatology 92:64-66.
haarman, M. and J. knol. 2005. Quantitative real-time PCR assays to identify and quantify 
fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Appl Environ 
Microbiol 71:2318-2324.
harmsen, h. J. M., g. C. Raangs, T. he, J. e. degener, and g. W. Welling. 2002. Extensive 
set of 16S rRNA-based probes for detection of bacteria in human feces. Appl Environ Microbiol 
68:2982-2990.
Thesis-Rolf-v3.indd   139 2-1-2011   23:33:36
Chapter 8
140
harmsen, h., a. Wildeboer-Veloo, g. Raangs, a. Wagendorp, N. klijn, J. Bindels, and g. 
Welling. 2000. Analysis of intestinal flora development in breast-fed and formula-fed infants 
by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 30:61-
67.
hart, a. l., k. lammers, p. Brigidi, B. Vitali, F. Rizzello, p. gionchetti, M. Campieri, M. a. 
kamm, S. C. knight, and a. J. Stagg. 2004. Modulation of human dendritic cell phenotype 
and function by probiotic bacteria. Gut 53:1602-1609.
hayden, M. S. and S. ghosh. 2004. Signaling to NF-kB. Genes Dev. 18:2195-2224.
he, F., h. Morita, a. C. Ouwehand, M. hosoda, M. hiramatsu, J. kurisaki, e. Isolauri, y. 
Benno, and S. Salminen. 2002. Stimulation of the secretion of pro-inflammatory cytokines by 
Bifidobacterium strains. Microbiol Immunol 46:781-785.
he, F., a. C. Ouwehand, e. Isolauri, h. hashimoto, y. Benno, and S. Salminen. 2001b. 
Comparison of mucosal adhesion and species identification of bifidobacteria isolated from 
healthy and allergic infants. FEMS Immunol Med Microbiol 30:43-47.
he, F., a. C. Ouwehand, e. Isolauri, M. hosoda, y. Benno, and S. Salminen. 2001a. 
Differences in composition and mucosal adhesion of bifidobacteria isolated from healthy adults 
and healthy seniors. Curr Opin Microbiol 43:351-354.
heilig, h. g. h. J., e. g. Zoetendal, e. e. Vaughan, p. Marteau, a. d. l. akkermans, and W. 
M. de Vos. 2002. Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the 
human intestine as determined by specific amplification of 16S ribosomal DNA. Appl Environ 
Microbiol 68:114-123.
hoffen, e. v., N. korthagen, S. d. kivit, B. Schouten, B. Bardoel, a. duivelshof, J. knol, 
J. garssen, and l. Willemsen. 2010. Exposure of intestinal epithelial cells to UV-killed 
Lactobacillus GG but not Bifidobacterium breve enhances the effector immune response in 
vitro. Int Arch Allergy Immunol 152:159-168.
hooper, l. and J. gordon. 2001. Commensal host-bacterial relationships in the gut. Science 
292:1115-1118.
hooper, l. V. 2004. Bacterial contributions to mammalian gut development. Trends Microbiol 
12:129-134.
hooper, l. V., T. Midtvedt, and J. I. gordon. 2002. How host-microbial interactions shape the 
nutrient environment of the mammalian intestine. Annu Rev Nutr 22:283-307.
hopkins, M. J. and g. T. Macfarlane. 2003. Nondigestible oligosaccharides enhance bacterial 
colonization resistance against Clostridium difficile in vitro. Appl Environ Microbiol 69:1920-
1927.
Thesis-Rolf-v3.indd   140 2-1-2011   23:33:36
Nederlandse samenvatting, References, Dankwoord, About the author, Publications , VLAG activities
141
Ch
ap
te
r  8
hopkins, M. J., g. T. Macfarlane, e. Furrie, a. Fite, and S. Macfarlane. 2005. Characterisation 
of intestinal bacteria in infant stools using real-time PCR and northern hybridisation analyses. 
FEMS Microbiol Ecol 54:77-85.
horvath, p., a. C. Coûté-Monvoisin, d. a. Romero, p. Boyaval, C. Fremaux, and R. 
Barrangou. 2009. Comparative analysis of CRISPR loci in lactic acid bacteria genomes. Int 
J Food Microbiol 131:62-70.
hougee, S., a. Vriesema, s. Wijering, l. knippels, g. Folkerts, F. Nijkamp, J. knol, and 
J. garssen. 2010. Oral treatment with probiotic reduces allergic symptoms in ovalbumin-
sensitized mice: a bacterial strain comparative study. Int Arch Allergy Immunol 151:107-117.
hung, M. N., Z. xia, N. T. hu, and B. h. lee. 2001. Molecular and biochemical analysis of two 
b-galactosidases from Bifidobacterium infantis HL96. Appl Environ Microbiol 67:4256-4263.
Ivanov, d., C. emonet, F. Foata, M. affolter, M. delley, M. Fisseha, S. Blum-Sperisen, 
S. kochhar, and F. arigoni. 2006. A serpin from the gut bacterium Bifidobacterium longum 
inhibits eukaryotic elastase-like serine proteases. J Biol Chem 281:17246-17252.
Janeway, C. 1989. Approaching the asymptote? Evolution and revolution in immunology. 
Cold Spring Harb Symp Quant Biol 54:1-13.
Jian, W., l. Zhu, and x. dong. 2001. New approach to phylogenetic analysis of the genus 
Bifidobacterium based on partial HSP60 gene sequences. Int J Syst Evol Microbiol 51:1633-
1638.
Juntunen, M., p. V. kirjavainen, a. C. Ouwehand, S. J. Salminen, and e. Isolauri. 2001. 
Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during 
rotavirus infection. Clin Diagn Lab Immun 8(2): 293-296.
kanauchi, O., y. Fuijyama, k. Mitsuyama, y. araki, T. Ishii, T. Nakamura, y. hitomi, 
k. agata, T. Saiki, a. andoh, a. Toyonaga, and T. Bamba. 1999. Increased growth of 
Bifidobacterium and Eubacterium by germinated barley foodstuff, accompanied by enhanced 
butyrate production in healthy volunteers. Int J Mol Med 3:175-179.
kelly, d., J. Campbell, T. king, g. grant, e. Jansson, a. Coutts, S. pettersson, and S. 
Conway. 2004. Commensal anaerobic gut bacteria attenuate inflammation by regulating 
nuclear-cytoplasmic shuttling of PPAR-g and RelA. Nat Immunol 5:104-112.
kim, J. F., h. Jeong, d. S. yu, S. h. Choi, C. g. hur, M. S. park, S. h. yoon, d. W. kim, 
g. e. Ji, h. S. park, and T. k. Oh. 2009. Genome sequence of the probiotic bacterium 
Bifidobacterium animalis subsp. lactis AD011. J Bacteriol 191:678-679
kim, N., J. kunisawa, M. N. kweon, g. eog Ji, and h. kiyono. 2007. Oral feeding of 
Bifidobacterium bifidum (BGN4) prevents CD4(+) CD45RB(high) T cell-mediated inflammatory 
bowel disease by inhibition of disordered T cell activation. Clin Immunol 123:30-39.
Thesis-Rolf-v3.indd   141 2-1-2011   23:33:36
Chapter 8
142
kitaoka, M., J. Tian, and M. Nishimoto. 2005. Novel putative galactose operon involving 
lacto-N-biose phosphorylase in Bifidobacterium longum. Appl Environ Microbiol 71:3158-
3162.
klaassens, e. S., R. J. Boesten, M. haarman, J. knol, F. h. Schuren, e. e. Vaughan, and 
W. M. de Vos. 2009. Mixed-species genomic microarray analysis of fecal samples reveals 
differential transcriptional responses of bifidobacteria in breast- and formula-fed infants. Appl 
Environ Microbiol 75:2668-2676.
klaassens, e. S., W. M. de Vos, and e. e. Vaughan. 2007. Metaproteomics approach to 
study the functionality of the microbiota in the human infant gastrointestinal tract. Appl Environ 
Microbiol 73:1388-1392.
klaassens, e., W. Vos de, and e. Vaughan. 2007. Molecular approaches to assess activity 
and functionality of commensal and ingested bifidobacteria in the human intestinal tract 
In M. Saarela (ed.), Functional dairy products volume 2. Woodhead Publishing Limited, 
Cambridge.
klaenhammer, T. R., R. Barrangou, B. l. Buck, M. a. Zcarate-peril, and e. altermann. 
2005. Genomic features of lactic acid bacteria effecting bioprocessing and health. FEMS 
Microbiol Rev 29:393-409.
kleerebezem, M., J. Boekhorst, R. van kranenburg, d. Molenaar, O. p. kuipers, R. leer, 
R. Tarchini, S. a. peters, h. M. Sandbrink, M. W. Fiers, W. Stiekema, R. M. lankhorst, p. 
a. Bron, S. M. hoffer, M. N. groot, R. kerkhoven, M. de Vries, B. ursing, W. M. de Vos, 
and R. J. Siezen. 2003. Complete genome sequence of Lactobacillus plantarum WCFS1. 
Proc Natl Acad Sci USA 100:1990-1995.
klijn, a., a. Mercenier, and F. arigoni. 2005. Lessons from the genomes of bifidobacteria. 
FEMS Microbiol Rev 29:491-509.
koenig, J. e., a. Spor, N. Scalfone, a. d. Fricker, J. Stombaugh, R. knight, l. T. angenent, 
and R. e. ley. 2010. Succession of microbial consortia in the developing infant gut microbiome. 
Proc Nat Acad Sci USA [epub ahead of print]:doi10.1073/pnas.1000081107
konstantinidis, k. T., a. Ramette, and J. M. Tiedje. 2006. Toward a more robust assessment 
of intraspecies diversity, using fewer genetic markers. Appl Environ Microbiol 72:7286-7293.
konstantinov, S. R., h. Smidt, W. M. de Vos, S. C. M. Bruijns, S. k. Singh, F. Valence, d. 
Molle, S. lortal, e. altermann, T. R. klaenhammer, and y. van kooyk. 2008. S layer protein 
A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. 
Proc Nat Acad Sci 105:19474-19479.
korfali, N., S. Ruchaud, d. loegering, d. Bernard, C. dingwall, S. h. kaufmann, and W. 
C. earnshaw. 2004. Caspase-7 gene disruption reveals an involvement of the enzyme during 
the early stages of apoptosis. J Biol Chem 279:1030-1039.
Thesis-Rolf-v3.indd   142 2-1-2011   23:33:36
Nederlandse samenvatting, References, Dankwoord, About the author, Publications , VLAG activities
143
Ch
ap
te
r  8
kot, e. and a. Bezkorovainy. 1993. Effects of MG2+ and Ca2+ on Fe2+ uptake by Bifidobacterium 
thermophilum. Int J Biochem 25:1029-1033.
kovatcheva-datchary, p. 2010. Analyzing the functionality of the human intestinal microbiota 
by stable isotope probing. Thesis ISBN 978-90-8585-685-6.
kuipers, O. p., M. M. Beerthuyzen, R. J. Siezen, and W. M. de Vos. 1993. Characterization 
of the nisin gene cluster nisABTCIPR of Lactococcus lactis. Eur J Biochem 216:281-291.
kunin, V., R. Sorek, and p. hugenholtz. 2007. Evolutionary conservation of sequence and 
secondary structure in CRISPR repeats. Genome Biology 8:R61.
kurokawa, k., T. Itoh, T. kuwahara, k. Oshima, h. Toh, a. Toyoda, h. Takami, h. Morita, 
V. k. Sharma, T. p. Srivastava, T. d. Taylor, h. Noguchi, h. Mori, y. Ogura, d. S. ehrlich, 
k. Itoh, T. Takagi, y. Sakaki, T. hayashi, and M. hattori. 2007. Comparative metagenomics 
revealed commonly enriched gene sets in human gut microbiomes. DNA Res 14:169-181.
Kwon, h., e. yang, S. lee, S. yeon, B. kang, and T. kim. 2005. Rapid identification of 
potentially probiotic Bifidobacterium species by multiplex PCR using species-specific primers 
based on the region extending from 16S rRNA through 23S rRNA. FEMS Microbiol Lett 
250:55-62.
lauer, e. and O. kandler. 1983. DNA-DNA homology, murein types and enzyme patterns in 
the type strains of the genus Bifidobacterium. Syst Appl Microbiol 4:42-64.
le Jeune, C., a. lonvaud-Funel, B. ten Brink, h. hofstra, and J. van der Vossen. 1995. 
Development of a detection system for histidine decarboxylating lactic acid bacteria based on 
DNA probes, PCR and activity test. J Appl Bacteriol 78:316-326.
leahy, S. C., d. g. higgins, g. F. Fitzgerald, and d. v. Sinderen. 2005. Getting better with 
bifidobacteria. J Appl Microbiol 98:1303-1315.
leavis, h. l., R. J. l. Willems, W. J. B. Wamel, F. h. Schuren, M. p. M. Caspers, and M. 
J. M. Bonten. 2007. Insertion sequence-driven diversification creates a globally dispersed 
emerging multiresistant subspecies of E. faecium. PLoS Pathog 3(1): e7.
lebeer, S., T. l. a. Verhoeven, M. perea Velez, J. Vanderleyden, and S. C. J. de 
keersmaecker. 2007. Impact of environmental and genetic factors on biofilm formation by 
the probiotic strain Lactobacillus rhamnosus GG. Appl Environ Microbiol 73:6768-6775.
leblond-Bourget, N., h. philippe, I. Mangin, and B. decaris. 1996. 16S rRNA and 16S to 23S 
internal transcribed spacer sequence analyses reveal inter- and intraspecific Bifidobacterium 
phylogeny. Int J Syst Evol Microbiol 46:102-111.
lee, J. h. and d. J. O’Sullivan. 2010. Genomic insights into bifidobacteria. Microbiol Mol Biol 
Rev 74:378-416.
Thesis-Rolf-v3.indd   143 2-1-2011   23:33:36
Chapter 8
144
lee, J. h., V. N. karamychev, S. a. kozyavkin, d. Mills, a. R. pavlov, N. V. pavlova, N. 
N. polouchine, p. M. Richardson, V. V. Shakhova, a. I. Slesarev, B. Weimer, and d. J. 
O’Sullivan. 2008. Comparative genomic analysis of the gut bacterium Bifidobacterium longum 
reveals loci susceptible to deletion during pure culture growth. BMC Genomics 9:247.
li, Q. and I. M. Verma. 2002. NF-kB regulation in the immune system. Nat Rev Immunol 
2:725-734.
lin, h. C. and W. J. Visek. 1991. Large intestinal pH and ammonia in rats: dietary fat and 
protein interactions. J Nutr 121:832-843.
liu, M., F. h. J. van enckevort, and R. J. Siezen. 2005. Genome update: lactic acid bacteria 
genome sequencing is booming. Microbiology 151:3811-3814.
loCascio, R. g., M. R. Ninonuevo, S. l. Freeman, d. a. Sela, R. grimm, C. B. lebrilla, 
d. a. Mills, and J. B. german. 2007. Glycoprofiling of bifidobacterial consumption of human 
milk oligosaccharides demonstrates strain specific, preferential consumption of small chain 
glycans secreted in early human lactation. J Agric Food Chem 55:8914-8919.
lovering, a. l., l. h. de Castro, d. lim, and N. C. J. Strynadka. 2007. Structural insight 
into the transglycosylation step of bacterial cell-wall biosynthesis. Science 315:1402-1405.
Ma, d., p. Forsythe, and J. Bienenstock. 2004. Live Lactobacillus reuteri is essential for the 
inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infect Immun 
72:5308-5314.
MacConaill, l. e., g. F. Fitzgerald, and d. van Sinderen. 2003. Investigation of protein 
export in Bifidobacterium breve UCC2003. Appl Environ Microbiol 69:6994-7001.
Magne, F., W. hachelaf, a. Suau, g. Boudraa, I. Mangin, M. Touhami, k. Bouziane-Nedjadi, 
and p. pochart. 2006. A longitudinal study of infant faecal microbiota during weaning. FEMS 
Microbiol Ecol 58:563-571.
Makarova k, a. Slesarev, y. Wolf, a. Sorokin, B. Mirkin, e. koonin, a. pavlov, N. pavlova, 
V. karamychev, N. polouchine, V. Shakhova, I. grigoriev, y. lou, d. Rohksar, S. lucas, 
k. huang, d. M. goodstein, T. hawkins, V. plengvidhya, d. Welker, J. hughes, y. goh, 
a. Benson, k. Baldwin, J. h. lee, I. díaz-Muñiz, B. dosti, V. Smeianov, W. Wechter, R. 
Barabote, g. lorca, e. altermann, R. Barrangou, B. ganesan, y. xie, h. Rawsthorne, d. 
Tamir, C. parker, F. Breidt, J. Broadbent, R. hutkins, d. O’Sullivan, J. Steele, g. unlu, 
M. Saier, T. klaenhammer, p. Richardson, S. kozyavkin, B. Weimer, and d. Mills. 2006. 
Comparative genomics of the lactic acid bacteria. Proc Nat Acad Sci 103:15611-15616
Marchesi, J. and F. Shanahan. 2007. The Normal Intestinal Microbiota. Curr opin infect dis 
20:508-513.
Marco, M. l., R. S. Bongers, W. M. de Vos, and M. kleerebezem. 2007. Spatial and 
temporal expression of Lactobacillus plantarum genes in the gastrointestinal tracts of mice. 
Appl Environ Microbiol 73:124-132.
Thesis-Rolf-v3.indd   144 2-1-2011   23:33:37
Nederlandse samenvatting, References, Dankwoord, About the author, Publications , VLAG activities
145
Ch
ap
te
r  8
Marco, M. l., S. pavan, and M. kleerebezem. 2006. Towards understanding molecular 
modes of probiotic action. Curr Opin Biotechnol 17:204-210.
Margolles, a., a. B. Florez, J. a. Moreno, d. van Sinderen, and C. de los Reyes-gavilan. 
2006. Two membrane proteins from Bifidobacterium breve UCC2003 constitute an ABC-type 
multidrug transporter. Microbiology 152:3497-3505.
Marione, J. C., C. e. Mason, S. M. Mane, M. Stephens, and y. gilad. 2008. RNA-seq: An 
assesment of technical reproducibility and comparison with gene expression arrays. Genome 
Res 18:1509-1517
Marraffini, L. A., A. C. DeDent, and O. Schneewind. 2006. Sortases and the art of anchoring 
proteins to the envelopes of gram-positive bacteria. Microbiol Mol Biol Rev 70:192-221.
Marteau, p., p. pochart, J. dore, C. Bera-Maillet, a. Bernalier, and g. Corthier. 2001. 
Comparative study of bacterial groups within the human cecal and fecal microbiota. Appl 
Environ Microbiol 67:4939-4942
Martín, R., S. langa, C. Reviriego, e. Jiménez, M. l. Marin, M. Olivares, J. Boza, J. 
Jiménez, l. Fernández, J. xaus, J. M. Rodríguez. 2004. The commensal microflora of 
human milk: new perspectives for food bacteriotherapy and probiotics. Trends Food Sci 
Technol 15:121-127.
Masco, l., M. Ventura, R. Zink, g. huys, and J. Swings. 2004. Polyphasic taxonomic 
analysis of Bifidobacterium animalis and Bifidobacterium lactis reveals relatedness at the 
subspecies level: reclassification of Bifidobacterium animalis as Bifidobacterium animalis 
subsp. animalis subsp. nov. and Bifidobacterium lactis as Bifidobacterium animalis subsp. 
lactis subsp. nov. Int J Syst Evol Microbiol 54 (Pt 4):1137-1143.
Maslowski, k. M., a. T. Vieira, a. Ng, J. kranich, F. Sierro, y. di, h. C. Schilter, M. S. 
Rolph, F. Mackay, d. artis, R. J. xavier, M. M. Teixeira, and C. R. Mackay. 2009. Regulation 
of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 
461:1282-1286.
Matsuki, T., k. Watanabe, J. Fujimoto, T. Takada, and R. Tanaka. 2004. Use of 16S rRNA 
gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in 
human feces. Appl Environ Microbiol 70:7220-7228.
Matsuki, T., k. Watanabe, R. Tanaka, and h. Oyaizu. 1998. Rapid identification of human 
intestinal bifidobacteria by 16S rRNA-targeted species- and group-specific primers. FEMS 
Microbiol Lett 167:113-121.
Matsuki, T., k. Watanabe, R. Tanaka, M. Fukuda, and h. Oyaizu. 1999. Distribution of 
bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted 
species-specific primers. Appl Environ Microbiol 65:4506-4512.
Thesis-Rolf-v3.indd   145 2-1-2011   23:33:37
Chapter 8
146
Mattarelli, p., C. Bonaparte, B. pot, and B. Biavati. 2008. Proposal to reclassify the three 
biotypes of Bifidobacterium longum as three subspecies: Bifidobacterium longum subsp. 
longum subsp. nov., Bifidobacterium longum subsp. infantis comb. nov. and Bifidobacterium 
longum subsp. suis comb. nov. Int J Syst Evol Microbiol 58:767-772.
Mayer, J. 1948. Development of a new infant food with Lactobacillus bifidus. Kinderheilkd 
65:319-345.
Maze, a., M. O’Connell-Motherway, g. F. Fitzgerald, J. deutscher, and d. van Sinderen. 
2007. Identification and characterization of a fructose phosphotransferase system in 
Bifidobacterium breve UCC2003. Appl Environ Microbiol 73:545-553.
McCarthy, J., l. O’Mahony, l. O’Callaghan, B. Sheil, e. e. Vaughan, N. Fitzsimons, J. 
Fitzgibbon, g. C. O’Sullivan, B. kiely, J. k. Collins, and F. Shanahan. 2003. Double blind, 
placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic 
link with cytokine balance. Gut 52:975-980.
Mcginnis, S. and T. l. Madden. 2004. BLAST: at the core of a powerful and diverse set of 
sequence analysis tools. Nucleic Acids Res 32:W20-W25.
Medzhitov, R. 2007. Recognition of microorganisms and activation of the immune response. 
Nature 449:819-826.
Meile, l., W. ludwig, u. Rueger, C. gut, p. kaufmann, g. dasen, S. Wenger, and M. 
Teuber. 1997. Bifidobacterium lactis sp. nov., a moderately oxygen tolerant species isolated 
from fermented milk. Syst Appl Microbiol 20:57-64.
Menard, S., d. laharie, C. asensio, T. Vidal-Martinez, C. Candalh, a. Rullier, F. Zerbib, 
F. Megraud, T. Matysiak-Budnik, and M. heyman. 2005. Bifidobacterium breve and 
Streptococcus thermophilus secretion products enhance T helper 1 immune response and 
intestinal barrier in mice. Exp Biol Med 230:749-756.
Metzker, M. l. 2010. Sequencing technologies ─ the next generation. Nat Rev Genet 11:31-
46.
Mitsou, e. k., e. kirtzalidou, I. Oikonomou, g. liosis, and a. kyriacou. 2008. Fecal 
microflora of Greek healthy neonates. Anaerobe 14:94-101.
Mitsuoka, T. 1969. Vergleichende Untersuchungen uber die Bifidobakterien aus dem 
Verdauungstrakt van Menschen und Tieren. Zentralbl Bakteriol [Orig a] 210:52-64.
Mohan, R., C. koebnick, J. Schildt, S. Schnidt, M. Mueller, M. possner, M. Radke, and M. 
Blaut. 2006. Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota 
of preterm infants: a double-blind, placebo-controlled randomized study. J Clin Microbiol 
4025-4031.
Thesis-Rolf-v3.indd   146 2-1-2011   23:33:37
Nederlandse samenvatting, References, Dankwoord, About the author, Publications , VLAG activities
147
Ch
ap
te
r  8
Moro, g., S. arslanoglu, B. Stahl, J. Jelinek, u. Wahn, and g. Boehm. 2006. A mixture 
of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six 
months of age. Arch Dis Child 91:814-819.
Moroni, O., e. kheadr, y. Boutin, C. lacroix, and I. Fliss. 2006. Inactivation of adhesion 
and invasion of food-borne Listeria monocytogenes by bacteriocin-producing Bifidobacterium 
strains of human origin. Appl Environ Microbiol 72:6894-6901.
Moter, a. and u. gobel. 2000. Fluorescence in situ hybridization (FISH) for direct visualization 
of microorganisms. J Microbiol Meth 41:85-112.
Mukai, T., T. Toba, and h. Ohori. 1997. Collagen binding of Bifidobacterium adolescentis. 
Curr Microbiol 34:326-331.
Muyzer, g., e. Waal de, and a. uitterlinden. 1993. Profiling of complex microbial populations 
by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified 
genes coding for 16S rRNA. Appl Environ Microbiol 59:695-700.
Muzio, M., d. Bosisio, N. polentarutti, g. d’amico, a. Stoppacciaro, R. Mancinelli, C. 
van’t Veer, g. penton-Rol, l. p. Ruco, p. allavena, and a. Mantovani. 2000. Differential 
expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression 
of TLR3 in dendritic cells. J Immunol 164:5998-6004.
Nagashima, k., T. hisada, M. Sato, and J. Mochizuki. 2003. Application of new primer-
enzyme combinations to terminal restriction fragment length polymorphism profiling of 
bacterial populations in human feces. Appl Environ Microbiol 69:1251-1262.
Nakano, T., M. Sugawara, and h. kawakami. 2001. Sialic acid in human milk: composition 
and functions. Acta Paediatr 42:11-17.
Neish, a., a. gewirtz, h. Zeng, a. young, M. hobert, V. karmali, a. Rao, and J. Madara. 
2000. Prokaryotic regulation of epithelial responses by inhibition of IkB-α ubiquitination. 
Science 289:1560-1563.
Nelson, k., g. Weinstock, S. highlander, k. Worley, h. Creasy, J. Wortma, d. Rusch, M. 
Mitreva, e. Sodergren, a. Chinwalla, M. Feldgarden, d. gevers, B. haas, R. Madupu, 
and d. Ward. 2010. A catalog of reference genomes from the human microbiome. Science 
328:994-999.
Netea, M. g., J. W. M. Van der Meer, and B. J. kullberg. 2004. Toll-like receptors as an 
escape mechanism from the host defense. Trends Microbiol 12:484-488.
Nishimoto, M., and M. kitaoka. 2007. Identification of N-acetylhexosamine 1-kinase in the 
complete lacto-N-biose I/galacto-N-biose metabolic pathway in Bifidobacterium longum. Appl 
Environ Microbiol 73:6444-6449.
Thesis-Rolf-v3.indd   147 2-1-2011   23:33:37
Chapter 8
148
Nubel, u., B. engelen, a. Felske, J. Snaidr, a. Wieshuber, R. I. amann, W. ludwig, and h. 
Backhaus. 1996. Sequence heterogeneities of genes encoding 16S rRNAs in Paenibacillus 
polymyxa detected by temperature gradient gel electrophoresis. J Bacteriol 178:5636-5643.
O’Connell Motherway, M., g. F. Fitzgerald, S. Neirunck, S. Ryan, l. Steidler, and d. van 
Sinderen. 2008. Characterization of ApuB, an extracellular type II amylopullulanase from 
Bifidobacterium breve UCC2003. Appl Environ Microbiol 74:6271-6279.
O’hara, a. and F. Shanahan. 2006. The gut flora as a forgotten organ. Eur Mol Biol Org 
7:688-693.
O’hara, a. M., p. O’Regan, a. Fanning, C. O’Mahony, J. MacSharry, a. lyons, J. 
Bienenstock, l. O’Mahony, and F. Shanahan. 2006. Functional modulation of human 
intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. 
Immunology 118:202-215.
O’Mahony, l., J. McCarthy, p. kelly, g. hurley, F. luo, k. Chen, g. C. O’Sullivan, B. kiely, 
J. k. Collins, F. Shanahan, and e. M. M. Quigley. 2005. Lactobacillus and Bifidobacterium 
in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. 
Gastroenterol 128:541-551.
Orla-Jensen, S. 1924. La classification des bactéries lactiques. Lait 4:468-474.
Oshlack, a., d. emslie, l. M. Corcoran, and g. k. Smyth. 2007. Normalization of boutique 
two-color microarrays with a high proportion of differentially expressed probes. Genome 
Biology 8:R2.
O’Sullivan, d. 2008. Genomics can advance the potential for probiotic cultures to improve 
liver and overall health. Curr Pharm Des 14:1376-1381.
O’Sullivan, d. J. 2001. Screening of intestinal microflora for effective probiotic bacteria. J 
Agric Food Chem 49:1751-1760.
Ouwehand, a. C., M. derrien, W. M. de Vos, k. Tiihonen, and N. Rautonen. 2005. Prebiotics 
and other microbial substrates for gut functionality. Curr Opin Biotechnol 16:212-217.
Ouwehand, a., e. Isolauri, and S. Salminen. 2002. The role of the intestinal microflora for 
the development of the immune system in early childhood. Eur J Nutr 41:(Suppl1)i32-7
palmer, C., e. Bik, d. digiulio, d. a. Relman, and p. Brown. 2007. Development of the 
human infant intestinal microbiota. PLoS Biol 5:e177.
palmerini, F., e. devilard, a. Jarry, F. Birg, and l. xerri. 2001. Caspase 7 downregulation 
as an immunohistochemical marker of colonic carcinoma. Hum Pathol 32:461-467.
parche, S., J. amon, I. Jankovic, e. Rezzonico, M. Beleut, h. Barutçu, I. Schendel, M. 
p. eddy, a. Burkovski, F. arigoni, and F. Titgemeyer. 2007. Sugar transport systems of 
Bifidobacterium longum  NCC2705. J Mol Microbiol Biotechnol 12:9-19.
Thesis-Rolf-v3.indd   148 2-1-2011   23:33:37
Nederlandse samenvatting, References, Dankwoord, About the author, Publications , VLAG activities
149
Ch
ap
te
r  8
park, h. J., S. S. kim, y. M. Seong, k. h. kim, h. g. goo, e. J. yoon, d. S. Min, S. kang, 
and h. Rhim. 2006. Beta-amyloid precursor protein is a direct cleavage target of HtrA2 serine 
protease: implications for the physiological function of HtrA2 in the mitochondria. J Biol Chem 
281:34277-34287.
parro, V., and M. Moreno-paz. 2003. Gene function analysis in environmental isolates: the 
nif regulon of the strict iron oxidizing bacterium Leptospirillum ferrooxidans. Proc Natl Acad 
Sci USA 100:7883-7888.
parvez, S., k. a. Malik, S. a. kang, and h.-y. kim. 2006. Probiotics and their fermented food 
products are beneficial for health. J Appl Microbiol 1171-1185.
penders, J., C. Thijs, C. Vink, F. F. Stelma, B. Snijders, I. kummeling, et al. 2006. Factors 
influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118:511-
521.
penders, J., C. Vink, C. driessen, N. london, C. Thijs, and e. e. Stobberingh. 2005. 
Quantification of Bifidobacterium spp., Escherichia coli and Clostridium difficile in faecal 
samples of breast-fed and formula-fed infants by real-time PCR. FEMS Microbiol Lett 243:141-
147.
perez, p. F., J. dore, M. leclerc, F. levenez, J. Benyacoub, p. Serrant, et al. 2007. 
Bacterial imprinting of the neonatal immune system: lessons from maternal cells? Pediatrics 
119:e724-e732.
petrof, e. O., k. kojima, M. J. Ropeleski, M. W. Musch, y. Tao, C. de Simone, and e. B. 
Chang. 2004. Probiotics inhibit nuclear factor-κB and induce heat shock proteins in colonic 
epithelial cells through proteasome inhibition. Gastroenterology 127:1474-1487.
pompei, a., l. Cordisco, a. amaretti, S. Zanoni, d. Matteuzzi, and M. Rossi. 2007. Folate 
production by bifidobacteria as a potential probiotic property. Appl Environ Microbiol 73:179-
185.
pretzer, g., J. Snel, d. Molenaar, a. Wiersma, p. a. Bron, J. lambert, W. M. de Vos, R. 
van der Meer, M. a. Smits, and M. kleerebezem. 2005. Biodiversity-based identification 
and functional characterization of the mannose-specific adhesin of Lactobacillus plantarum. J 
Bacteriol 187:6128-6136.
prevot, a. 1971. Les laits modifies par le lactobacille acidophile dans la dietique hospitaliere. 
Infect Diet 8:19-21.
Qin, J., R. li, J. Raes, M. arumugam, k. S. Burgdorf, C. Manichanh, et al. (2010) A human 
gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59-65.
Radtke, S., S. Wuller, x. p. yang, B. e. lippok, B. Mutze, C. Mais, h. S.-V. de leur, J. g. 
Bode, M. gaestel, p. C. heinrich, I. Behrmann, F. Schaper, and h. M. hermanns. 2010. 
Cross-regulation of cytokine signalling: pro-inflammatory cytokines restrict IL-6 signalling 
through receptor internalisation and degradation. J Cell Sci 123:947-959.
Thesis-Rolf-v3.indd   149 2-1-2011   23:33:37
Chapter 8
150
Rajilic-Stojanovic, M., h. g. h. J. heilig, d. Molenaar, k. kajander, a. Surakka, h. Smidt, 
and d. W. M. Vos. 2009. Development and application of the human intestinal tract chip, 
a phylogenetic microarray: analysis o funiversally conserved phylotypes in the abundant 
microbiota of young and elderly adults. Environ Microbiol 11:1736-1751.
Rajilic-Stojanovic, M., h. Smidt, and W. M. de Vos. 2007. Diversity of the human 
gastrointestinal tract microbiota revisited. Environ Microbiol 9:2125-2136.
Rakoff-Nahoum, S., J. paglino, F. eslami-Varzaneh, S. edberg, and R. Medzhitov. 
2004. Recognition of commensal microflora by Toll-Like receptors is required for intestinal 
homeostasis. Cell 118:229-241.
Reimer, T., M. Brcic, M. Schweizer, and T. W. Jungi. 2008. poly(I:C) and LPS induce distinct 
IRF3 and NF-kB signaling during type-I IFN and TNF responses in human macrophages. J 
Leukoc Biol 83:1249-1257.
Reuter, g. 1963. Vergleichende untersuchungen über die Bifidus-Flora im säuglings- und 
erwachsenenstuhl. Zentrabl Bakteriol [Orig A] 1:286-507.
Reuter, g. 1969. Composition and use of bacterial cultures for therapeutic purposes. 
Arzneimittelforschung 19:103-109.
Riedel, C. u., F. Foata, d. philippe, O. adolfsson, B. eikmanns, and S. Blum. 2006. 
Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NK-kB. World J 
Gastroenterol 12:3729-3735.
Roger, l., a. Costabile, d. holland, l. hoyles, and a. McCartney. 2010. Examination of 
faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months 
of life. Microbiol 156(Pt11):3329-3341.
Ruas-Madiedo, p., M. gueimonde, a. Margolles, l. l.-g. de, g. Clara, and S. Salminen. 
2006. Exopolysaccharides produced by probiotic strains modify the adhesion of probiotics 
and enteropathogens to human intestinal mucus. J Food Prot 69:2011-2015.
Ryan, S. M., g. F. Fitzgerald, and d. van Sinderen. 2006. Screening for and identification of 
starch-, amylopectin-, and pullulan-degrading activities in bifidobacterial strains. Appl Environ 
Microbiol 72:5289-5296.
Saavedra, J. and a. Tschernia. 2002. Human studies with probiotics and prebiotics: clinical 
implications. Br J Nutr 87:S241-S246.
Saha, B. C. and R. J. Bothast. 1998. Purification and characterization of a novel thermostable 
a-L-arabinofuranosidase from a color-variant strain of Aureobasidium pullulans. Appl Environ 
Microbiol 64:216-220.
Said, h. M. and Z. M. Mohammed. 2006. Intestinal absorption of water-soluble vitamins: an 
update. Curr Opin Gastroenterol 22(2):140-146.
Thesis-Rolf-v3.indd   150 2-1-2011   23:33:37
Nederlandse samenvatting, References, Dankwoord, About the author, Publications , VLAG activities
151
Ch
ap
te
r  8
Sakamoto, M., h. hayashi, and y. Benno. 2003. Terminal restriction fragment lenght 
polymorphism analysis for human fecal microbiota and its application for analysis of complex 
bifidobacterial communities. Microbiol. Immunol. 47:133-142.
Sakata, S., C. S. Ryu, M. kitahara, M. Sakamoto, h. hayashi, M. Fukuyama, and y. Benno. 
2005. Characterization of the genus Bifidobacterium by automated ribotyping and 16S rRNA 
gene sequences. Microbiol Immunol 50:1-10.
Sakata, S., M. kitahara, M. Sakamoto, h. hayashi, M. Fukuyama, and y. Benno. 2002. 
Unification of Bifidobacterium infantis and Bifidobacterium suis as Bifidobacterium longum. Int 
J Syst Evol Microbiol 52 (Pt 6):1945-1951.
Salminen, S. J., M. gueimonde, and e. Isolauri. 2005. Probiotics that modify disease risk. 
J Nutr 135:1294-1298.
Salonen, a., J. Nikkila, J. Jalanka-Tuovinen, O. Immonen, M. Rajilic-Stojanovic, R. 
a. kekkonen, et al. 2010. Comparative analysis of fecal DNA extraction methods with 
phylogenetic microarray: effective recovery of bacterial and archaeal DNA using mechanical 
cell lysis. J Microbiol Meth 81:127-134.
Santos, F., J. l. Vera, R. van der heijden, g. Valdez, W. M. de Vos, F. Sesma, and J. 
hugenholtz. 2008. The complete coenzyme B12 biosynthesis gene cluster of Lactobacillus 
reuteri CRL1098. Microbiology 154:81-93.
Satokari, R. M., e. e. Vaughan, a. d. l. akkermans, M. Saarela, and W. M. de Vos. 2001. 
Bifidobacterial diversity in human feces detected by genus-specific PCR and denaturing 
gradient gel electrophoresis. Appl Environ Microbiol 67:504-513.
Satokari, R., T. grönroos, k. laitinen, S. Salminen, and e. Isolauri. (2009) Bifidobacterium 
and Lactobacillus DNA in the human placenta. Lett Appl Microbiol 48:8-12.
Saulnier, d. M. a., d. Molenaar, W. M. de Vos, g. R. gibson, and S. kolida. 2007. 
Identification of prebiotic fructooligosaccharide metabolism in Lactobacillus plantarum WCFS1 
through microarrays. Appl Environ Microbiol 73:1753-1765.
Saxelin, M., S. Tynkkynen, T. Mattila-Sandholm, and W. M. de Vos. 2005. Probiotic and 
other functional microbes: from markets to mechanisms. Curr Opin Biotechnol 16:204-211.
Scardovi, V. 1986. The genus Bifidobacterium Orla-Jensen 1924, p. 1418-1434. In P. Sneath, 
N. Mair, M. Sharpe, and J. Holt (eds.), Bergey’s manual of systematic bacteriology. Williams 
& Wilkins Co., Baltimore.
Scardovi, V. and F. Crociani. 1974. Bifidobacterium catenulatum, Bifidobacterium dentium, 
and Bifidobacterium angulatum: three new species and their deoxyribonucleic acid homology 
relationships. Int J Syst Bacteriol 24:21-28.
Scardovi, V., g. Zani, and l. Trovatelli. 1970. Deoxyribonucleic acid homology among the 
species of the genus Bifidobacterium isolated from animals. Arch Mikrobiol 72:318-325.
Thesis-Rolf-v3.indd   151 2-1-2011   23:33:37
Chapter 8
152
Schatz, d. g., M. a. Oettinger, and M. S. Schlissel. 1992. V(D)J recombination: molecular 
biology and regulation. Ann Rev Immunol 10:359-383.
Schell, M. a., M. karmirantzou, B. Snel, d. Vilanova, B. Berger, g. pessi, M. C. Zwahlen, 
F. desiere, p. Bork, M. delley, R. d. pridmore, and F. arigoni. 2002. The genome sequence 
of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc Natl 
Acad Sci USA 99:14422-14427.
Schiffrin, e. and S. Blum. 2002. Original communication: Interactions between the microbiota 
and the intestinal mucosa. Eur J Clin Nutr 56:S60-S64.
Schouten, B., B. C. a. M. van esch, g. a. hofman, S. a. C. M. van doorn, J. knol, a. 
J. Nauta, J. garssen, l. e. M. Willemsen, and l. M. J. knippels. 2009. Cow milk allergy 
symptoms are reduced in mice fed dietary synbiotics during oral sensitization with whey. J 
Nutr 139:1398-1403.
Schuerer-Maly, C., l. eckmann, M. kagnoff, M. Falco, and F. e. Maly. 1994. Colonic 
epithelial cell lines as a source of interleukin-8: stimulation by inflammatory cytokines and 
bacterial lipopolysaccharide. Immunol 81:85-91.
Schwandner, R., R. dziarski, h. Wesche, M. Rothe, and C. kirschning. 1999. Peptidoglycan- 
and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 
274:17406-17409.
Sela, d. a., J. Chapman, a. adeuya, J. h. kim, F. Chen, T. R. Whitehead, a. lapidus, d. S. 
Rokhsar, C. B. lebrilla, J. B. german, N. p. price, p. M. Richardson, and d. a. Mills. 2008. 
The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk 
utilization within the infant microbiome. Proc Nat Acad Sci 105:18964-18969.
Smith, T. F., and M. S. Waterman. 1981. Identification of common molecular subsequences. 
J Mol Biol 147:195-197.
Sonnenburg, J. l., J. xu, d. d. leip, C. h. Chen, B. p. Westover, J. Weatherford, J. d. 
Buhler, and J. I. gordon. 2005. Glycan foraging in vivo by an intestine-adapted bacterial 
symbiont. Science 307:1955-1959.
Sonnenburg, J., C. Chen, and J. gordon. 2006. Genomic and metabolic studies of the 
impact of probiotics on a model gut symbiont and host. PLoS Biol 4:e413, DOI: 10.1371/
journal.pbio.0040413.
Stsepetova, J., e. Sepp, k. Julge, e. Vaughan, M. Mikelsaar, and W. M. de Vos. 2007. 
Molecularly assessed shifts of Bifidobacterium ssp. and less diverse microbial communities 
are characteristic of 5-year-old allergic children. FEMS Immunol Med Microbiol 51:260-269.
Sturme, M. h. J., J. Nakayama, d. Molenaar, y. Murakami, R. kunugi, T. Fujii, e. e. 
Vaughan, M. kleerebezem, and W. M. de Vos. 2005. An agr-like two-component regulatory 
system in Lactobacillus plantarum is involved in production of a novel cyclic peptide and 
regulation of adherence. J Bacteriol 187:5224-5235.
Thesis-Rolf-v3.indd   152 2-1-2011   23:33:37
Nederlandse samenvatting, References, Dankwoord, About the author, Publications , VLAG activities
153
Ch
ap
te
r  8
Sturme, M., M. kleerebezem, J. Nakayama, a. akkermans, e. Vaughan, and W. de Vos. 
2002. Cell to cell communication by autoinducing peptides in gram-positive bacteria. Ant 
Leeuwenh 81:233-243.
Suzuki, T., y. Tuda, N. kano, k. Inoue, k. kumazaki, k. yasui, N. Saori, k. Tanaka, and k. 
Watanabe. 2007. Presented at the Second International Symposium on Propionibacteria and 
Bifidobacteria: Dairy and Probiotic Applications, Norway.
Takeda, k., T. kaisho, and S. akira. 2003. Toll-like receptors. Ann Rev Immunol 21:335-
376.
Tanaka, h., k. doesburg, T. Iwasaki, and I. Mierau. 1999. Screening of lactic acid bacteria 
for bile salt hydrolase activity. J Dairy Sci 82:2530-2535.
Tao, y., k. a. drabik, T. S. Waypa, M. W. Musch, J. C. alverdy, O. Schneewind, e. B. 
Chang, and e. O. petrof. 2006. Soluble factors from Lactobacillus GG activate MAPKs 
and induce cytoprotective heat shock proteins in intestinal epithelial cells. Am J Physiol Cell 
Physiol 290:C1018-C1030.
Tap, J., S. Mondot, F. levenez, e. pelletier, C. Caron, J. Furet, e. ugarte, R. Muñoz-
Tamayo, d. l. paslier, R. Nalin, J. dore, M. leclerc. 2009. Towards the human intestinal 
microbiota phylogenetic core. Environ Microbiol 11:2574-2584.
Temmerman, R., I. Scheirlinck, g. huys, and J. Swings. 2002. Culture-independent 
analysis of probiotic products by denaturing gradient gel electrophoresis. Appl Environ 
Microbiol 69:220-226.
Tissier, h. 1906. Traitement des infections intestinales par la methode de la flore bacteriennede 
l’intestin. Crit Rev Soc Biol 60:359-361.
Tomida, M. 2000. Structural and functional studies on the leukemia inhibitory factor receptor 
(LIF-R): gene and soluble form of LIF-R, and cytoplasmic domain of LIF-R required for 
differentiation and growth arrest of myeloid leukemic cells. Leuk Lymphoma 37:517-525.
Troost, F., p. van Baarlen, p. lindsey, a. kodde, W. de Vos, M. kleerebezem, and R. J. 
Brummer. 2008. Identification of the transcriptional response of human intestinal mucosa to 
Lactobacillus plantarum WCFS1 in vivo. BMC Genomics 9:374.
Turnbaugh, p. J., M. hamady, T. yatsunenko, B. l. Cantarel, a. duncan, R. e. ley, M. l. 
Sogin, W. J. Jones, B. a. Roe, J. p. affourtit, M. egholm, B. henrissat, a. C. heath, R. 
knight, J. I. gordon. 2009. A core gut microbiome in obese and lean twins. Nature 457:480-
484.
Turroni, F., e. Foroni, p. pizzetti, V. giubellini, a. Ribbera, p. Merusi, p. Cagnasso, B. 
Bizzarri, g. l. de’angelis, F. Shanahan, d. van Sinderen, and M. Ventura. 2009. Exploring 
the diversity of the bifidobacterial population in the human intestinal tract. Appl Environ 
Microbiol 75:1534-1545.
Thesis-Rolf-v3.indd   153 2-1-2011   23:33:37
Chapter 8
154
Turroni, F., F. Bottacini, e. Foroni, I. Mulder, J. kim, a. Zomer, B. Sanchez, a. Bidossi, a. 
Ferrarini, V. giubellini, M. delledonne, b. henrissat, p. Coutinho, M. Oggioni, g. Fitzgerald, 
a. Margolles, d. kelly, and d. van Sinderen. 2010. Genome analysis of Bifidobacterium 
bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging. Proc Natl 
Acad Sci USA 107(45):19514-9.
Turroni, F., J. R. Marchesi, e. Foroni, M. gueimonde, F. Shanahan, a. Margolles, et al. 
2009b. Microbiomic analysis of the bifidobacterial population in the human distal gut. ISME J 
3:745-751.
van Baarlen, p., F. J. Troost, S. van hemert, C. van der Meer, W. M. de Vos, p. J. de 
groot, et al. 2009. Differential NF-κB pathways induction by Lactobacillus plantarum in the 
duodenum of healthy humans correlating with immune tolerance. Proc Natl Acad Sci USA 
106:2371-2376.
van pijkeren, J. p., C. Canchaya, k. a. Ryan, y. li, M. J. Claesson, B. Sheil, l. Steidler, 
l. O’Mahony, g. F. Fitzgerald, d. van Sinderen, and p. W. O’Toole. 2006. Comparative and 
functional analysis of sortase-dependent proteins in the predicted secretome of Lactobacillus 
salivarius UCC118. Appl Environ Microbiol 72:4143-4153.
Vaughan, e. e., h. g. h. J. heilig, k. Ben-amor, and W. M. de Vos. 2005. Diversity, vitality 
and activities of intestinal lactic acid bacteria and bifidobacteria assessed by molecular 
approaches. FEMS Microbiol Rev 29:277-490.
Veiga, p., C. a. gallini, C. Beal, M. Michaud, M. l. delaney, a. duBois, a. khlebnikov, 
J. e. T. van hylckama Vlieg, S. punit, J. N. glickman, a. Onderdonk, l. h. glimcher, 
and W. S. garrett. 2010. Bifidobacterium animalis subsp. lactis fermented milk product 
reduces inflammation by altering a niche for colitogenic microbes. Proc Nat Acad Sci USA 
107(42):18132-7.
Ventura, M. and R. Zink. 2002. Rapid identification, differentiation, and proposal new 
taxonomic classification of Bifidobacterium lactis. Appl Environ Microbiol 68:6429-6434.
Ventura, M. and R. Zink. 2003. Comparative sequence analisis of the tuf and recA genes and 
restriction fragment lenght polymorphism of the internal transcribed spacer region sequences 
supple additional tools for discriminating Bifidobacterium lactis from Bifidobacterium animalis. 
Appl Environ Microbiol 69:7517-7522.
Ventura, M., C. Canchaya, a. d. Casale, F. dellaglio, e. Neviani, g. F. Fitzgerald, and d. 
van Sinderen. 2006. Analysis of bifidobacterial evolution using a multilocus approach. Int J 
Syst Bacteriol 56:2783-2792.
Ventura, M., C. Canchaya, a. Tauch, g. Chandra, g. F. Fitzgerald, k. F. Chater, and d. van 
Sinderen. 2007a. Genomics of Actinobacteria: tracing the evolutionary history of an ancient 
phylum. Microbiol Mol Biol Rev 71:495-548.
Ventura, M., d. van Sinderen, g. F. Fitzgerald, and R. Zink. 2004. Insights into the taxonomiy, 
genetics and physiology of bifidobacteria. Ant Leeuwenh 86:205-223.
Thesis-Rolf-v3.indd   154 2-1-2011   23:33:37
Nederlandse samenvatting, References, Dankwoord, About the author, Publications , VLAG activities
155
Ch
ap
te
r  8
Ventura, M., M. O’Connell-Motherway, S. leahy, J. a. Moreno-Munoz, g. F. Fitzgerald, 
and d. van Sinderen. 2007b. From bacterial genome to functionality; case bifidobacteria. Int 
J Food Microbiol doi:10.1016/j.ijfoodmicro.2007.06.011.
Ventura, M., S. O’Flaherty, M. J. Claesson, F. Turroni, T. R. klaenhammer, d. van 
Sinderen, and p. W. O’Toole. 2009. Genome-scale analyses of health-promoting bacteria: 
probiogenomics. Nat Rev Micro 7:61-71.
Vitali, B., V. Wasinger, p. Brigidi, and M. guilhaus. 2005. A proteomic view of Bifidobacterium 
infantis generated by multi-dimensional chromatography coupled with tandem mass 
spectrometry. Proteomics 5:1859-1867.
Vizoso pinto, M., M. Rodriguez gómez, S. Seifert, B. Watzl, W. holzapfel, and C. Franz. 
2009. Lactobacilli stimulate the innate immune response and modulate the TLR expression of 
HT29 intestinal epithelial cells in vitro. Int J Food Microbiol 133:86-93.
Vlaminckx, B. J. M., F. h. J. Schuren, R. C. Montijn, M. p. M. Caspers, a. C. Fluit, W. 
J. B. Wannet, l. M. Schouls, J. Verhoef, and W. T. M. Jansen. 2007. Determination of 
the relationship between group a streptococcal genome content, m type, and toxic shock 
syndrome by a mixed genome microarray. Infect Immun 75:2603-2611.
Wada, J., T. ando, M. kiyohara, h. ashida, M. kitaoka, M. yamaguchi, h. kumagai, T. 
katayama, and k. yamamoto. 2008. Bifidobacterium bifidum lacto-N-biosidase, a critical 
enzyme for the degradation of human milk oligosaccharides with a type 1 structure. Appl 
Environ Microbiol 74:3996-4004.
Wall, R., S. hussey, C. Ryan, M. O’Neill, g. F. Fitzgerald, C. Stanton, and R. Ross. 2007. 
Presence of two Lactobacillus and Bifidobacterium probiotic strains in the neonatal ileum. 
ISME J 2:83-91.
Wang, Z., M. gerstein, and M. Snyder. 2009. RNA-seq: a revolutionary tool for transcriptomics. 
Nat Rev Genet 10:57-63
Ward, R. e., M. Niñonuevo, d. a. Mills, C. B. lebrilla, and J. B. german. 2006. In vitro 
fermentation of breast milk oligosaccharides by Bifidobacterium infantis and Lactobacillus 
gasseri. Appl Environ Microbiol 72:4497-4499.
Ward, R., M. Niñonuevo, d. Mills, C. lebrilla, and J. german. 2007. In vitro fermentability of 
human milk oligosaccharides by several strains of bifidobacteria. Mol Nutr Food Res 51:1398-
1405.
Weber, C., d. Raleigh, l. Su, l. Shen, e. Sullivan, y. Wang, and J. Turner. 2010. Epithelial 
myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight 
junction ion selectivity. J Biol Chem 285:12037-12046.
Wegkamp, a., M. Starrenburg, W. M. de Vos, J. hugenholtz, and W. Sybesma. 2004. 
Transformation of folate-consuming Lactobacillus gasseri into a folate producer. Appl Environ 
Microbiol 70:3146-3148.
Thesis-Rolf-v3.indd   155 2-1-2011   23:33:37
Chapter 8
156
Whitman, W. B., d. C. Coleman, and W. J. Wiebe. 1998. Prokaryotes: The unseen majority. 
Proc Natl Acad Sci USA 95:6578-6583
Wiater, a., a. Choma, and J. Szczodrak. 1999. Insoluble glucans synthesized by cariogenic 
streptococci: a structural study. J Basic Microbiol 39:265-273.
Winkler, p., d. ghadimi, J. Schrezenmeir, and J. p. kraehenbuhl. 2007. Molecular and 
cellular basis of microflora-host interactions. J Nutr 137:756S-7772.
Woodmansey, e. J., M. e. T. McMurdo, g. T. Macfarlane, and S. Macfarlane. 2004. 
Comparison of compositions and metabolic activities of fecal microbiotas in young adults 
and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol 
70:6113-6122.
xu, J. and J. I. gordon. 2003. Honor thy symbionts. Proc Natl Acad Sci USA 100:10452-
10459.
yaeshima, T., T. Fujisawa, and T. Mitsuoka. 1992. Bifidobacterium globosum, subjective 
synomym of Bifidobacterium pseudolongum, and description of Bifidoacterium pseudologum 
subsp. pseudolongum comb. nov. and Bifidobacterium pseudolongum subsp. globosum 
comb. nov. Syst Appl Microbiol 15:280-385.
yildirim, Z., d. Winters, and M. Johnson. 1999. Purification, amino acid sequence and mode 
of action of bifidocin B produced by Bifidobacterium bifidum NCFB 1454. J Appl Microbiol 
86:45-54.
yoshimura, a., e. lien, R. R. Ingalls, e. Tuomanen, R. dziarski, and d. golenbock. 
1999. Cutting Edge: recognition of gram-positive bacterial cell wall components by the innate 
immune system occurs via toll-like receptor 2. J Immunol 163:1-5.
young, S. l., M. a. Simon, M. a. Baird, g. W. Tannock, R. Bibiloni, k. Spencely, J. M. 
lane, p. Fitzharris, J. Crane, I. Town, e. addo-yobo, C. S. Murray, and a. Woodcock. 
2004. Bifidobacterial species differentially affect expression of cell surface markers and 
cytokines of dendritic cells harvested from cord blood. Clin Vac Immunol 11:686-690.
Zhang, l., N. li, R. Caicedo, and J. Neu. 2005. Alive and dead Lactobacillus rhamnosus 
GG decrease tumor necrosis factor-a-induced interleukin-8 production in Caco-2 cells. J Nutr 
135:1752-1756.
Zivkovic, a. M., J. B. german, C. B. lebrilla, and d. a. Mills. 2010. Human milk glycobiome 
and its impact on the infant gastrointestinal microbiota. Proc Nat Acad Sci [epub ahead of 
print];doi:10.1073/pnas.1000083107
Zoetendal, e. g., a. d. akkermans, and W. M. de Vos. 1998. Temperature gradient gel 
electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-
specific communities of active bacteria. Appl Environ Microbiol 64:3854-3859.
Thesis-Rolf-v3.indd   156 2-1-2011   23:33:37
Nederlandse samenvatting, References, Dankwoord, About the author, Publications , VLAG activities
157
Ch
ap
te
r  8
Zoetendal, e. g., a. von Wright, T. Vilpponen-Salmela, k. Ben-amor, a. d. l. akkermans, 
and W. M. de Vos. 2002. Mucosa-associated bacteria in the human gastrointestinal tract are 
uniformly distributed along the colon and differ from the community recovered from feces. 
Appl Environ Microbiol 68:3401-3407.
Zoetendal, e. g., C. C. Booijink, e. S. klaassens, h. g. heilig, M. kleerebezem, h. Smidt, 
and W. M. de Vos. 2006. Isolation of RNA from bacterial samples of the human gastrointestinal 
tract. Nat Protoc 1:954-959.
Zoetendal, e. g., e. e. Vaughan, and W. M. de Vos. 2006. A microbial world within us. Mol 
Microbiol 59:1639-1650.
Zoetendal, e. g., k. Ben-amor, a. d. l. akkermans, T. abee, and W. M. de Vos. 2001. DNA 
isolation protocols affect the detection limit of PCR approaches of bacteria in samples from 
the human gastrointestinal tract. Syst Appl Microbiol 24:405-410.
Zoetendal, e., M. Rajilic-Stojanovic, and W. M. de Vos. 2008. High-throughput diversity and 
functionality analysis of the gastrointestinal tract microbiota. Gut 57:1605-1615.
Thesis-Rolf-v3.indd   157 2-1-2011   23:33:37
Chapter 8
158
Thesis-Rolf-v3.indd   158 2-1-2011   23:33:37
Nederlandse samenvatting, References, Dankwoord, About the author, Publications , VLAG activities
159
Ch
ap
te
r  8
daNkWOORd
Eindelijk is het dan zo ver, ik ben toegekomen aan het schrijven van het dankwoord. 
Ik moet eerlijk bekennen, dat ik naar dit moment heb uitgekeken. De afgelopen 
periode zijn mijn gedachten regelmatig afgedwaald, waarbij ik me de inhoud van 
deze paragraaf probeerde voor te stellen. Iedere keer opnieuw leek er geen einde 
aan te komen. Dit maal zal ik mijn best doen het kort te houden, zonder mensen te 
vergeten.
Willem, allereerst wil ik jou bedanken voor je intensieve begeleiding. Je hebt een 
grote bijdrage geleverd aan mijn wetenschappelijke ontwikkeling. Verbazend snel 
en compleet was altijd je feedback op mijn manuscripten. Ik heb veel geleerd van 
jou relevante en opbouwende kritiek. Onze prettige samenwerking heb ik altijd erg 
gewaardeerd.
Frank, op het ‘genomics’-lab heb ik veel praktische kennis opgedaan. Jij hebt me 
inzicht geven in de toepassingsmogelijkheden van microarrays. Ik kon altijd je kamer 
binnenlopen met vragen. Vooral tijdens de eerste jaren heb ik daar veel gebruik van 
gemaakt. Bedankt voor de dagelijkse begeleiding.
 Eline, gedetacheerd bij TNO was ik een beetje geïsoleerd van de andere AIO’s 
op de WUR. Gelukkig kon ik altijd bij jou terecht met WUR-AIO-gerelateerde vragen. 
Ik heb altijd met plezier met je samengewerkt.
Ook wil ik de andere collega’s uit Wagingen bedanken. Met name de studiereis 
naar Japan heeft veel indruk op mij gemaakt, niet alleen vanwege het land maar ook 
vanwege het reisgezelschap.
Collega’s van het IOP project, volgens mij ben ik de laatste AIO die mag 
promoveren. Bedankt voor jullie bijdrage tijdens de meetings.
Mijn collega’s van TNO wil ik ook zeker niet vergeten. Mijn huidige kennis van 
laboratorium technieken is voor een groot gedeelte de verzameling van jullie tips 
en uitleg. Verder waren er naast de professionele samenwerking er ook de koffie-
pauzes, lunch-pauzes, TNO-bandjes, zaalvoetbalteams en eetclubjes waar ik veel 
plezier aan heb beleefd. Sonia, thank you for contribution to the cell line work and for 
your feedback during the PhD meetings.
Robert en Machtelt, we hebben veel gelachen samen op de AIO-kamer. Het mooie 
was dat we daarnaast ook regelmatig discussies hadden over wetenschappelijke 
vragenstukken of ander ‘belangrijke’ onderwerpen. Machtelt, ik ben trots dat jij mijn 
paranimf wilt zijn. Robert, vind jij het ook niet jammer dat stelling 10 van Machtelts 
proefschrift niet hoefde voor te lezen tijdens Machtelt’s verdediging ;-)? Machtelt en 
Robert, jullie zijn meer dan collega’s geworden.
Marleen en Marco, bedank voor gezellige etentjes.
Thesis-Rolf-v3.indd   159 2-1-2011   23:33:37
Chapter 8
160
Martien, ik kan er niet onderuit om jou te bedanken voor hulp bij het oplossen van 
allerlei data-analyse vraagstukken. Jij wist altijd weer met creatieve, slimme ideeën 
te komen.
Jan, Aldwin, Linette, Monique, Tiemen, Kaouther, Richèle, Jolanda, Arjan en 
Menno-Jan, bedankt voor jullie ondersteunende werk bij Danone.
Mijn CBS collega’s, ook al hebben ze mij niet gekend tijdens het uitvoeren van mijn 
promotieonderzoek, hebben daadwerkelijk een bijdrage geleverd aan de afronding. 
Vooral in de vorm van “motiverende” opmerkingen tijdens de koffie pauzes ;-). 
Richard en Manon, bedankt voor de layout-tips. Bart, bedankt voor het brainstormen 
over de stellingen. CBS room mates, thank you for supporting me. Tineke vd B, Joost 
en Timon bedankt voor jullie steun. Ferry, bedankt voor het reviewen en succes met 
de laatste loodjes. Teun, jij hebt me altijd gemotiveerd en me de tijd gegeven om mijn 
proefschrift af te ronden. Tineke v D, erg leuk dat je mijn paranimf wilt zijn. Bedankt 
allemaal!
Vrienden uit Waalre, jaja… eindelijk heeft ie het afgerond! Wat ie nu allemaal 
uitgespookt heeft met die vieze beestjes, al die jaren, kan je in dit boekje lezen. Jullie 
hebben altijd veel interesse getoond in mijn onderzoek. Dat kan ik erg waarderen. De 
afgelopen jaren heb ik veel energie kunnen halen uit de gezellige feestjes, etentjes, 
het stappen, honkballen bij DVS, de wintersport vakanties, etc, etc… Wat mij betreft 
houden we die tradities hoog! Ik blijf natuurlijk altijd een Brabander.
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Van de saxofoon, die ik 22 jaar geleden o.a. van jullie gekregen heb, geniet ik nog 
wekelijks. Verder stimuleerde jullie me om te gaan studeren. Het resultaat is dit 
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Rudolf (Rolf) Johan Boesten was born in Eindhoven on the 29th of June, 1977, 
in the Netherlands. He grew up in the beautiful village of Waalre. He graduated 
twice from high-school: the first  time in 1994 when he obtained his HAVO diploma 
and secondly when he graduated from VWO  in 1996 both at the Were Di College 
of Valkenswaard. In September of that same year he moved to Utrecht to start a 
study in Biology, at the University of Utrecht. During this study, the major subjects 
were animal behavior, developmental biology, cell biology, and microbiology. In the 
course of his traineeship at the Microbiology group of Prof. Jan Tommassen he has 
contributed to the understanding of the molecular mechanism of the Escherichia coli 
page shock protein (PSP) operon. Subsequently, during his second traineeship, at 
TNO Food & Nutrition in Zeist, he studied the gene-expression profiles of Aspergillus 
niger, while supervised by Dr. Frank H.J. Schuren. He concluded his MSc with a 
thesis on biofilm formation under the supervision of both Dr. Fank H.J. Schuren 
and Prof. Jan Tommassen. He formally graduated at the University of Utrecht on 
August 2002, just after he started his PhD at the Laboratory of Microbiology at 
Wageningen University, under supervision of Prof. Willem M. de Vos and Dr. Frank 
H.J. Schuren. His PhD-research was part of the IOP Genomics Project “A genomics 
approach towards gut health”, which was conducted at the Microbiology Department 
of TNO Quality of Life in Zeist. His scientific output with respect to this project is 
presented in this thesis. In 2008, he started his first post-doctorate at the CBS-
KNAW Fungal Biodiversity Centre in Utrecht, working on a project for improving 
molecular diagnostics of clinically important Candida yeasts.
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